Modulation of the human gut microbiome in  order to promote host health and well-being by Evans, James
 
 
 
 
 
 
  
Modulation of the human gut microbiome in  
order to promote host health  
and well-being 
Thesis presented for the Degree of Philosophiae Doctor 
By 
James Michael Evans, BSc (Hons) Microbiology 
In candidature for the Degree of Philosophiae Doctor 
Organisms and the Environment Division  
Cardiff School of Biosciences 
Cardiff University 
I 
 
DECLARATION 
 
 
This work has not previously been accepted in substance for any degree and is not concurrently 
submitted in candidature for any degree. 
 
Signed ………………………………………… (candidate)       Date ………………………… 
 
 
 
STATEMENT 1 
 
This thesis is being submitted in partial fulfillment of the requirements for the degree of PhD. 
 
Signed ………………………………………… (candidate)       Date ………………………… 
 
 
 
STATEMENT 2 
 
This thesis is the result of my own independent work/investigation, except where otherwise stated. 
Other sources are acknowledged by explicit references.   
 
Signed ………………………………………… (candidate)       Date ………………………… 
 
 
 
STATEMENT 3 
 
I hereby give consent for my thesis, if accepted, to be available for photocopying and for inter-library 
loan, and for the title and summary to be made available to outside organisations. 
 
Signed ………………………………………… (candidate)       Date ………………………… 
 
 
 
STATEMENT 4 
 
I hereby give consent for my thesis, if accepted, to be available for photocopying and for inter-library 
loans after expiry of a bar on access previously approved by the Graduate Development 
Committee.  
 
Signed ………………………………………… (candidate)       Date ………………………… 
 
 
 
 
II 
 
ACKNOWLEDGEMENTS 
 
 
I would like to extend my sincerest thanks to the following people for their help and support 
throughout my studies: 
 Dr. Julian Marchesi for his fantastic supervision, guidance and help with all matters over the 
past 3 years. 
 
 Prof. Eshwar Mahenthiralingam for his highly valuedinput into the project and help 
throughout my studies. 
 
 Dr. Sue Plummer and Dr. Iveta Garaiova from Cultech Ltd., my company partner for keeping 
me on my toes, their valued contribution to the project and help. 
 
 Dr. Jia Li, Imperial College London, for her patience, expertise and kindness while I carried 
out metabonomic analysis. 
 
 KESS and the EU for funding this studentship and to Cultech Ltd. for their partnership 
throughout my studies. 
 
 My work colleagues and friends , Dr. Laura Rushton, Dr. Matt Bull, Laura Morris and Beky 
Weiser for their friendship, advice and brilliant support during my studies. 
 
 My housemates and friends including Dr. Imran Howell, Darryl Shehan, Dan Wood, Vesa 
Kahilampi, Helbert Kholowa, Talal Nabulsi, Tom Greene, Patch Cheshire, Joe Shipcott, Ali Al-
Talib and Dwayne Keany for keeping me sane and for some pretty fun times. 
 
 My dad Michael, my mam Christine and my sister Becky for their love and continued support 
in particular during times of financial hardship. I will be forever grateful. 
 
 My girlfriend Sophie Morris for her love, help and ability to put up with me through some 
tough times of late. To the moon and back. 
 
III 
 
SCIENTIFIC CONFERENCES AND AWARDS 
 
 
Poster presentations 
 The Society for General Microbiology Spring conference 2012, Dublin, Ireland 
 The International Society for Microbial Ecology 2012, Copenhagen, Denmark 
 The Society for General Microbiology Spring conference 2013, Manchester, UK 
 Federation of European Microbiologists, Leipzig, Germany 
 
Oral presentations 
 MITREG, Postgraduate Research day, Cardiff, UK 
 KESS "Pecha Kucha" event 2011, awarded the winning presentation, Bangor, UK 
 
 
 
 
 
 
 
 
 
 
 
 
 
IV 
 
PUBLICATIONS 
 
 
Morris, L. S., Evans, J. and Marchesi, J. R. (2012). A robust plate assay for detection of extracellular 
microbial protease activity in metagenomic screens and pure cultures. Journal of Microbiological 
Methods 91:144-146. 
 
 
 
Evans, J. M., Morris, L. S. and Marchesi, J. R (2013). The gut microbiome: The role of a virtual organ 
in the endocrinology of the host. Journal of Endocrinology. 
V 
 
SUMMARY 
 
 
Background 
Numerous studies into the effect of probiotic supplementation in the infirm have been carried out. 
However, research into the effect of long-term probiotic supplementation in healthy individuals is 
lacking. With this in mind the PROHEMI study, a randomized, double-blinded, multi-centre and long-
term (6 months) probiotic feeding study in healthy males was designed and carried out. Through the 
use of varied culture dependent and independent techniques, the effects of long-term probiotic 
consumption were researched. In addition, a study into the effect of freezing faecal material on its 
bacterial composition was also carried out. 
 
 
Results 
Through a community fingerprinting technique and next generation sequencing it was shown that 
the distal gut bacterial community is unaffected by probiotic supplementation. Functional screening 
of faecal material showed a reduction in bacteria expressing protease activity when probiotic 
supplementation began. In addition, bacteria expressing β-galactosidase and β-glucuronidase 
activity increased during probiotic supplementation. Metabonomic analysis showed no difference in 
metabolite profiles attributable to probiotic supplementation. However, differences between the 
gut bacterial community, metabonomic profiles, and bacteria expressing functions were observed 
between the two study centres. Freezing of faecal material at -20°C detrimentally affected its 
bacterial composition between 2 weeks and 3 month storage time-points. Significant reductions in 
the abundance of the Bacteroidetes phylum observed following 6 months of storage at -20°C. 
 
 
Conclusions 
Long-term probiotic administration in healthy individuals did not seem to affect the distal gut 
bacterial community in these individuals and did not affect metabonomic profiles. However, some 
functions expressed by the resident distal gut bacterial community were significantly affected during 
probiotic supplementation. DNA extraction from faecal material should ideally be carried out from 
fresh samples. Failing this it is not recommended to store samples at -20°C for longer than 2 weeks 
prior to DNA extraction. 
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“Well, there we are then” 
Michael Evans 
CHAPTER 1 – INTRODUCTION 
20 
 
1 INTRODUCTION 
 
1.1 The human gut microbiome 
Human associated microbes referred to as our microbiome, have been extensively studied in 
recent years with a particular focus on bacteria. The Human Microbiome Project (HMP) 
(Turnbaugh et al. 2007) aims to fill in gaps of knowledge from the Human Genome Project. The 
cells, which make up our microbiome, significantly outnumber our own cells by a factor of 10 and 
in this sense we can consider ourselves more microbial than human. Through the significant 
increase in our gene pool, which is provided by these organisms, we can think of humans as 
super-organisms (Lederberg 2000). There is an intimate association between us and our co-
evolved microbiome. The human gut, with an approximate area of a tennis court, harbours most 
of our associated bacteria (Whitman et al. 1998) containing approximately 1014 bacterial cells 
(Ley et al. 2006a). The gut of new-born babies was initially thought to be sterile and becomes 
colonised at birth by bacteria from the mother’s vagina and environment. Succession of microbial 
consortia follows until a fairly uniform microbial community is established (Mändar and Mikelsaar 
1996; Palmer et al. 2007). However, in a more recent study it has been shown that the 
meconium, the first stool passed by new-born babies, is not sterile. It contains bacteria, fungi, 
viruses and Euryarcheota (Koenig et al. 2011). It has been argued by Koenig and co-workers that 
there are four steps in the development of an adult gut in infants. The first step is characterised 
by an abundance of the number of lactose/galactose metabolising genes due to breast milk 
feeding. The steps are separated by life events with events such as fever separating steps 1-2. 
The introduction of solids separates steps 2-3. Finally the commencement of an adult diet in 
conjunction with antibiotic therapy separates steps 3-4. By step 4 the gut microbiota and genes 
expressed resemble an adult gut. With regards to the adult gut, there is a general consensus that 
a core gut microbiome is shared amongst adults. Analysis of the distal microbial community of 3 
adults (43, 50 and 50 years old respectively) showed that the major phyla were the Firmicutes 
and Bacteroidetes (Eckburg et al. 2005). Other phyla such as the Proteobacteria and 
Actinobacteria were present at a lower abundance. While the abundance of phyla remained 
relatively uniform across the subjects, there were inter-person differences at lower taxonomic 
levels, showing that there is variation from person to person in terms of their distal gut 
community. In a more recent analysis of the distal gut community, Turnbaugh and colleagues 
strengthened the notion of inter-personal differences in the distal gut community of individuals 
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(Turnbaugh et al. 2009). However, it was suggested that a core microbiome is present but at the 
gene level rather than at a taxonomic level and gives rise to functional redundancy. In a short 
review Turnbaugh and Gordon suggest that changes to the core microbiome and specifically the 
genes expressed can give rise to obesity in individuals, as genes responsible for energy harvest 
may be more abundant in these individuals (Turnbaugh and Gordon 2009).  
 
1.1.1 The human gut microbiome in health 
Within the gut, services are provided by our microbiota such as vitamin B synthesis (Burkholder 
and McVeigh 1942), the importance of which may have been overlooked previously, as it has 
been shown that carrier mediated absorption of riboflavin occurs in the rat colon (Yuasa et al. 
2000). Our gut microbiota provides protection against pathogens (O'Hara and Shanahan 2006). 
This protection is further highlighted in a study showing that the human gut microbiota decreases 
Shiga toxin 2 (Stx2) production in entero-haemorrhagic Escherichia coli (EHEC) O157:H7 (de 
Sablet et al. 2009). The human gut microbiota also exert immunomodulatory effects (Round and 
Mazmanian 2009). The gut microbiome has been shown to play a pivotal role in intestinal 
homeostasis where it has been suggested that the intestinal microbiota is a selective regulator of 
nuclear receptors (Arulampalam et al. 2006). This regulation in turn gives rise to anti and pro-
inflammatory responses within the gut. The importance of the gut microbiota is now being 
understood in terms of its effect on our endocrine system. There is an increasing volume of 
research in this area and has recently been reviewed (Evans et al. 2013). For instance, the gut 
produces a high level of dopamine and norepinephrine. Murine models show that this occurs 
through the cleavage of their conjugated inactive forms by bacterial β-glucuronidases in the gut 
lumen (Asano et al. 2012). The concept of gut commensals and pathogens driving the correct 
development of the immune system has been researched for some years, especially since the 
advent of the "hygiene hypothesis" concept (Strachan 1989, 2000). However, it has been shown 
in a more recent study that correct intestinal immune system maturation occurs through host 
specific gut commensal microbes and not just any gut commensal (Chung et al. 2012). This was 
shown through the use of germ-free (GF) mice, mouse specific microbiota and human specific 
microbiota. Colonisation of the GF mouse with human specific microbiota resulted in an 
immature intestinal immune system. The human microbiota associated GF mice showed lower 
levels of T-lymphocytes and lower levels of dendritic cells in the small intestine. Furthermore, 
when challenged with Salmonella typhimurium Serovar Typhimurium the human microbiota 
offered the GF mice worse protection than the mouse specific microbiota. Higher loads of the 
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pathogen were observed four days post-infection. There was a highly significant (p<0.001) 
increase in the level of pathogen translocation to the spleen and inflammation of the cecal wall 
observed in the human microbiota GF mice. This research highlights the role that a host's closely 
evolved gut microbiota has upon the development of its own immune system. The gut microbiota 
also drives the development of the gut as an organ. It has been shown that transplantation of a 
normal murine cecal microbiota into GF mice drives vascular remodelling in the small intestine 
(Reinhardt et al. 2012). The authors highlight a novel mechanism whereby the colonisation drives 
an increase in the localisation of tissue factor TF. This localisation in turn leads to coagulation 
cascade activation and leads to vascular remodelling through angiopoietin-1 (Ang-1). Remodelling 
is achieved through a series of steps which involve the phosphorylation of the cytoplasmic 
domain of TF by protease-activated receptor 1 (PAR1). Changes in the morphology of the gut 
have also been observed in GF pigs, where it was observed that GF and mono-associated pig guts 
had long villi and shorter crypts than conventionally raised pigs (Shirkey et al. 2006). Germ free 
animals also exhibit smaller Payer's patches, a decrease in the amount of lamina propria and the 
development of a mega caecum in gnotobiotic rodents (Thompson and Trexler 1971). We should 
therefore think of our gut microbiota as completely necessary for the development of healthy gut 
morphology and function therein.  
1.1.2 The human gut microbiome in disease  
Many studies have highlighted the associated perturbation of the host gut microbiome following 
antibiotic therapy in both mice (Antonopoulos et al. 2009; Sekirov et al. 2008) and in humans 
(Dethlefsen et al. 2008; Jernberg et al. 2007). These perturbations can give rise to complications 
such as antibiotic associated diarrhoea (AAD) (Wiström et al. 2001) and pseudomembranous 
colitis due to overgrowth of Clostridium difficile. Both arise as a result of decreased competition 
(Bartlett et al. 1978; Wiström et al. 2001). Perturbations of the gut microbiome have been linked 
to an increased susceptibility of enteric infections in mice (Sekirov et al. 2008). The gut 
microbiota in many instances has been implicated in the progression of complex disorders within 
the human body including type II diabetes (Larsen et al. 2010; Qin et al. 2012) and controversially 
in both obesity (Ley et al. 2006b; Schwiertz et al. 2009) and autism (Finegold 2008; Sandler et al. 
2000; Song et al. 2004). With regards to obesity, it has been suggested that the gut microbiota of 
some individuals is more adept at extracting energy from food sources (Bäckhed et al. 2004) and 
this contributes to the progression of the disease. Furthermore, it has been shown that the gut 
bacterial community of obese mice is different to those who are not, with a reduction in the ratio 
of Bacteroidetes to Firmicutes, the two major bacteria phyla present in the human gut (Ley et al. 
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2005). However, more recent research, in humans, challenges this observation. Duncan and 
colleagues (Duncan et al. 2008) have shown no significant difference in the percentage of 
Bacteroidetes in obese and non-obese individuals (27.2% vs. 21.9% respectively, p=0.084). It must 
be noted however, that the measure used, body mass index (BMI), does not solely take into 
account body fat percentage. Another study has shown that GF mice also developed obesity 
while on a high fat diet (Fleissner et al. 2010). This confusion highlights the need for further 
research into the effect of the human microbiome in health and disease. 
 
1.2 Methods implemented in order to analyse the gut microbiota 
composition and functions 
In order to analyse the gut microbiota and its functions a whole suite of techniques and methods 
are needed. Initially many of the techniques used to analyse any ecosystem were culture 
dependent. Researchers became aware of the caveats associated with using these techniques 
with the coining of the "great plate count anomaly" (Staley and Konopka 1985). With regards to 
the gut microbiome itself, there was already concern around the issue of biased culture 
dependent methods prior to Staley and Konopka. There was a particular focus on the effect of 
the culturing methods implemented at the time on the recovery of anaerobic bacteria from the 
human gut (Hughes 1972). There have been significant advances in the molecular field of biology. 
These advances include the advent of the polymerase chain reaction (PCR) (Saiki et al. 1985) and 
Sanger sequencing (Sanger et al. 1977). This was followed by next generation sequencing (NGS) 
through pyrosequencing (Margulies et al. 2005) and now through the use of protons (Rothberg et 
al. 2011). There has also been an increase in the understanding of the underlying biology of 
microorganisms. An example of this is the use of ribosomal RNA (rRNA) genes as molecular 
chronographs (Woese et al. 1990), that is to say the use of these genes to provide an account of 
the evolutionary history of bacteria. The advancement in technical expertise and knowledge has 
led to a culture independent revolution in biology.  
 
1.2.1 The use of culture dependent methods in order to analyse the gut microbiota 
and functions 
While culture dependent methods have their drawbacks, they still provide a useful set of tools in 
order to interrogate the gut microbiota and the functions provided therein. It is sometimes 
advantageous or of interest to select for specific groups of bacteria. This can be achieved through 
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the use of selective media such as the use of de Man, Rogosa and Sharpe (MRS) agar for the 
selection of Lactobacilli (De Man et al. 1960). MRS agar has been used in order to recover 
Lactobacillus rhamnosus from human colonic biopsy samples (Alander et al. 1997). Specific media 
formulations also allow for functional screening of the gut microbiota such as cholesterol 
degraders and bile salt hydrolase (BSH) tolerant organisms (Pereira and Gibson 2002). Culture 
dependent methods can also be used in order to test for the genotoxicity of faecal water, that is 
to say the ability of faecal water to induce DNA damage. The genotoxicity of faecal water can be 
measured through the incubation of faecal water with a test organism (Venitt and Bosworth 
1986). 
1.2.2 The use of culture independent methods in order to analyse the gut microbiota 
and functions 
1.2.2.1 The use of 16S rRNA as a target in bacterial communities 
The use of the 16S rRNA as a target for phylogenetic analysis was pioneered by Carl Woese and 
was used, amongst other rRNA targets, in his construction of the three domains of life, namely 
the Bacteria, Archaea and Eucarya (Woese et al. 1990). The 16S rRNA genes are still a target for 
many molecular microbiologists today. The reasons for their use have been previously discussed 
(Janda and Abbott 2007). 16S rRNA genes are essential housekeeping genes and are therefore 
ubiquitous amongst bacteria. The genes according to Janda and colleagues are also big enough 
for informatics use. Following the elucidation of its secondary structure in 1980 (Woese et al. 
1980) it was determined that there are conserved and hypervariable regions, V1-V9. Through 
designing various PCR primers these variable regions, with flanking conserved regions can be 
targeted and phylogenetic information can be gleaned (Chakravorty et al. 2007). Due to the 
variable nature of these regions it can be difficult to design primers which can target all bacteria 
equally. This problem has been recently discussed (Pinto and Raskin 2012) where biases in mutli-
template 16S rRNA PCR affected the relative numbers of bacteria detected through 
pyrosequencing. This is of particular concern as many researchers focus on the relative 
abundance of specific bacterial taxa whilst analysing their datasets. 
1.2.2.2 Community profiling of faecal DNA 
Community profiling of the gut microbiota can be carried out using denaturing gradient gel 
electrophoresis (DGGE) of the 16S rRNA genes obtained from faecal DNA (Simpson et al. 2000), 
terminal fragment length polymorphism (t-RFLP) analysis of faecal DNA (Dicksved et al. 2007) or 
length heterogeneity PCR (LHPCR) of 16S rRNA genes obtained from faecal DNA (Bjerketorp et al. 
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2008). These methods are relatively high-throughput and inexpensive to carry out and are 
appropriate for use in the PROHEMI study, due to their previous published use with faecal DNA. 
With regards to DGGE and LHPCR the primers used in order to amplify the 16S rRNA and the 
products generated are different and this arises from how the products are treated. In their 
analysis Simpson and colleagues (Simpson et al. 2000) used ~200 bp products to run on 
denaturing gradient gels for their DGGE analysis. In contrast, LHPCR utilises a labelled forward 
primer and the use of a capillary sequencer in order to determine the length of fragments 
generated. The primers used are also varied with some researchers generating ~350 bp 
(Bjerketorp et al. 2008) LHPCR products and others generating ~530 bp products (Eusebio et al. 
2011). 
1.2.2.3 NGS and metagenomics in order to determine bacterial community structure and 
functions 
However, recently more emphasis is being placed upon characterisation of complex 
communities, such as the gut microbiome, through NGS. This is due to its high throughput 
nature, vast reduction in cost and volume of information generated. Technologies, such as 454 
pyrosequencing, have been applied to the gut microbiome. NGS of amplified 16S rRNA genes 
from faecal DNA were used in order to assess the composition of the core gut microbiome in 
obese and lean twins (Turnbaugh et al. 2009). NGS technologies are constantly evolving. The use 
of new sequencing platforms such as the Illumina HiSeq and MiSeq have been successfully 
applied to sequence 16S rRNA genes obtained from DNA from a range of sources. These sources 
include the soil, mouth, skin and more importantly human faecal material (Caporaso et al. 2012). 
It is also possible to predict the functions, such as butyrate synthesis or methanogenesis, present 
in a community from sequenced 16S rRNA genes. This information, obtained from the community 
in question, can be analysed using software called PICRUSt (Langille et al. 2013). The software 
utilises databases such as the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway 
database to assign functions for a given 16S rRNA gene sequence. Through this the functions 
present within the community as a whole may be inferred. While this software infers functions 
within communities it is possible to interrogate the functions present within a community 
through metagenomics and metatranscriptomics. Metagenomic approaches have been 
successfully applied to the human gut through the NGS of a metagenomic library. Libraries are 
constructed from human faecal DNA (Qin et al. 2010) and provide a wealth of information on the 
genes present within the community. However, metagenomic libraries generated from DNA do 
not tell us whether the genes are actually expressed within the community under investigation. It 
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is also possible to combine culture independent and dependent approaches in order to answer 
questions about the community we are analysing. This can be achieved through functional 
metagenomics. Metagenomic libraries are created in a host organism such as Escherichia coli or 
Bacillus subtilis. Then screening for a function of interest, for example the screening of protease 
activity (Morris et al. 2012), from a metagenomic library can be carried out. However, 
metagenomic screening does have its drawbacks, such as problems with expression of the gene 
of interest (de Lorenzo 2005). 
1.3 Probiotic supplementation 
The definition of a probiotic has long been disputed with Schrezenmeir and de Vrese arguing for 
the adoption of the following definition: "a preparation of or a product containing viable, defined 
microorganisms in sufficient numbers, which alter the microflora (by implantation or 
colonisation) in a compartment of the host and by that exert beneficial health effects in this host" 
(Schrezenmeir and de Vrese 2001). This wholly encompassing definition has since been simplified 
by the World Health Organisation (WHO) and is generally regarded as the definition of a probiotic 
where probiotics are defined as "live microorganisms which when administered in adequate 
amounts confer a health benefit on the host" (WHO 2002). The probiotic market itself is rather 
lucrative with an estimated market share of $24.23 billion in 2011 (Markets and Markets 2013). 
Much of the revenue generated is due to the health claims which surround these products. These 
health claims are now coming under scrutiny by bodies such as the European Food Safety 
Authority (EFSA). In order to ensure that consumers were not falling prey to smart marketing, 
where there was little or no evidence of a health benefit from a specific probiotic preparation, 
health claims were submitted to the EFSA. These health claims were then reviewed by a panel. Of 
143 health claims submitted for probiotic products none were found to be substantiated by the 
EFSA (Guarner et al. 2011). While protecting consumers from unsubstantiated health claims the 
authors expressed concern that products which did have scientific proof of efficacy were being 
rejected due to too stringent guidelines. In Japan the Labelling Regulation for Foods for Specified 
Health Use (FOSHU) decree has been passed. Industrial producers of probiotic products can 
voluntarily submit evidence of health benefits in order to advertise their claims on the products' 
labels (Rousseaux et al. 2007). 
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Probiotic supplementation has been and is being researched in healthy people and in the infirm. 
Although logic would drive us to assume that research is being directed at their effects solely 
within the gastro-intestinal tract (GIT) this is not the case. It is becoming increasingly apparent 
that the gut microbiota extends an influence on the host far beyond its niche; positively and 
negatively affecting host health and well-being (Sekirov 2010) (Fig. 1.1). All probiotic organisms 
destined for human consumption have been isolated from humans and re-administered. The 
majority of probiotic organisms used are bacteria, including members of the lactic acid bacteria 
(LAB) family such as Lactobacillus acidophilus, Actinobacteria such as Bifidobacterium breve, even 
the archetypical gut commensal E. coli. However, the yeast Saccharomyces boulardii has also 
been used. The choice of probiotic organism used is often driven by cultural and geographical 
reasons. For example, the use of a Weisella strain after isolation from fermented foods in Nigeria. 
LAB strains have also been used due to their isolation from fermented milk in Africa and 
Mongolia and after isolation from the fermented yak milk derived Kurut in China (Fontana et al. 
2013). The safety of a probiotic organism is of utmost concern as these are usually fed at high 
numbers and in many instances to those who are unwell. There has been some concern 
surrounding the use of Lactobacillus rhamnosus GG especially in the infirm, as cases of 
bacteraemia have been reported. In an infant that received heart surgery, broad spectrum 
antibiotics were administered. Upon development of diarrhoea supplementation with L. 
rhamnosus GG (1 x 1010 cells per day) was carried out. This patient developed fever, an increase 
in leukocytes and was blood culture positive for Lactobacillus. Probiotic treatment was halted 
and the patient showed improvement in the 48 to 72 hours following cessation of probiotic 
treatment (Land et al. 2005). The authors also highlighted another case where a 6 year old 
presenting with a urinary tract infection was treated with many courses of antibiotics and 
received L. rhamnosus GG (1 x 1010 cells per day). This was in an effort to combat her perceived 
antibiotic associated diarrhoea. The girl showed symptoms of fever and was blood culture 
positive for Lactobacillus; probiotic treatment was halted and intravenous administration of 
ampicillin was introduced for 10 days. The patient showed no symptoms of fever after 4 days of 
antibiotic treatment and was culture negative for Lactobacillus. Bacteraemia was also seen in two 
patients with short gut syndrome. Blood cultures from these patients tested positive for 
Lactobacillus following treatment with L. rhamnosus GG (Kunz et al. 2004) Lactobacillus 
bacteraemia was also observed in a paediatric ulcerative colitis (UC) patient (Vahabnezhad et al. 
2013). 
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The probiotic yeast Saccharomyces boulardii has also been implicated in fungemia. Four cases of 
this were observed in vascular catheterised patients. It was thought that the opening of packets 
containing the probiotic contaminated the catheters, which in turn acted as a source for the 
fungemia (Hennequin et al. 2000). Fungemia caused by S. boulardii supplementation was also 
seen in seven critically ill patients, 3 of whom were immunocompromised. All patients had 
central venous catheters and all patients were undergoing broad spectrum antibiotic therapy 
(Lherm et al. 2002). The probiotic was administered in an effort to reduce antibiotic associated 
diarrhoea, but instead was linked with fungemia with the exact mechanism unknown. However, 
the authors suggest that central venous catheter contamination may have occurred, in the same 
manner as previously described by Hennequin and colleagues. It has also been suggested that 
overgrowth due to broad spectrum antibiotic therapy, especially in the immunocompromised, 
was another mechanism for the development of the fungemia. In all of the aforementioned cases 
the patients had underlying health problems. It is therefore imperative that the safety testing of a 
specific probiotic strain is carried out prior to mass administration in these ill patients. 
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Figure 1.1| The impact of the gut microbiota on the gut and beyond – the figure has been adapted from (Sekirov 2010) and (Culligan et al. 2012). 
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1.3.1 The use of probiotic supplements in unhealthy individuals 
The literature on the use of probiotic supplementation is growing. There are studies providing 
evidence for symptom and disease management in the infirm. Equally studies show little to no 
effect in some instances. 
Many studies focus on the use of probiotic supplements as treatments or adjuvants to current 
therapies for disorders of the GIT, which is unsurprising due to its microbial load. The positive 
effects of some probiotic species are shown (Table 1.1-1.3) and have been discussed. 
There is an abundance of research showing the positive effects that probiotic supplementation 
can exhibit in the infirm. However, there are also studies which show that supplementation 
exerts no benefits, and in extreme cases can cause worsening of the disease (Table 1.4 and 1.5).  
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Table 1.1| The positive effects of probiotic supplementation in the infirm 
*marks a significant effect (p<0.05) when compared with the placebo group 
 
Ailment Probiotic preparation Dose Period of intervention Effect Reference 
IBS 
B. infantis 35624 
 
 
B. breve Bb99, L. 
rhamnosus GG, L 
rhamnosus LC705 and P. 
freudenreichii ssp. 
Shermanii JS 
1 x 1010/day 
 
1 x 108 CFU/mL 
 
 
 
 
 
8-9 CFU/day 
8 weeks 
 
4 weeks 
 
 
 
 
 
6 months 
Normalisation of IL-10 levels 
 
Reduction in pain and scores 
for bloating, bowel 
dysfunction, incomplete 
evacuation, straining and 
passage of gas 
 
Reduction in symptom score* 
{O'Mahony, 2005 #540 
} 
(Whorwell et al. 2006) 
 
 
 
 
 
(Kajander et al. 2005) 
IBD 
B. longum + FOS + Inulin 
 
S. boulardii 
 
 
E. coli Nissle 1917 
2 x 1011 viable cells + 6 g 
twice daily 
 
250 mg probiotic 
capsule alongside 1 g 
mesalazine treatment 
three times daily 
200 mg capsule 
4 weeks 
 
 
4 weeks 
 
 
12 months 
Reduction in TNF-α and IL-
1α* 
 
Clinical remission 
Reduction in clinical score 
index* 
Probiotic maintained 
remission as effective as 
mesalazine treatment 
(Furrie et al. 2005) 
 
 
(Guslandi et al. 2003) 
 
 
(Kruis et al. 2004) 
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Table 1.2| Continued from Table 1. 1 
*marks a significant effect (p<0.05) and ** marks a highly significant effect when compared with the placebo group 
 
Ailment Probiotic preparation Dose Period of intervention Effect Reference 
Pouchitis VSL#3 9 x 1011CFU/day 1 year 
Lower occurrence * 
 
Maintenance of antibiotic 
induced remission** 
(Gionchetti et al. 2003) 
 
(Mimura et al. 2004) 
AAD 
L. casei, L. bulgaricus and S. 
thermophilus 
 
VSL#3 
1 x 108, 1 x 107 and 1 x 
108 CFU/ml respectively 
twice daily 
 
90 x 1010/day 
During one week of 
antibiotic therapy and one 
week after 
During the course of 
antibiotic therapy and one 
week after 
 
Reduced incidence* 
 
 
Reduced incidence* 
 
(Hickson et al. 2007) 
 
 
(Selinger et al. 2013) 
CDAD 
L. casei, L. bulgaricus and S. 
thermophilus 
1 x 108, 1 x 107 and 1 x 
108 CFU/ml respectively 
twice daily 
During one week of 
antibiotic therapy and one 
week after 
Reduced incidence* (Hickson et al. 2007) 
Liver 
transplant 
P. pentosaceus, Leu. 
paracasei, L. paracasei and 
L. plantarum , betaglucan, 
inulin, pectin and resistant 
starch 
1 x 1010 viable cells with 
2.5 g each of 
betaglucan, inulin , 
pectin and resistant 
starch twice daily 
Started on the day of liver 
transplant and continued for 
14 days after 
Shorter period of antibiotic 
therapy required 
Reduced incidence of 
bacterial infections* 
(Rayes et al. 2005) 
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Table 1.3| Continued from Table 1. 1 
*marks a significant effect (p<0.05) when compared with the placebo group 
 
Ailment Probiotic preparation Dose Period of intervention Effect Reference 
NEC 
L. acidophilus and B. 
infantis 
 
B. infantis, S. thermophilus 
and B. bifidus 
25 mg/kg dose twice 
daily 
 
0.35 x 109 CFU/day 
 
 
Until discharged 
 
Continued until VLBW 
infants reached 36 weeks 
post-conceptual age 
 
Reduced incidence* 
 
Reduced incidence* 
Reduced incidence of 
clinically significant NEC 
 
(Lin et al. 2005) 
 
 
(Bin-Nun et al. 2005) 
AE 
 
L. rhamnosus and L. reuteri 
 
L. rhamnosus GG, L. 
rhamnosus LC705, B. breve 
Bb99 and P. freudenreichii 
ssp, shermanii JS + galacto-
oligosaccharides in new-
borns 
 
 
1 x 1010CFU twice daily 
 
5 x 109, 5 x 109, 2 x 108 
and 2 x 109 CFU 
respectively twice daily. 
New-borns also 
received 0.8 g galacto-
oligosaccharides 
 
6 weeks 
 
 
Given to mother's at 35 
weeks of gestational age and 
continued in new-borns for 6 
months 
 
Reduced severity* 
 
 
 
Reduced incidence 
 
(Rosenfeldt et al. 2003) 
 
 
 
(Kukkonen et al. 2007) 
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Table 1.4| The negative and no effects of probiotic supplementation in the infirm 
†when compared with the placebo group 
* marks a significant effect (p<0.05) when compared with the placebo group 
 
Ailment Probiotic 
preparation 
Dose Period of intervention Effect Reference 
Pancreatitis 
L. casei, L. 
salivarius, L. 
lactis, B. 
bifidum, B. 
lactis 
1 x 1010 bacteria/day Maximum of 28 days 
No significant difference in 
primary end-point†. 
More deaths*. 
Increase incidence of bowel 
ischemia*. 
(Besselink et al. 2008) 
IBS VSL#3 9 x 1011 bacteria/day 8 weeks 
No significant difference in 
GIT transit time, relief of 
symptoms, stool frequency, 
consistency or ease of 
passage† 
(Kim et al. 2003) 
IBD 
L. rhamnosus 
GG 
 
L. johnsonii LA1 
1 x 109 CFU twice daily 
 
1 x 109 CFU twice daily 
 
6 months following antibiotic 
induced remission 
 
6 months 
No significant difference in 
antibiotic induced CD 
remission† 
No significant difference in 
recurrence rates† 
(Schultz et al. 2004) 
 
(Marteau et al. 2006) 
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Table 1.5| Continued from Table 2. 1 
†when compared with the placebo group 
* marks a significant effect (p<0.05) when compared with the placebo group 
 
Ailment Probiotic preparation Dose Period of intervention Effect Reference 
Pouchitis L. rhamnosus GG 
0.5-1.0 x 1010 CFU four 
times daily 
3 months 
No significant difference in 
PDAI scores† 
(Kuisma et al. 2003) 
AE 
 
L. acidophilus LAVRI-A1 
 
 
 
 
 
 
 
 
L. rhamnosus GG 
 
3 x 109 bacteria/day 
 
 
 
 
 
 
 
 
5 x 109 CFU twice daily 
 
6 months 
 
 
 
 
 
 
 
4-6 weeks before expected 
birth and 6 months following 
birth 
 
No significant difference in 
rate of AE†. 
Increased rate of sensitisation 
to allergens*. 
 
No significant difference in 
episodes of fever, airway 
infections, IgE levels nor 
sensitisation to inhalant 
allergens†. 
Increased frequency of 
recurrent wheezing 
bronchitis*. 
 
(Taylor et al. 2007) 
 
 
 
 
 
 
 
 
 
(Kopp et al. 2008) 
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1.3.1.1 The positive effects of probiotic supplementation in irritable bowel syndrome 
Irritable bowel syndrome (IBS), "comprises a group of functional bowel disorders in which 
abdominal discomfort or pain is associated with defecation or a change in bowel habit, and with 
features of disordered defecation," (Thompson et al. 1999). IBS is thought to affect around 10-
20% of adults and adolescents worldwide (Longstreth et al. 2006). The exact cause of IBS is 
unknown and is thought to be multi-factorial with genetic factors, motor dysfunction of the GIT, 
visceral hypersensitivity, infection, inflammation, immunity as well as psychopathological factors 
playing roles (Quigley 2003). While most therapies are aimed at reducing patient discomfort, 
studies are now researching the impact of probiotic supplementation as treatment for the 
syndrome. The rationales behind their use are the potential of probiotic organisms to produce 
antibacterial compounds such as bacteriocins (Corr et al. 2007), exertion of immunomodulatory 
effects, improvement of epithelial function and reduction of gut leakiness through tight junction 
strengthening (Corr et al. 2009). The efficacy of Bifidobacterium infantis 35624 and Lactobacillus 
salivarius UCC4331 in the treatment of IBS have been compared (O'Mahony et al. 2005). IBS 
sufferers consumed a daily malted drink containing either 1 x 1010 viable cells of B. infantis or L. 
salivarius for an 8 week period; the malted milk drink alone served as a placebo. Symptom scores 
were taken for each patient throughout the study with B. infantis showing the greatest 
therapeutic response. Measurements of cytokine release from peripheral blood mononuclear 
cells were also taken. The authors studied the ratio of Interleukin (IL)-10 to IL-12 in IBS sufferers 
(n=69±15) and healthy volunteers (n=176±31); the ratio of IL-10 to IL-12 significantly differed 
between the two groups (p=0.003). IBS sufferers had lower levels of IL-10 which, according to the 
authors, suggests a T helper cell type 1 (Th1) proinflammatory state. However, supplementation 
with B. infantis normalised IL-10 levels with pre-feeding and feeding IL-10 levels differing 
significantly (p=0.001). This suggests that B. infantis 35624 can exert anti-inflammatory effects 
through increasing IL-10 levels in IBS patients. Daily supplementation of B. infantis 35624 at 1 x 
108 colony forming units (CFU)/mL also alleviated IBS symptoms in women when compared to a 
placebo taking group (Whorwell et al. 2006). Single strains, such as B. infantis 35624 are not the 
only probiotic preparations which have been studied for their effects on IBS sufferers. The mixed 
preparation containing 8-9 x 109 CFU/day of B. breve Bb99, L. rhamnosus GG, L. rhamnosus LC705 
and Propionibacterium freudenreichii ssp. shermanii JS in equal amounts was taken daily by IBS 
sufferers (n=52). Sufferers were compared to a placebo group (n=51) in a 6 month trial (Kajander 
et al. 2005). The probiotic supplemented group saw a significant total symptom score reduction 
(p=0.037) when compared to the placebo group. It is difficult to assign specific reasons as to why 
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probiotic organisms alleviate IBS symptoms; we may be seeing a multifactorial response in a 
multifactorial syndrome. 
 
1.3.1.2 The positive effects of probiotic supplementation inflammatory bowel disease 
Inflammatory bowel disease (IBD) is caused by the ongoing activation of mucosal immune 
responses by our normal commensal gut microbiota at an inappropriate level. It is driven by 
impaired barrier function at the intestinal mucosal surface and over-reaction of its associated 
immune system (Podolsky 2002). It has been argued that two disease states exist: UC and Crohn's 
disease (CD). However, Podolsky highlights that confusion remains in the literature, are these two 
separate disease states or do these diseases exist on a continuum (Podolsky 2002)? It has been 
argued that genetic factors play a crucial role in the manifestation and progression of IBD e.g. IL-
33 (part of the IL-1 family) and Interleukin receptor like 1 (ILRL1) polymorphism (Latiano et al. 
2013). Environmental factors such as diet and hygiene have also been implicated (Ng et al. 2013). 
Treatment of these diseases has historically centred on the use of corticosteroids. More recently 
inhibitors of specific pro-inflammatory factors within the human body, such as the use of 
infliximab a monoclonal antibody which binds tumour necrosis factor α (TNF-α), have been used 
(Rutgeerts et al. 2004). Surgical intervention is sometimes required in extreme cases. Due to the 
proposed commensal driven dysregulation of immune responses at the gut epithelial surface, it 
follows that modulation of this community could provide an alternative therapy for IBD. 
Probiotics have once again been used for this purpose with studies determining their effect in IBD 
patients alongside prebiotic supplementation. Prebiotics ,as defined by Gibson and colleagues 
(Gibson and Roberfroid 1995), are “nondigestible road ingredients that beneficially affect the 
host by selectively stimulating the growth and/or activity of one or a limited number of bacterial 
species already resident in the colon”. The synbiotic (probiotic and prebiotic) mixture of B. 
longum, at a concentration of 2 x 1011 viable cells, and a 6 g sachet of the prebiotics fructo-
oligosaccharides (FOS) and inulin were fed to active UC patients twice daily for four weeks and 
compared to a placebo group (Furrie et al. 2005). The synbiotic group saw a significant reduction 
in the levels of pro-inflammatory TNF-α (p=0.0177) and IL-1α (p=0.0051). This shows the possible 
anti-inflammatory effects exerted by the probiotic/prebiotic synergistic mixture. 
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The probiotic yeast S. boulardii has also been assessed as a treatment for UC. In one study a 250 
mg capsule of the organism was fed 3 times daily alongside standard anti-inflammatory 
mesalazine treatment (1 g, 3 times daily) for 4 weeks. The results showed clinical remission in all 
cases, as confirmed through sigmoidoscopy, a surgical procedure involving inspecting the bowels 
with a sigmoidoscope. The disease, as with many other diseases, is measured through a clinical 
index score, whereby symptoms are measured in terms of severity and are scored. Combinatorial 
UC therapy with mesalazine and S. boulardii also gave rise to a significant reduction in clinical 
index score (p<0.05) and a deemed successful clinical index score of 5 or less in 68% of cases 
(Guslandi et al. 2003). The study used a probiotic organism in conjunction with traditional 
therapy. However, it has been shown that once UC remission has been achieved E. coli Nissle 
1917 alone is as effective as mesalazine in maintaining remission (Kruis et al. 2004). The probiotic 
group (n=110) and mesalazine placebo group (n=112) showed significant equivalence (p=0.003) in 
patient relapse, 36.4% and 33.9% respectively. Probiotic supplementation has also been used in 
order to treat CD. Active CD patients who failed to reach remission through standard treatment 
were fed a synbiotic mixture of B. breve (3 x 1010 CFU), Lactobacillus casei (3 x 1010 CFU), B. 
longum (1.5 x 1010 CFU) daily in conjunction with 3 daily 3.3 g doses of the prebiotic plant 
psyllium. Crohn's disease activity index (CDAI) scores for these patients were significantly lower 
after therapy (p=0.009) (Fujimori et al. 2007). 
 
The aetiology and development of IBD makes researching how probiotic supplementation 
alleviates this condition difficult. It has been suggested that probiotics exert anti-inflammatory 
effects, and through this drives alleviation of symptoms. Furthermore, a mechanism for how 
these anti-inflammatory effects arise has been suggested. Fernandez and colleagues propose that 
the cell-wall components of probiotic bacteria exert anti-inflammatory effects. Specifically 
muropeptides, arising during the degradation of peptidoglycan, interact with nucleotide-binding 
oligomerisation domain 2 (NOD2) in the cytosol of the host through a specific NOD2 ligand. This is 
associated with a significant down-regulation of pro-inflammatory genes (Macho Fernandez et al. 
2011). The authors also suggest that probiotic bacteria and cell-wall components can be 
internalised through phagocytosis. Internalised cell wall components interact with toll-like 
receptors (TLR) and recruit myeloid differentiation primary response 88 (MyD88) giving rise to 
anti-inflammatory responses. This interaction was highlighted in MyD88 deficient mice where 
peptidoglycan lost the ability to protect against colitis.  
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1.3.1.3 The positive effects of probiotic supplementation in pouchitis 
UC cases can become severe, requiring surgical intervention in the form of a colectomy. Since 
1977 postcolectomy ileal pouch-anal anastomosis has been routinely carried out, in an attempt 
to restore function lost through colectomy (McGuire et al. 2007). Inflammation events can occur 
within the ileal pouch reservoir giving rise to pouchitis. Traditional therapy makes use of anti-
inflammatory compounds. However, there has been much focus on the use of probiotic 
organisms as an alternative treatment and preventative of pouchitis. The multi-species (B. breve, 
B. longum, B. infantis, L. acidophilus, L. plantarum, L. paracasei, L. delbrueckii ssp. bulgaricus (L. 
bulgaricus) and Streptococcus thermophilus at 9 x 1011 viable cells/day) probiotic VSL#3 has been 
researched in this respect. Following ileal pouch-anal anastomosis patients either received the 
probiotic mixture (n=20) or a placebo (n=20) for one year. The number of acute episodes of 
pouchitis was lower in the probiotic group than the placebo group, 10% and 40% respectively. 
There was also an observable difference in the number of relapses with 90% of the probiotic 
group still in remission one year later compared to 60% of patients in the placebo group 
(Gionchetti et al. 2003). In a follow-up study the number of patients in antibiotic induced 
remission, after one year, was significantly higher in the VSL#3 group than the placebo group 
(85% vs. 6% respectively, p<0.0001) (Mimura et al. 2004). 
 
1.3.1.4 The positive effects of probiotic supplementation in antibiotic associated diarrhoea, 
Clostridium difficile associated diarrhoea and bacterial infections following operative 
procedures 
Treatment of bacterial infections often leads to the unwanted side-effect of antibiotic associated 
diarrhoea (AAD). This arises from the perturbation caused by consumption of a broad range 
antibiotic. In turn this leads to diarrhoea, as the commensal gut bacteria are affected. The 
incidence of antibiotic diarrhoea is estimated at 5-39%; lengthening hospital stays and therefore, 
increases costs (Videlock and Cremonini 2012). AAD should not be confused with Clostridium 
difficile associated diarrhoea (CDAD). In this instance administration of a broad spectrum 
antibiotic allows the overgrowth of C. difficile due to reduction of competing gut commensal 
bacteria. CDAD cases have increased each year since 2000 in North American and European 
hospitals (Balassiano et al. 2012). C. difficile infection can give rise to a range of disease states 
from CDAD through to pseudomembranous colitis and toxic megacolon (Balassiano et al. 2012). 
The two latter diseases have the potential to be life threatening. The twice daily consumption of 
a probiotic drink containing L. casei (1 x 108 CFU/mL), L. bulgaricus (1 x 107 CFU/mL) and S. 
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thermophilus (1 x 108 CFU/mL) throughout a week's course of antibiotics, and for one week after 
course completion, has been shown to decrease the incidence of AAD and CDAD (Hickson et al. 
2007). The probiotic group (n=57) showed significantly less cases of AAD than the placebo group 
(n=56), 12% vs. 34% respectively (p=0.007). There was an absolute risk reduction of 22% by 
taking the probiotic mixture. This study also showed a significant reduction in the incidence of 
CDAD (p=0.001) with no cases in the probiotic group and 9 cases in the placebo group. AAD 
incidence has also been shown to decrease upon twice daily administration of the previously 
described probiotic mixture VSL#3 during antibiotic therapy, and a week thereafter (Selinger et 
al. 2013). Per-protocol analysis showed a significant reduction of AAD incidence in the probiotic 
taking group, 0 cases vs. 7 cases in the placebo group (p=0.006). Meta-analysis of the literature 
has also shown that the feeding of probiotics can reduce the relative risk of AAD. Mcfarland has 
shown that out of 25 clinical trials probiotic supplementation significantly reduced the relative 
risk (RR) of AAD (RR = 0.43, p<0.001). The research highlighted a significant reduction in the 
incidence of AAD in 13 trials (52%) when probiotic supplements were administered (McFarland 
2006). However, the remaining 12 trials (48%) showed no difference between the probiotic and 
placebo groups. The author suggests that the ambiguity surrounding the efficacy of probiotic 
supplementation in reducing AAD incidence could be due to many factors. These include the 
range of demographics enrolled in different studies, the probiotic used (species, mixture of two 
or a synbiotic mixture) and also the dose used. It is interesting to note that a high dose of 
probiotic (≥1010 cells/day) exhibited significant efficacy against AAD development in 67% of the 
positive trials. In a more recent meta-analysis, 20 of the aforementioned 25 studies were 
analysed with an additional 14 new studies (Videlock and Cremonini 2012). This study showed a 
reduced relative risk (RR=0.53) in the probiotic supplemented group. Synbiotic supplementation 
has also been shown to decrease the length of post-operative antibiotic administration in liver 
transplant patients, as well as the rate of bacterial infection (Rayes et al. 2005). These patients 
received either the synbiotic mixture (Pediococcus pentosaceus, Leuconostoc paracasei, L. 
paracasei and L. plantarum at 1010 viable cells with the 4 prebiotics betaglucan, inulin, pectin and 
resistant starch at 2.5 g each) twice daily, or a twice daily dose of just the 4 prebiotics (control). 
The synbiotic group (n=33) required a significantly shorter period of antibiotic therapy than the 
control group (n=33), 0.1 ± 0.1 vs. 3.8 ± 0.9 days respectively (p<0.05) and had significantly less 
bacterial infections, 3% vs. 16% respectively (p<0.05).  
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1.3.1.5 The positive effects of probiotic supplementation in necrotising enterocolitis 
Necrotising enterocolitis (NEC) is a poorly understood disease which primarily affects premature 
very low birth weight (VLBW) infants. The disease is associated with high mortality rates ranging 
from 10-50% (Henry and Moss 2009). The exact mechanisms of the disease remain unclear. 
However, it has been suggested that the disease is multifactorial with inflammation and bacterial 
overgrowth playing roles (Ballance et al. 1990). Often surgical intervention is used as treatment 
for the disease. It has been argued that the gut bacterial make up of NEC infants is different to 
that of healthy infants. Using sequencing approaches it has been shown that NEC infants have a 
significantly lower number of operational taxonomic units (OTU)s than healthy infant controls 
(10.4±6.1 vs. 19±6.7 respectively, p=0.008), indicating a lower level of diversity (Wang et al. 
2009). This study also showed that the relative abundance of Proteobacteria compared to other 
phyla was significantly higher in the NEC infant group (p<0.01). This suggests that the gut 
bacterial composition of NEC infants is different from healthy infants. 
 
Conversely however, in a more recent study using 16S rRNA gene 454 pyrosequencing of faecal 
samples, NEC infants (n=10) were compared to control infants (n=10) over 7 weeks. No significant 
difference in the gut bacterial community of NEC infants was observed (Normann et al. 2013). 
While there were no differences between the two groups overall there were observable, albeit 
non-significant, differences between the two groups during the first week. The samples of NEC 
infants during the 1st week were dominated by Enterobacteriaceae and Bacillales, while 
Enterococcus was more abundant in the samples from healthy individuals. While these 
differences were non-significant, the authors suggest that differences in the gut bacterial 
community of preterm babies could play a pivotal role in the onset and progression of this 
disease. It therefore follows that modulation of the gut bacterial community in VLBW infants 
could provide a normalising effect. To this end the efficacy of probiotic supplementation as a 
prophylactic treatment for NEC development is now being researched. Supplementation of the 
probiotic organisms L. acidophilus and B. infantis in VLBW infants has been carried out (Lin et al. 
2005). The probiotic group (n=180) showed a significantly lower NEC incidence than the control 
group (n=187), 1.1% vs. 5.3% (p=0.04). When data for the incidences of death, NEC or sepsis were 
combined there was a significant difference between the probiotic treatment group and control 
(17.2% vs. 32.1% respectively, p<0.009). The authors suggest that feeding probiotic organisms to 
VLBW infants may provide competition against pathogens at the epithelial surface. This could 
also give rise to an increased barrier to translocation of bacteria and their products across the 
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epithelial surface. In another study the feeding of a different set of probiotic organisms (B. 
infantis, S. thermophilus and Bifidobacterium bifidus all at 0.35 x 109 CFU/day) alongside either 
mother's or formula milk also showed a significantly reduced NEC incidence, at 4% in the active 
group vs. 16.4% in the control group (p=0.03) (Bin-Nun et al. 2005). It was shown that only 1% of 
NEC cases were clinically significant in the probiotic group compared to 14% of cases in the 
placebo group. This was a statistically significant difference (p=0.013), suggesting that if probiotic 
administration fails to protect against the onset of NEC it can decrease the severity. This study is 
in concurrence with the previously mentioned study by Lin and co-workers. The authors of this 
study suggest that probiotics exert their protective effects through strengthening intestinal 
epithelial barrier function. The authors also suggest that bacteriocin production could play a 
crucial role in bacterial exclusion at the mucosal surface.  
 
Meta-analysis of the literature on the effect of probiotic administration on NEC in in preterm 
VLBW infants has been carried out by Deshpande and colleagues (Deshpande et al. 2010). 
Probiotic organisms administered in the 11 studies used for meta-analysis included LAB, 
Bifiodobacteria, and S. boulardii with the majority being administered at 109 CFU/day. The 
authors show that a higher proportion of VLBW infants developed NEC in the placebo group 
(n=1082) than the probiotic group (n=1094), 6.56% vs. 2.37% respectively. In addition there was a 
significantly lower risk of developing NEC in the probiotic group, with a relative risk of 0.35 
(p<0.0001). Probiotic supplementation showed a reduced risk of mortality versus the control 
group with a relative risk of 0.42 (p<0.00001). In their conclusions Deshpande and colleagues 
highlight that parents, in light of the favourable evidence, would be unlikely to take a chance with 
their infant's health and would opt for probiotic treatment instead of taking part in a clinical trial.
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1.3.1.6 The positive effects of probiotic supplementation in atopic eczema  
Interactions within the gut can have implications far beyond its locality. Atopic eczema (AE), an 
inflammatory skin condition, was shown to affect 20% of children under 12 months in England in 
Wales during 2006 (Schofield et al. 2011). The ailment cost an estimated £465 million to treat in 
1996 (Ellis et al. 2002). In a review of the literature by Williams and Grindlay the causes of AE 
were suggested as being method of birth (vaginal vs. caesarean) and mutations in the gene 
filaggrin (Williams and Grindlay 2010). The influence of the gut and its resident microbiota were 
overlooked in this instance. Characterisation of the gut microbiota of AE sufferers has been 
carried out in a recent study (Abrahamsson et al. 2012). Next generation sequencing of the 16S 
rRNA gene amplified from faecal sample DNA from infants with atopic eczema and healthy 
controls has shown differences in their associated microbiota. Shannon diversity indices show 
that AE infants have a significantly lower total diversity (p=0.04) at one month. Furthermore, 
there is significantly lower diversity of Bacteroidetes and specifically Bacteroides spp. within the 
phylum (p=0.02 and p=0.01 respectively) at one month. The study also highlighted lower diversity 
of Proteobacteria and Bacteroidetes at 12 months in the AE group (p=0.02 and p=0.08 
respectively). The results suggest that AE sufferers have lower bacterial diversity than healthy 
controls. The authors have also shown a lower abundance of Proteobacteria in infants presenting 
with AE and highlight that the cell walls of the bacteria in this phylum contain lipopolysaccharide 
(LPS) which has the ability to elicit an immune response, in particular the response of Th1. The 
authors highlight the findings of another study (Gehring et al. 2001) in which low exposure to LPS 
in infancy was linked with a higher risk of AE. The lower level of LPS coupled with low bacterial 
diversity could possibly play a role in the development of the disease through poor stimulation of 
the immune system. However, it must be noted that the effect of the gut microbiota on the 
incidence and progression of AE is difficult to elucidate and indeed is likely to be multifactorial.  
 
Considering that there is a link between our gut microbiota and the incidence of AE, it follows 
that the efficacy of probiotic supplementation as a preventative measure and also as a treatment 
for AE has been researched. In a cross over study it has been shown that twice daily 
administration of L. rhamnosus and Lactobacillus reuteri significantly (p=0.001) reduced the 
severity of the eczema in the patients' opinion. Following treatment 56% of active patients (n=39) 
believed that their eczema severity had decreased vs. 15% in the placebo group (n=39) 
(Rosenfeldt et al. 2003). In another study, expectant mothers of children at high-risk of 
developing immunoglobulin E (IgE) associated atopic diseases were randomised to a placebo 
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group or active group at 35 gestational weeks (Kukkonen et al. 2007). The active probiotic group 
received a twice daily capsule containing L. rhamnosus GG (5 x 109 CFU), L. rhamnosus LC705 (5 x 
109 CFU), B. breve Bb99 (2 x 108 CFU) and P. freudenreichii ssp. shermanii JS (2 x 109 CFU) up until 
delivery. Supplementation was continued after birth where a single capsule was opened and 
mixed with 20 drops of sugar syrup and 0.8g of galacto-oligosaccharides (prebiotic), and fed daily 
to the new-borns for 6 months after birth. The placebo group (expectant mothers) received twice 
daily capsules  containing micro-crystalline cellulose while the new-borns received a single open 
placebo capsule mixed with 20 drops of sugar but no prebiotic. Probiotic treatment reduced the 
incidence of atopic eczema by 34% when compared to the placebo group. In a meta-analysis of 
the literature it was shown that probiotics given in a pre and/or post-natal manner reduced the 
risk of prolonged AE as much as 61% (Lee et al. 2008). The analysis showed that probiotic 
supplementation is effective as a preventative measure, but showed no statistical significance as 
a treatment. 
 
1.3.1.7 The negative effects of probiotic supplementation in pancreatitis 
Inflammation of the pancreas, pancreatitis, is characterised by 3 phases which include: activation 
of trypsin, induction of inflammatory pathways giving rise to inflammation of the pancreas and 
inflammation that is not localised to the pancreas (Banks and Freeman 2006). It is estimated that 
there are 210,000 admissions of acute pancreatitis each year in the US (Banks and Freeman 
2006). In this disease pancreatic tissue can become necrotised, due to translocation of intestinal 
bacteria as a result of the pro-inflammatory response arising from this disease. This in turn gives 
rise to infectious complications within this tissue (Besselink et al. 2008). Probiotic 
supplementation has been investigated as a prophylactic treatment for patients who were 
predicted to develop severe acute pancreatitis (Besselink et al. 2008). Patients admitted with a 
first episode of acute pancreatitis were enrolled in the multi-centre, randomised placebo-
controlled study. The probiotic group (n=153) received a mixture of L. acidophilus, L. casei, L. 
salivarius, Lactococcus lactis, B. bifidum, Bifidobacterium lactis at a total dose of 1010 bacteria 
with cornstarch and maltodextrins daily. However the placebo group received cornstarch and 
maltodextrins only. Both groups received treatment for a maximum of 28 days. There was no 
significant difference between the two groups in terms of primary endpoint (any infectious 
complication, infected necrosis, bacteraemia, pneumonia, urosepsis and infected ascites). 
Alarmingly however, there were significantly more deaths in the probiotic group than the 
placebo group (16% vs. 6% respectively, p=0.01). Bowel ischaemia occurred at a significant 
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number in the probiotic group (9 patients vs. 0 patients in the placebo group, p=0.004), 8/9 
patients passed away. It has therefore been advised that probiotic supplementation should not 
be given to patients likely to develop severe acute pancreatitis  
1.3.1.8 The little to no effects of probiotic supplementation in irritable bowel syndrome 
The aetiology and symptoms of IBS have previously been discussed, as have the positive effects 
that probiotic supplementation can have on sufferers. However, probiotics can sometimes have 
no effect upon the sufferer. The probiotic mixture VSL#3 was fed twice daily (4.5 x 1011 bacteria 
per day) to sufferers who exhibited diarrhoea predominant IBS (n=12). Whereas the placebo 
group (n=13) received a powder which contained starch. Both groups received treatment for 8 
weeks. There were no significant differences between GIT transit times, relief of symptoms, stool 
frequency, consistency and ease of passage between the two groups. The only positive metric 
from this study was a significant reduction of bloating (p=0.05) (Kim et al. 2003). In a follow-up 
study using the same treatment regime (active group n=24, placebo n=24) in IBS sufferers with 
significant abdominal bloating, VSL#3 did not exert positive effects once again (Kim et al. 2005). 
Treatment with this mixture showed no significant effect on urgency, pain, ease of passage and 
stool form. Furthermore, in contradiction to the previous study bloating was not significantly 
reduced in the active group. In this study the only symptom which showed a significant difference 
was the score for flatulence (p=0.01).  
 
1.3.1.9 No effect of probiotic supplementation in inflammatory bowel disease 
Whilst there is an abundance of evidence for the positive effects of probiotic supplementation in 
IBD sufferers in general, there are studies which show that probiotic supplementation has no 
effect upon CD sufferers. It has been shown that feeding L. rhamnosus GG to CD sufferers at 2 x 
109 CFU/day made no significant difference to time in antibiotic induced remission. The median 
time to relapse in this instance was 16 ± 4 weeks in the probiotic group and 12 ± 4.3 weeks in the 
placebo group (p=0.5) (Schultz et al. 2004). The use of another probiotic organism, L. johnsonii 
LA1, has been assessed as a prophylactic treatment for CD (Marteau et al. 2006). In this study the 
active group (n=48) received two daily doses of L. johnsonii (2 x 109 CFU per dose), and the 
placebo group (n=50) received maltodextrin. Both treatments were given for a 6 month period. 
Although the recurrence rate was lower in the probiotic group than the placebo group (49% and 
64% respectively) the effect failed to reach significance (p=0.15). Recurrence differences, as 
measured through endoscopy, also failed to reach significance. Recurrence was observed in 63% 
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of the placebo group compared to 49% of the active group (p=0.21). Severe endoscopic 
recurrence occurred in 26% of the placebo group and 21% of active patients (p=0.61). The 
authors therefore concluded that L. jonsonii LA1 at the dose given did not provide a statistically 
significant benefit.  
 
The treatment of ileal pouch-anal anastomosis following postcolectomy in UC patients has 
previously been discussed, as have the benefits of probiotic supplementation. The use of L. 
rhamnosus GG has also been researched in the treatment of pouchitis (Kuisma et al. 2003). 
Participants were enrolled if they had been treated for pouchitis at least once. Gelatine capsules 
of L. rhamnosus (0.5-1.0 x 1010 CFU/capsule) were fed 4 times daily for 3 months to participants 
in an active group (n=10). Microcrystalline cellulose was fed to the placebo group (n=10). There 
was no significant difference in pouchitis disease activity index (PDAI) scores between the two 
groups; with a pre-treatment PDAI mean score of 8.4 ±0.7 in the placebo group and 8.0 ± 0.8 in 
the active group (p=0.44). This trend was not altered by probiotic administration as the mean 
PDAI scores were highly similar in both post-treatment groups (8.0 ±0.7 in the placebo group and 
8.0 ± 1.1 in the active group, p=0.97). 
 
1.3.1.10 No effect and the negative effect of probiotic administration in atopic eczema 
Studies have suggested that probiotic administration is beneficial for the prevention of IgE 
associated AE. However, ambiguity still remains as there are studies which show that probiotic 
supplementation has no effect upon this ailment. High-risk new-borns, that is to say new-borns 
from mothers with atopic disease, were recruited for a feeding study (Taylor et al. 2007). 
Treatments were administered for 6 months with the active group (n=89) receiving a daily dose 
of 3 x 109 L. acidophilus LAVRI-A1 and the placebo group (n= 89) receiving maltodextrin. The rates 
for AE were similar between the active and placebo group after 6 months of feeding, 25.8% and 
22.7% respectively (p=0.629). When patients were reassessed at 12 months there were no 
significant differences in AE rate nor severity between treatment groups (p=0.581 and p=0.995 
respectively). It was in fact shown that probiotic supplementation in this instance was linked to a 
higher rate of sensitisation to common allergens (p=0.03). This suggests that supplementation 
with this organism in this instance can potentially have negative effects as opposed to positive 
ones.  
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Twice daily prenatal (4-6 weeks before delivery) and postnatal feeding (for 6 months) with L. 
rhamnosus GG at 5 x 109 CFU/dose showed no significant difference in outcome when compared 
to a microcrystalline cellulose placebo (Kopp et al. 2008). For this study 105 pregnant women 
were recruited from families with ≥ 1 member suffering from an atopic disease. The criteria 
included mother, father or any other children in the family. The probiotic group (n=50), at the age 
of 2 years, showed no significant difference in episodes of fever, airway infections, total IgE nor 
sensitisation to an inhalant allergen (p=0.22, p=0.23, p=0.38 and p=0.61 respectively). Although 
there were no beneficial significant differences, there was a detrimental significant difference. 
Recurrent episodes of wheezing bronchitis (≥5 episodes) occurred significantly more frequently in 
the probiotic group than the placebo group (26% vs. 9.1%, p=0.03). Once again there is evidence 
that probiotic supplementation can have no effect and furthermore can exacerbate the 
condition. 
 
1.3.2 The use of probiotic supplements in healthy individuals 
While many researchers focus on the effects of probiotics in the infirm, others research the 
effects of probiotic supplementation in healthy individuals. Many healthy people purchase 
probiotic supplements therefore it is imperative that scientific research into their effects is 
carried out to benefit the individual and the producing company (due to EFSA guidelines). 
1.3.2.1 Gut bacterial modulation and survivability of probiotic strain in the GIT 
Much attention has been focused on whether probiotic consumption can modulate the gut 
bacterial community in healthy individuals. It has been shown in numerous instances that the 
organism which is fed can be recovered after passage through the GIT, and the organism 
increases the levels of its own genus. Feeding of B. lactis HN019 at 1.9 x 107 CFU/day with 2.4 
g/day of prebiotic galacto-saccharide in healthy children showed a significant increase in B. lactis 
in faecal material when compared to a placebo group (p<0.001) (Prasad et al. 2013). L. casei has 
the ability to survive GIT transit with a study showing that L. casei Shirota levels were 7.1 ± 0.4 
Log10 CFU/gram of faeces after 7 days of supplementation. This level was maintained with no 
significant difference for 21 days during the feeding study and persisted for a further 7 days after 
the study. (Tuohy et al. 2007). There was also a significant increase in the total numbers of 
lactobacilli recovered in faecal material throughout the study.  
Another strain of L. casei, DN-114001, was delivered to healthy individuals (n=12) three times 
daily for 10 days in milk which this organism had fermented along with S. thermophilus and L. 
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bulgaricus at a total of 108 CFU/mL (Rochet et al. 2006). Faecal samples were taken at day 0 
(before supplementation), day 10 (end of supplementation) and at day 20 (10 days after 
supplementation ceased). There was a significant (p<0.01) increase in the number of L. paracasei 
group specific quantitative PCR (qPCR) products (of which L. casei is part) per gram of faeces at 
day 10. Research has shown that recovery of B. lactis BB12 occurs in a dose-dependent manner 
(Larsen et al. 2006). BB12 was fed with L. paracasei CRL-431 at 108, 109, 1010 or 1011 CFU/day and 
compared to a placebo group (n=15 per group). The results showed a dose dependent response 
in faecal recovery when the dose was treated as a linear and continuous variable. L. paracasei 
CRL-431 however, was not detected in any of the faecal samples.  
While these studies have shown that recovery of the fed organism occurs, there is no significant 
impact on the gut microbiota as a whole from feeding these probiotic organisms. Tuohy and 
colleagues show no significant changes in Bacteroides spp., Eubacterium rectale group and 
Atopobium group numbers (Tuohy et al. 2007). Rochet and co-workers showed no significant 
changes in mean proportions of Atopobium, Bacteroides-Preveotella, Bifidobacterium, 
Clostridium coccoides, Faecalibacterium prausnitzii, Enterobacteria and Lactobacillus-
Enterococcus groups (Rochet et al. 2006). Similarly Larsen and associates saw no significant 
change in major gut bacterial groups including Bacteroides and Clostridia (Larsen et al. 2006). The 
administration of the probiotic yeast S. boulardii also did not alter the global gut bacterial 
community of healthy individuals. The probiotic yeast was fed at a daily concentration of 2.5 x 
109 viable cells for 4 weeks (Vanhoutte et al. 2006). However the daily feeding of lactulose, a 
prebiotic, at 10 g showed a bifidogenic response with a significant increase in total bifidobacteria 
observed during feeding than levels at baseline (p=0.007). The aforementioned studies suggest 
that probiotics are unable to alter the global community of the gut microbiota. However, it has 
been shown that probiotic consumption can modify the gut bacterial community. Healthy but 
over-weight individuals (n=28) received either a control yoghurt, yoghurt containing 1.39 x 109 
CFU L. amylovorus or yoghurt containing 1.08 x 109 CFU L. fermentum in a cross-over trial. All 
participants received each treatment for 43 days separated by a 6 week washout period (Omar et 
al. 2013). Both L. amylovorus and L. fermentum significantly (p=0.008) increased its own genus 
Lactobacillus spp., as measured through qPCR of faecal DNA, mirroring the previously mentioned 
studies. However in contradiction to the previously mentioned studies, L. amylovorus 
supplementation gave rise to a significant (p<0.038) 2-log fold reduction in Clostridium cluster IV 
as measured by qPCR of faecal DNA. These data suggest that modulation of gut bacterial 
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community can be achieved, in this instance, through the consumption of this probiotic 
organism. 
 
1.3.2.2 Immunomodulatory effects 
Probiotic organisms are often regarded as beneficial due to the immunomodulatory effects which 
they reportedly exert. Researchers are keen to answer whether or not probiotic strains exert 
these effects in healthy individuals. In order to assess this question Olivares and colleagues 
recruited 30 healthy individuals. These individuals were randomly assigned to receive control 
yoghurt (yoghurt made with the conventional starters L. bulgaricus and S. thermophilus) or 
probiotic yoghurt. The probiotic yoghurt was made using S. thermophilus, at the same 
concentration as the placebo. However, L. bulgaricus was replaced with Lactobacillus 
coryniformis CECT5711 and L. gasseri CEC5714 at 2 x 109 CFU each as starter cultures (Olivares et 
al. 2006). Participants received either the control or probiotic yoghurt daily for 4 weeks and 
provided a weekly faecal sample. Leukocyte subset proportions were analysed, and 
immunoglobulin and cytokine measurements were taken. Comparisons were carried out against 
week 0. After two weeks of consumption the probiotic group showed a significant (p<0.05) 
increase in proportion of monocytes and T lymphocytes. A significant increase was also observed 
in the proportion of neutrophils and a significant (p<0.05) decrease of lymphocytes at week 2 in 
the control group. Whilst there was a significant difference in neutrophil and lymphocyte 
proportions in the control group, highly significant differences were observed in the probiotic 
group. These included a highly significant (p<0.01) increase in neutrophil proportion and a highly 
significant (p<0.01) decrease in lymphocyte proportion. Comparisons between week 0 and week 
4 showed a highly significant (p<0.01) decrease in B lymphocytes in the control group; no other 
leukocyte subsets were significantly different. However, comparisons of leukocyte subset 
proportions between week 0 and week 4 in the probiotic group showed a highly significant 
(p<0.01) increase in the proportion of neutrophils. A highly significant (p<0.01) decrease in T 
lymphocytes and significant (p<0.05) decreases in the proportion of lymphocytes, T memory cells 
and B lymphocytes was also observed. Furthermore, at week 2 there was a significant (p<0.05) 
increase in the proportion of natural killer (NK) cells in the probiotic group when compared to 
week 0. This trend returned to a non-significant difference after 4 weeks. The 
immunomodulatory effect at two weeks was also shown through a significant (p<0.05) increase 
in IL-4, IL-10 and a significant (p<0.05) decrease in IgE. This study suggests that probiotics may 
exert immunomodulatory effects in the short-term.  
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Immunomodulatory effects may well be strain specific as while the previous study shows that this 
probiotic mixture exerts these effects, the same cannot be said for other probiotic species. B. 
lactis BB12 and L. paracasei ssp. paracasei CRL-431 were fed to healthy adults who were 
randomised to receive the probiotic mixture at either 108, 109, 1010, 1011 CFU/day-or a placebo 
(n=15 for each group) daily for 3 weeks (Christensen et al. 2006). There was no significant 
difference between the probiotic groups and placebo group at any concentration in terms of 
phagocytosis difference (difference between activity before intervention and immediately after). 
No significant change in faecal immunoglobulin A (IgA) and no significant difference in stimulated 
blood sample production of interferon-γ (IFN-γ) and IL-10 was also observed. The authors also 
measured the recovery of B. lactis BB12 and L. paracasei CRL-431 from faecal material. L. 
paracasei CRL-431 could not be recovered while B. lactis BB12 could. When the authors plotted 
IFN-γ difference (difference in levels before intervention and immediately after) against recovery 
of B. lactis BB12 (log CFU/g-1) a significant negative (p=0.011) correlation was observed. Increased 
B. infantis BB12 recovery correlated with a decrease in IFN-γ difference. This work furthers the 
idea that different probiotic strains possess different immunomodulatory capabilities. 
Furthermore, this evokes the notion that survivability of the chosen probiotic organism is a key 
factor for exertion of any positive effects.   
 
1.3.2.3 Effects on bowel habit and incidence of diarrhoea 
Probiotic supplementation in healthy individuals has also been shown to exert other benefits. 
One such benefit is the improvement in bowel habits with multiple species showing a positive 
effect. It has been shown that supplementation with B. lactis BB12 at an increasing dose has a 
significant (p=0.018) linear effect on faecal consistency whereby the stool became looser as the 
probiotic dose increased from 108 CFU/day through to 1011 CFU/day (Larsen et al. 2006). 
Improvements in bowel habits were also seen through the consumption of L. rhamnosus IMC 501 
and L. paracasei IMC 502 in food products (both species were at 1 x 109 CFU per serving) 
(Verdenelli et al. 2011). Active participants (n=25) were told to consume at least one portion of 
these functional foods per day for 12 weeks, while placebo participants (n=25) consumed the 
same foods with no probiotic organisms added. Participants recorded their bowel habits using a 
zero to ten scale (0 = worse, 5 = no change, 10 = best). There was a significant (p<0.05) increase 
in intestinal regularity and stool volume observed in the probiotic group when compared to the 
placebo group. These two studies suggest a role for probiotics in improving the well-being of 
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healthy individuals. Participants did not have bowel complaints, but probiotic supplementation 
still improved these two facets of bowel function.  
 
Closely linked to intestinal well-being, the effect of probiotic supplementation on acute diarrhoea 
in healthy infants has been researched (Thibault et al. 2004). Formula fed infants were 
randomised to receive either formula fermented by B. breve C50 and S. thermophilus 065 (n=464) 
or standard formula (n=449). The incidence, number of episodes, duration and severity of 
diarrhoea were recorded. There was no significant difference in the incidence, number of 
episodes, duration of diarrhoea or number of hospitalisations between the two groups. However, 
there was a significant reduction in signs of dehydration (p=0.01) and prescriptions of oral 
rehydration salts (p=0.003) in the probiotic group. The data suggest that in those infants who 
require hospitalisation due to the severity of diarrhoea (0.9% in the probiotic group and 0.5% in 
the placebo group), probiotics may exert a positive effect through alleviating the level of 
dehydration. In another study young and healthy male soldiers were recruited to assess the 
effect of L. casei DN-114 on diarrhoea. The incidence of diarrhoea was non-significantly reduced 
(12.2% in the probiotic group and 16.1% in the placebo group, p=0.207) (Pereg et al. 2005). The 
probiotic was provided in the form of a commercially available fermented yogurt which 
contained 108 CFU/mL of the organism which was taken daily for 6 days per week for 8 weeks. 
There was also no significant difference in mean duration of diarrhoea, fever, vomiting or 
abdominal pain (p=0.276, p=0.12, p=0.082) between the two treatment groups. We can 
therefore surmise that strains exert specific effects and that the age of the participants and 
length of treatment can all play a role in the end result. 
1.3.2.4 Effects in other illnesses 
It is thought that probiotics exert immuomodulatory effects and through these effects can prime 
the immune system. It is therefore logical to study the effect of probiotics on the prevention of 
some infectious illnesses such as the common cold. Healthy Taiwanese school children (age 8-13) 
were randomised to receive either a twice daily capsule containing L. acidophilus and B. bifidum 
(both at 1x 109 per capsule) or a placebo for 3 months (Rerksuppaphol and Rerksuppaphol 2012). 
The probiotic group (n=40) had significantly fewer children developing fever and cough (p=0.025 
and p=0.01 respectively) and significantly fewer secondary outcomes of school absence and cold-
related school absence (p<0.001 and p=0.001 respectively). However, probiotic supplementation 
did not decrease the number of children developing vomiting, diarrhoea or decrease antibiotic 
usage (p=0.600, p=0.630 and p=0.432 respectively). The data suggest a role for probiotic 
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supplementation in the prevention of common school acquired ailments and could decrease 
absenteeism due to illness. The age at which intervention is administered seems to have an 
impact on the efficacy of probiotic supplementation in the prevention of infectious illnesses. 
Formula fed infants (4 to 10 months old) from child care centres were recruited to assess the 
effect of probiotic supplementation on acquired infections (Weizman et al. 2005). Participants 
were randomised to receive either a control milk formula (n=60) or the control milk formula 
enriched with either B. lactis BB12 (n=73) or L. reuteri (n=68) each at 1 x 107 CFU/g of formula 
powder for 12 weeks. Species specific effects were once again observed with L. reuteri 
significantly reducing the number of days with fever, clinic visits, absences from child care centres 
and prescriptions of antibiotics (p<0.001, p=0.002, p=0.015 and p=0.037 respectively). Whereas 
both L. reuteri and B. lactis showed a significant decrease in the number of fever episodes, days 
with diarrhoea and episodes of diarrhoea (p=<0.001) in each instance. Probiotic supplementation 
did not have a complete protective effect however. The number of days and episodes of 
respiratory illness did not differ significantly between the placebo group and either of the 
probiotic groups.  
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1.4 The Probiotics in Healthy Gut Microbiota (PROHEMI) study 
There is an apparent discrepancy in the number of studies which look at the effect of 
probiotic supplementation in healthy individuals. Furthermore, in these recent studies the 
active period is relatively short and therefore only addresses effects seen in the short term. 
In an older study the effect of 6 months of probiotic supplementation in healthy individuals 
was carried out, which constitutes a far more long-term study than the more recent 
literature (Tannock et al. 2000). The aim of the study was to determine whether the gut 
microbiota and functions therein could be modulated in healthy individuals through long-
term probiotic supplementation. The probiotics in healthy gut microbiota (PROHEMI) study 
was the vehicle for data generation in order to answer our global questions. This pilot study 
aimed to determine whether daily supplementation with a probiotic supplement had an 
effect upon healthy individuals. I aimed to achieve this through the use of both culture 
dependent and independent approaches. The PROHEMI probiotic mixture has previously 
been researched with regards to its efficacy in the infirm; where a difference in the number 
of elderly patients who were C. difficile toxin positive (46% in the probiotic group vs. 78% in 
the placebo group) was observed (Plummer et al. 2004). The same probiotic mixture has 
been shown to reduce the symptom severity scores in IBS sufferers (Williams et al. 2009). It 
must be noted however, that in this study significant reductions in symptom score were also 
apparent in the placebo group; this highlights a rather marked placebo effect in this 
instance. Even though symptom score reduction was also seen in the placebo group, the 
biggest reduction in symptom score was seen in the probiotic group. Strain type tracking 
through random amplified polymorphic DNA (RAPD) of L. acidophilus Cul21 has also been 
carried out. Recovery of this strain was observed in the faecal material of 10/12 healthy 
participants following daily feeding of this strain for 14 days (Mahenthiralingam et al. 2009). 
This study shows that this strain can survive transit through the GIT.  
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1.5 Project aims 
This PhD studentship was funded by a Knowledge Economy Skills Scholarship (KESS) with 
funding from European Social Funds (ESF). KESS aims to promote knowledge exchange 
between higher education institutions and small and medium enterprises (SMEs). The 
overall aim of the project was to determine the efficacy of a probiotic product produced by 
Cultech (Cultech Ltd., Port Talbot, UK) in healthy human males. The specific hypotheses of 
the project were as follows: 
1. Probiotic administration affects the distal gut bacterial community of healthy male 
individuals (Chapters 3 and 5) 
Through the use of community fingerprinting and next generation sequencing 
techniques we aim to determine whether long-term probiotic consumption 
modulates the distal gut bacterial community of healthy male individuals or not 
 
2. Probiotic administration affects functions provided by the commensal distal gut 
microbiota of healthy male individuals (Chapter 4) 
Culture dependent techniques will be utilised in order to screen faecal samples from 
healthy male individuals for a range of functions provided by the commensal gut 
microbiota. We aim to determine whether long-term probiotic consumption affects 
the expression of these functions in healthy male individuals or not. 
 
3. Probiotic administration affects the genotoxicity of faecal waters from healthy 
male individuals (Chapter 4) 
Using a bacterial genotoxicity testing strain, the effect of long-term probiotic 
supplementation on the genotoxicity of healthy male faecal waters will be tested. 
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4. Probiotic administration affects the metabonomic profiles of faecal waters from 
healthy male individuals (Chapter 5) 
1H Nuclear Magnetic Resonance spectroscopic analysis will be carried out in 
partnership with Dr. Jia Li (Imperial College London) in order to determine whether 
long-term probiotic supplementation affects the metabonomic profiles of healthy 
male individuals. 
 
5. There are no geographical differences in the gross distal gut bacterial community, 
functions, and metabonomic profiles of faecal waters of healthy male individuals 
in the UK (Chapters 3, 4 and 5) 
The gross bacterial community, functions and metabonomic profiles of faecal waters 
of healthy male individuals from the UK will be compared in order to determine 
whether there are geographical differences. 
 
6. Freezing faecal material affects its bacterial composition 
The effect of storage at -20°C on the bacterial composition of faecal material will be 
determined in a 6 month study. 
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2. GENERAL METHODS AND MATERIALS 
2.1 The PROHEMI study design 
2.1.2 The probiotic mixture 
The probiotic supplement used in this pilot study was a mixture of Bifidobacterium bifidum 
(Cul20, NCIMB 30153), Bifidobacterium lactis (Cul34, NCIMB 30172) and two strains of 
Lactobacillus acidophilus (Cul21, NCIMB 30156) and (Cul60, NCIMB 30157) at 2.5 x 1010 
viable cells  and was produced by Cultech.  
2.1.2 Ethical approval 
Ethical approval for the PROHMEI study was granted by Cardiff School of Biosciences, Cardiff 
University (Cardiff University’s Research Ethics Committee. Ref: 1010-3) and the University 
of Sheffield Research Ethics committee (Ref: SMBRER168).  
2.1.3 Study design 
Healthy male adults (n=36), with an age range of 21-48 years old were enrolled for this 
placebo controlled, double blinded, multi-centre (Cardiff/Port Talbot and Sheffield) pilot 
study. The Cardiff/Port Talbot arm of the study comprised of a Pre-feeding period with no 
supplementation, an Active period of 6 months where supplementation took place and a 
Washout period. Participants from the Cardiff/Port Talbot (n=18) arm of the study were 
anonymised through random number assignment and randomly assigned to an Active group 
or placebo group. The Active group were instructed to consume a probiotic capsule daily 
with a meal, while the placebo group received a daily dummy capsule containing 
maltodextrin (300 mg). Both types of capsule looked identical and were provided in identical 
bottles labelled with the participant’s unique number (Fig 2.1). The Sheffield arm (n=18) of 
the study was carried out in the same manner where all participants were anonymised. 
However, all received the Active probiotic treatment for 6 months, this was due to ethical 
reasons and the initial Pre-feeding period was slightly longer (Fig 2.2). During the course of 
the study there were withdrawals with participant PH33 from the Cardiff/Port Talbot arm 
giving no samples, and participants PH3 and PH10 from the Sheffield arm withdrawing 
during the Pre-feeding period. Other withdrawals occurred during the course of the study 
(Fig 2.3). All participants were instructed not to consume other foods which contained 
probiotic organisms. Power and sample size calculations were not carried out for the 
PROHEMI study as it was a small-scale pilot study. Following completion of the Active 
CHAPTER 2 – GENERAL METHODS AND MATERIALS 
57 
 
period, participants were asked to return any capsules which were not taken in order to 
calculate compliance. Participants who remained in the study throughout had a compliance 
percentage of >80% (data not shown), this was in line with other probiotic feeding trials  
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Figure 2.1| Schematic of the Cardiff arm of the PROHEMI study  
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Figure 2.2| Schematic of the Sheffield arm of the PROHEMI study 
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Figure 2.3| The PROHEMI study enrolment – the numbers of participants enrolled in each 
arm of the study are shown. Withdrawals have been shown along with their respective 
participant numbers. 
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2.2 Processing of faecal samples 
Both study sites followed the same protocols for faecal sample processing whereby fresh 
faecal samples were weighed and scored using the Bristol Stool form Scale (Heaton 1999). 
Samples were homogenised with a spatula. Homogenised faecal samples were separated 
into relevant tubes for storage. 
2.2.1 Storage of faecal material for DNA extraction and for preparation of faecal 
water 
The homogenised faecal material (5 g) was stored at -20°C in preparation for DNA extraction 
and faecal water preparation within one week of freezing. 
2.2.2 Storage of faecal material in order to preserve bacterial cells 
Homogenised faecal material (1 g) was placed in 9 mL of maximum recovery diluent  (Oxoid 
Ltd, Basingstoke, England) which contained 20% w/v glycerol (Fisher Chemical, 
Loughborough, Leicestershire, UK) and 0.5% w/v L-cysteine hydrochloride (Sigma Aldrich 
company Ltd. Dorest, UK). The faecal material and cryo-protective liquid was mixed by 
vortex until a uniform suspension was achieved. The faecal suspension was stored at -80°C 
for future work. 
 
2.3 DNA extraction from bacterial cells 
2.3.1 SOP for DNA extraction from faecal material 
DNA extractions were carried out at both study centres from their respective participant 
samples using the same equipment, reagents, consumables and no sample transportation. 
DNA was obtained from human faecal material by using the QIAamp® DNA Stool Mini Kit 
(QIAGEN LTD. West Sussex, UK) according to manufacturer’s guidelines. However, an 
additional bead beating step was used, whereby 0.5 g of 0.1 mm zirconia/silica beads 
(BioSpec products Inc. Bartlesville, OK 74005, USA) were added to each sample and the cells 
lysed by 3 one min bursts at 5 m/s using a Fastprep®-24 machine (MP Biomedicals, Solon, 
OH 44139, USA). This bead beating step was carried out following the addition and mixing of 
the faecal sample with the first buffer. 
2.3.2 DNA extraction from single species 
Over-night culture (1 mL) was dispensed into a 1.5 mL microcentrifuge tube and centrifuged 
at a relative centrifugal force of 4,000 g for 2 min. The supernatant was removed and the 
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pellet was resuspended in 100 µL of 10 mM TRIS/EDTA (10 mM TRIS/HCl pH8 and 10 mM 
EDTA pH8) (MP Biomedicals, Aurora, Ohio). The cell suspension was transferred to a 2 mL 
tube which contained 0.5 mL of 0.1 mm zirconia/silica beads (BioSpec products Inc. 
Bartlesville, OK 74005, USA). To this 500 µL of lysis buffer (50 mM TRIS/HCl pH8, 70 mM 
EDTA pH8, 1% sodium dodecyl sulphate (SDS)) (Fisher Scientific, Loughborough, 
Leicestershire, UK) and 20 µl proteinase K (20 mg/mL) (QIAGEN LTD. West Sussex, UK) was 
added. The bacterial cells were lysed at 5 m/s for 30 s using a Fastprep®-24 machine (MP 
Biomedicaps, Ohio, USA). The cells were incubated at 37°C for 30 min before 200 µl of 
saturated ammonium acetate was added and vigorously mixed by vortex and tube inversion. 
To this suspension 600 µl of chloroform (Fisher Scientific, Loughborough, Leicestershire, UK) 
was added and vigorously mixed by vortex and tube inversion. The suspension was 
centrifuged at a relative centrifugal force of 14,000 g for 5 min before 700 µL of the clear 
supernatant was taken and transferred into a sterile 1.5 mL microcentrifuge tube. To this 
700 µL of propan-2-ol (Fisher Scientific, Loughborough, Leicestershire, UK) was added and 
mixed vigorously by tube inversion. The suspension was incubated at -20°C for 30 min 
before centrifugation at 14,000 g for 10 min. The supernatant was removed, leaving a white 
pellet of DNA which was washed with 100 µL of ethanol. Excess ethanol was removed and 
the remaining ethanol and DNA were centrifuged for 15 s at 14,000 g to form a pellet. The 
ethanol was removed and the sample was allowed to air dry before resuspension of the 
pellet in 200 µL of TRIS/HCl (10 mM, pH8).  
 
2.4 Ethanol precipitation of DNA samples 
NaCl (1 M) was added as a ratio of 0.3 to the volume of the DNA sample. To the combined 
DNA and NaCl, 2 volumes of cold 100% ethanol was added and mixed by inversion before 
incubation at -20°C over-night. The following morning, the mixture was centrifuged at 
16,000 g at 4°C for 15 min. The supernatant was poured off and 600 µL of cold ethanol (70%) 
was added before centrifugation at 16,000 g at 4°C for 15 min. The supernatant was poured 
off and the sample was allowed to air dry until all remaining ethanol had evaporated. The 
remaining pellet was resuspended in 30 µL of 10 mM TRIS/EDTA (10 mM TRIS/HCl pH8 and 
10 mM EDTA pH8). 
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2.5 SOP for faecal water generation from PROHEMI faecal samples 
Faecal water generation was carried out at both study centres from their respective 
participant samples using the same equipment, consumables and no sample transportation 
as previously described (Marchesi et al. 2007). Briefly, thawed faecal material was weighed 
and 2 volumes (v/w) of sterile phosphate buffered saline (1.9 mM Na2HPO4, 8.1 mM 
NaH2PO4, 150 mM NaCl, pH 7.4) was added. Homogenisation of this mixture was achieved 
through vortex mixing for 60 s in order to generate faecal slurries. The slurry was then 
centrifuged at 3,000 g for 15 min. Following this, the supernatant was removed and filtered 
through a 30 μm filter (Whatman 113V, GE Healthcare Life Sciences, Buckinghamshire, UK). 
The filtrate was further filtered through a 0.2 μm centrifugal filter (VWR International Ltd, 
Leighton Buzzard, UK) at 14,000 g for 15 min.  
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3. COMMUNITY PROFILING OF FAECAL DNA FROM THE PROHEMI STUDY 
3.1 Introduction 
Culture independent analysis of microbial communities has provided a wealth of knowledge 
and has the main advantage of negating “the great plate count anomaly” (Staley and 
Konopka 1985). The method, DGGE, was initially developed in order to discern differences in 
DNA mutation (Fischer and Lerman 1983). However, the technique has also been used as a 
community fingerprint method through the use of 16S rRNA genes (Muyzer et al. 1993). The 
method has been used in order to discern the bacterial community community of complex 
ecosystems. These ecosystems include the soil (Ellis et al. 2003) and more importantly the 
human distal gut (Schwiertz et al. 2003). DGGE has the advantage of the user being able to 
sequence excised bands in order to determine which organism/organisms are present within 
the sample. The advantages and disadvantages of this method have previously been 
discussed (Kirk et al. 2004). Although highly reproducible, this method relies on good 
laboratory techniques in order to compare gels. These techniques include, but are not 
limited to, good pipetting technique when setting up the PCR mixture and the ability to pour 
gels of a consistent volume. The difficulty in comparing different gels becomes apparent 
when band intensity is measured as a proxy for the abundance of a particular organism or 
organisms in the sample. 
Fingerprinting methods such as LHPCR, ribosomal intergenic spacer analysis (RISA) and 
automated ribosomal intergenic spacer analysis (ARISA) provide a snapshot of the 
community as a whole. These methods however, do not easily provide information on the 
specific bacterial make up of a community. It must be noted that DGGE, ARISA and LHPCR 
suffer with the 16S rRNA gene bias. Organisms of potential importance with a low copy 
number of 16S rRNA genes within a community may be overlooked, while those with a high 
copy number are not (Crosby and Criddle 2003). Due to the fact that these techniques rely 
on PCR prior to analysis, many biases can be introduced. These biases and problems have 
previously been discussed (V. Wintzingerode et al. 1997). This then produces a biased 
community fingerprint. These techniques however, can be used in order to assess gross 
changes within the community under investigation. LHPCR has been shown to be 
reproducible and has been successfully applied to complex communities, such as the soil 
(Ritchie et al. 2000) and more importantly the gut (Bjerketorp et al. 2008). LHPCR has also 
been used as a screening method for interesting samples which can be put forward for next 
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generation sequencing (Gillevet et al. 2010). ARISA has also been applied to assess complex 
communities such as freshwater (Fisher and Triplett 1999) and RISA to assess the microbiota 
associated with plant biomass in the herbivore gut (Larue et al. 2005). Both LHPCR and 
ARISA have the benefits of being high-throughput and the abundance of a peak can be easily 
calculated using dedicated software packages.  
It is difficult to ascertain which bacterial species are responsible for generating a fragment of 
a given length when using LHPCR and ARISA. However, it is not impossible to estimate which 
bacterial species will give rise to a fragment of a given length. In the instance of ARISA there 
is a dedicated database for this purpose. The ADAPT system takes ARISA data and uses 
multiple databases to assign taxonomic information to the submitted data (Schmieder 
2008). To my knowledge, there is no such database for LHPCR data. Therefore, an in silico 
LHPCR experiment using 16S rRNA gene information obtained from the ribosomal database 
project (RDP) (Maidak, 2000) was carried out This information can be combined with LHPCR 
data for rough taxonomic identity assignment for a given fragment length.  
Research into the effects of probiotic supplementation focuses on the potential of these 
organisms to exert immunomodulatory effects and to protect against disease. Some 
research has also focused on the ability of probiotics to modulate the gut bacterial 
community of individuals. Much of the research makes use of in vitro models, such as the 
anaerobic faecal batch culture system (Saulnier et al. 2008), in order to assess the ability of 
probiotics to modulate bacterial community. Due to the increasing evidence that the gut 
bacterial community of individuals may impact upon diseases such as obesity, it follows that 
modulation of our commensal gut bacterial community could be used as a therapy. There is 
a scarcity of research on the effect of probiotic supplementation in healthy individuals. 
Research into the effect of probiotic supplementation on the gut bacterial community of 
healthy individuals is scarcer. Therefore, in this study a mixture of community fingerprint 
profiling techniques were tested and applied in order to answer whether the long-term 
consumption of a probiotic, in healthy individuals, modulates the gut bacterial community. 
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3.1.1 Chapter Aims 
The aims of this chapter are as follows: 
 
1. to develop and apply published community profiling techniques on extracted faecal 
DNA from PROHEMI participants; 
 
2. to determine whether probiotic administration affects the gross bacterial community of 
healthy male individuals; 
 
3. to determine whether there is a difference in the gross bacterial community of 
individuals from the two study centres. 
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3.2 Materials and methods 
3.2.1 Length heterogeneity PCR (LHPCR) 
The universal 27F (5′-AGAGTTTGATCMTGGCTCAG-3′) primer was labelled with the 
fluorescein molecule 6-FAM at the 5’ end (Sigma Aldrich, United Kingdom) and used in 
conjunction with 3 different reverse primers: 338R (5'-GCTGCCTCCCGTAGGAGT-3') (Rogers 
et al. 2003), 358R (5′-ACTGCTGCCTCCCGTAGGAGT-3′) (Bjerketorp et al. 2008) and 534R (5’-
ATTACCGCGGCTGCTGG-3’) (Eusebio et al. 2011). Reactions (20 µL) were set-up as previously 
described. The thermal cycler (C1000™; BIO-RAD, Hertfordshire, UK) was programmed with 
an initial denaturing step of 95°C for 1 min, followed by 30 cycles of 95°C for 1 min, 55°C for 
1 min, 72°C for 1 min with a final extension step of 72°C for 10 min.  
All products were visualised by gel electrophoresis using the 2-log ladder DNA standard 
(New England Biolabs® Inc. Ipswich, MA 01938-2723) as a reference. Products were 
concentrated using the Eppendorf concentrator 5301 (Eppendorf UK Limited, Cambridge, 
UK). Hi-Di™ Formamide (10 µL) (Applied Biosystems, Cheshire, UK) and 0.25 µL of MRK 1000 
ROX ladder (Gel Company, San Fransisco, CA 94107, US) were added to each concentrated 
product. Fragment analysis of products was carried out using the ABI 3130xl Genetic 
Analyzer (Applied Biosystems, Life Technologies Corporation, CA 92008, US).  
3.2.1.2 Duplex target length heterogeneity PCR (DT-LHPCR) 
The use of a dual reverse primer combination for LHPCR was trialled. DT-LHPCR was carried 
out by setting-up 20 µL reactions as previously described. However; both 338R and 534R 
primers were added at a concentration of 0.04 µM each with 0.08 µM 6-FAM labelled 27F to 
give a final primer concentration of 0.16 µM. The thermal cycler programme used was the 
same as previously described for LHPCR. Products were visualised and treated as previously 
described for LHPCR. 
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3.2.1.3 Length heterogeneity PCR (in silico) 
Sequences for gut bacterial rRNA genes were obtained from the Ribosomal Database Project 
(available at: http://rdp.cme.msu.edu). The sequences were aligned using the ClustalW 
(Larkin et al. 2007) programme in BioEdit v7.0.5.3 (Hall 1999). Forward and reverse primers 
(27F and 358R respectively) were aligned to the sequences with excess bases and gaps 
subsequently removed. Sequences were uploaded as FASTA files to the compute sequence 
length function in Galaxy tools (available at: https://main.g2.bx.psu.edu/). The sequence 
length for a given bacterial species was used to assign an approximate bacterial species to a 
given peak in the electropherograms generated through LHPCR. The approximate fragment 
sizes generated are shown in Appendix I. 
3.2.1.4 LHPCR analysis of the probiotic organisms used in the study 
DNA from over-night cultures of B. bifidum (Cul 20), L. acidophilus (Cul 21) and L. acidophilus 
(Cul 60) was extracted as previously described (see Chapter 2.3.2). DNA from B. lactis (Cul 
34) was not extracted due to problems culturing the organism from freezer stocks. The 
extracted DNA was subjected to LHPCR analysis using the 358R primer as previously 
described. 
3.2.1.5 Bioinformatic analysis of LHPCR products 
Fragment analysis files generated from LHPCR products were imported into SoftGenetics 
GeneMarker Version 1.91 (SoftGenetics LLC, PA 16803, USA). Electropherograms were 
generated from fragment analysis files in the programme. These were inspected in order to 
ensure that the file was not corrupted or missing data. The areas for given peaks within a 
sample were exported and normalised. This was achieved by calculating the area ratio for 
each peak through dividing the area for a given peak by the total peak area within a sample. 
Normalised proportional peak area ratios (NPPARs) for given samples were imported into R 
Statistical software (R-Core-Team 2012). Heatmaps of data were generated using the 
heatmap2 function in the package gplots (Warnes 2010), or through the aheatmap function 
of the NMF package (Gaujoux and Seoighe 2010). Heatmaps were coloured using the colour 
palettes available in the RColorBrewer package (Neuwirth 2007) (Appendix II). Samples 
within the heatmap were clustered together by hierarchical clustering using calculated 
Euclidean distances of NPPARs through Ward's method. Principal coordinate analysis (PCoA), 
using calculated Euclidean distances of NPPARs, was carried out in R statistical software. This 
was achieved through the use of a custom script which utilised both vegan (Oksanen et al. 
CHAPTER 3 – COMMUNITY PROFILING OF FAECAL DNA FROM THE PROHEMI STUDY 
69 
 
2011) and labdsv (Roberts 2010) packages (Appendix II). Agglomerative nested clustering 
(AGNES), using Ward's method, of the calculated Euclidean distances of NPPARs and export 
in Newick format was carried out in R statistical software. In order to carry AGNES a custom 
script was used. The script utilised ape (Paradis et al. 2004), BiodiverstiyR (Kindt  and Coe 
2005) and cluster (Maechler et al. 2005) packages (Appendix II). Once exported in Newick 
format, the tree was manipulated using interActive tree of life (iTol) software online (Letunic 
and Bork 2011). 
Percentage changes between samples from the same individual were calculated as 
previously described (Marzorati et al. 2008). Pearson's r correlation coefficients were 
calculated between samples using SPSS (IBM, Portsmouth, UK) and subtracted from 100 in 
order to give the percentage change. The mean percentage change was calculated. 
Normality testing of data followed by Kruskal – Wallis H tests were carried out using IBM 
SPSS statistics 20 (IBM, Portsmouth, UK). 
 
3.2.2 Ribosomal Intergenic Spacer Analysis (RISA) 
RISA of faecal sample DNA was carried out by amplifying the intergenic region between the 
16S rRNA genes and 23S rRNA genes. Amplification of the ribosomal intergenic spacer region 
was achieved through the primer combination of 1406F (5’-TGYACACACCGCCCGT-3’) and 
23SR (5’-GGGTTBCCCCATTCRG-3’) (Fisher and Triplett 1999). PCR reactions (20 µL) were set-
up as previously described however; each reaction contained 40 ng of template DNA. The 
thermal cycler was programmed with an initial denaturing step of 95°C for 3 min, followed 
by 40 cycles of 95°C for 30 s, 55°C for 30 s, 72°C for 30 s with a final extension step of 72°C 
for 5 min. 
Products were initially visualised by gel electrophoresis before being loaded into either an 
Agilent 1000 or 7500 DNA chip (Agilent Technologies, Edinburgh, UK). Samples in the chip 
were visualised using the Agilent BioAnalyser 2100 (Agilent Technologies, Edinburgh, UK) 
micro-fluidics platform following manufacturer’s guidelines.  
3.2.2.1 Bioinformatic analysis of RISA products 
RISA data was exported from the Agilent Bioanalyser 2100 and was imported into 
GelCompar®II Version 4.5 (Applied Maths NV, Sint-Martens-Latem, Belgium) using a custom 
script. The script took the comma separated data from the Bioanalyser and converted the 
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data to GelCompar®II format Cluster analysis of percentage similarities between samples, as 
generated through Pearson's correlation coefficient, was carried out using Ward's method. 
Calculated Pearson's correlation coefficients for each sample were exported from the 
software. 
3.2.2.2 Automated Ribosomal Intergenic Spacer Analysis (ARISA) 
The same primers were used for ARISA as those in RISA. However, the primer 1406F was 
labelled with the fluorescein molecule 6-FAM at the 5’ end. ARISA products were treated as 
previously described for LHPCR. 
3.2.2.3 Bioinformatic analysis of ARISA products 
ARISA fragment analysis files were imported into SoftGenetics GeneMarker Version 1.91 and 
were processed as previously described for LHPCR. 
Raw AB1 ARISA fragment analysis files, generated through fragment analysis, were also 
uploaded to the ADAPT (Schmieder 2008) database for analysis. 
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3.3 Results 
3.3.1 Length heterogeneity PCR (LHPCR) testing 
3.3.1.1 Primer testing 
The single 6-FAM labelled 27F primer was tested with 3 different reverse primers (338R, 
358R and 534R) and a combination of 2 reverse primers (338R and 534R). For this 
experiment primer combination reproducibility was tested through the amplification of a 
single DNA sample in quadruplicate reactions using each primer combination. Through PCoA 
it was found that all primer combinations were highly reproducible (Fig. 3. 1). Both 534R and 
the dual target combination of 338R and 534R, clustered closely together. In order to inspect 
the reproducibility further, a heatmap (Fig. 3. 2) was generated which consolidated all the 
information from the electropherograms (Fig. 3. 3) of all the quadruplicate primer reactions. 
Samples NO9-NO16 appear to be clustered closely together, with no differentiation between 
the 534R primer alone and when it is combined with 338R as a dual target. Further 
inspection of the heatmap shows that the peaks generated by the 338R primer in the dual 
reaction (NO13-NO16) are low in their proportional abundance. Therefore, separate 
clustering of these 4 replicates from the 534R primer replicates (NO9-NO12) was not 
achieved. For further LHPCR experiments 358R will be used as the primer of choice, as this 
primer has previously been applied to LHPCR analysis of human faecal samples (Bjerketorp 
et al. 2008). 
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Figure 3.1| PCoA of LHPCR primer combinations– the first and second principal coordinates 
have been plotted, the variance explained is shown in brackets. The reverse primer used in 
conjunction with 6-FAM 27F have been colour coded, 338R, 358R, 534R and 338+534R are 
black, red, green and blue respectively. 
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Figure 3.2| Heatmap of LHPCR primer reproducibility– samples are shown on the right of 
the heatmap, NO1-NO4 = 338R, NO5-NO8 = 358R, NO9 -NO12 = 534R and NO13-NO16 = 
338/534R. Fragment sizes are shown in base pairs (bp) on the bottom of the heatmap. The 
proportion of each peak shown within a given sample is represented by a colour, which is 
shown in the Key. The software clusters the most similar samples next to one and other. 
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Figure 3.3| Electropherogram of a 534R LHPCR sample – Fragment sizes are shown on the 
bottom of the electropherogram and the fragment abundance, measured by fluorescence 
intensity, is shown by the peak height (which is measured on the left of the 
electropherogram). 
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3.3.1.2 Stability of the 6-FAM label on LHPCR products 
DNA was extracted from the 1st set of Cardiff faecal samples and subjected to LHPCR 
analysis. Products were subjected to immediate fragment analysis and also stored at -20°C 
for 2 weeks and 1 month before fragment analysis, to give 3 replicates for a given sample. 
The heatmap (Fig. 3. 4) shows that most replicates of a given sample clustered together (e.g. 
PH35 and PH30), while some replicates in a given sample did not (e.g. PH21 and PH25). 
Percentage change of samples, after storage at -20°C for 2 weeks and 1 month, was also 
calculated. This was achieved by comparing peak area ratios of stored LHPCR samples to 
their respective samples where fragment analysis was carried out immediately. The mean 
percentage change after storage for 2 weeks and 1 month was 15.71% (standard deviation 
from the mean (SD) = ± 16.9%) and 16.69% (SD = 18.8%) respectively (Fig. 3. 5). Therefore, it 
was decided that samples will be sent for fragment analysis without delay after LHPCR 
product generation. 
3.3.1.3 Reproducibility of LHPCR using the 358R primer and the reproducibility of faecal 
DNA extraction 
LHPCR was carried out twice on a single DNA sample obtained from three participants. The 
two LHPCR results for a given individual cluster together. Importantly individuals S1, S2 and 
S3 cluster separately from one and other (Fig. 3. 6). Through Pearson's correlation 
coefficient it is possible to see that S1 A and S1 B share 100% similarity, S2 A and S2 B share 
99.9% similarity and S3 A and S3 B share 99.5% similarity (Table 1). Therefore it is possible to 
conclude that intra-sample similarity is higher than the inter-sample similarity. For example 
S3 A and B share 89.2% and 88.9% similarity with S1 A respectively. This suggests that the 
technique is highly reproducible and can distinguish between DNA samples from different 
individuals.  
Five DNA extractions were performed on a single faecal sample and LHPCR analysis carried 
out on the DNA. After analysis and export of NPPARs the data was subjected to Pearson’s 
correlation coefficient analysis (Table 2). It is possible to see that the majority of the samples 
are highly similar. However, Extraction 3 shows a lower percentage similarity to the other 
extractions. This highlights the importance of the extraction method in a fingerprinting 
technique. 
 
.
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Figure 3.4| Heatmap to show 6-FAM stability – samples which were sent for fragment 
analysis immediately are shown in black, after 2 weeks of storage at -20°C in green and after 
4 weeks of storage at -20°C in blue. The proportional abundance of a fragment is 
represented by a colour, as shown in the key. 
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Figure 3.6| PCoA of two LHPCR analyses of a single DNA sample from 3 individuals – The 
first and second principal coordinates have been plotted, the variance explained is shown in 
brackets.  
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Figure 3.5| Mean percentage change in normalised peak area ratios of samples after storage at -
20°C – normalised peak area ratios of stored samples were compared to normalised peak area ratios 
of the same samples following immediate fragment analysis; error bars represent standard deviation 
from the mean. 
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Table 3.1| Pearson's correlation of two LHPCR runs from 3 individuals  
Single DNA extractions from 3 individuals (S1, S2 and S3) were subjected to LHPCR analysis 
twice; A = 1st LHPCR analysis and B= 2nd LHPCR analysis.  
 
S1 A S1 B S2 A S2 B S3 A S3 B 
S1 A 1.000      
S1 B 1.000 1.000     
S2 A .987 .987 1.000    
S2 B .988 .988 .999 1.000   
S3 A .892 .892 .893 .884 1.000  
S3 B .889 .889 .892 .884 .995 1.000 
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Table 3.2| Pearson's correlation of 5 DNA extractions using a single faecal sample  
5 DNA extractions were performed in a single faecal samples and were subjected to LHPCR 
analysis followed by Pearson’s correlation. 
 
Extraction 1 Extraction 2 Extraction 3 Extraction 4 Extraction 5 
Extraction 1 1.00     
      
Extraction 2 0.958 1.00 
  
 
     
 
Extraction 3 0.693 0.802 1.00 
 
 
     
 
Extraction 4 0.95 0.987 0.839 1.00  
     
 
Extraction 5 0.848 0.901 0.84 0.938 1.00 
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3.3.1.4 LHPCR analysis of probiotic strains used in study 
When subjected to LHPCR analysis the two L. acidophilus strains (Cul 21 and 60) showed a 
peak (fragment) at 372 bp while B. bifidum (Cul 20) showed a peak (fragment) at 351 bp. 
This information will be used while analysing the LHPCR profiles generated from study 
samples. 
 
3.3.2 LHPCR analysis of PROHEMI faecal DNA samples 
3.3.2.1 LHPCR analysis of all PROHEMI samples from Cardiff/Port Talbot and Sheffield 
based upon study period 
All Cardiff/Port Talbot and Sheffield faecal DNA samples were subjected to LHPCR analysis. 
PCoA of NPPARs based upon study period shows no effect of probiotic supplementation on 
the gross community profiles. Pre-feeding, Active and Washout samples clustered together 
(Fig. 3. 7). In order to interrogate the dataset further, the study centres were analysed 
separately. Probiotic supplementation showed no effect upon gross community profiles as 
shown by PCoA of Sheffield samples as Pre-feeding, Active and Washout samples clustered 
together (Fig. 3. 8). The same was observed in the Cardiff/Port Talbot samples where the 
Active and placebo groups were separated from one another and blindly assigned either 
Active group 1 (A1) or Active group 2 (A2). These two Active groups clustered together with 
Pre-feeding and Washout (Fig. 3. 9) following PCoA. It must be noted that outliers were 
observed in all groups, however, the majority of samples from each group clustered 
together. 
3.3.2.2 LHPCR analysis of all PROHEMI samples from Cardiff/Port Talbot and Sheffield 
based upon study centre 
PCoA of NPPARs, generated through LHPCR analysis, shows clustering based upon the study 
centre. Cardiff/Port Talbot and Sheffield samples clustered separately from one another (Fig. 
3. 10). Although there is an observable overlap between the two study centre clusters due to 
a few samples, it is clear that the two study centres cluster separately.  
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Figure 3.7| PCoA of all PROHEMI LHPCR samples with study period shown – study periods 
are shown on the plot (P = Pre-feeding, A = Active, W = Washout) and variation explained 
shown for each axis. PCoA was carried out using calculated Euclidean distances of NPPARs. 
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Figure 3.8| PCoA of Sheffield PROHEMI LHPCR samples with study period shown – study 
periods are shown on the plot (P = Pre-feeding, A = Active, W = Washout) and variation 
explained shown for each axis. PCoA was carried out using calculated Euclidean distances of 
NPPARs.
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Figure 3.9| PCoA of Cardiff/Port Talbot PROHEMI LHPCR samples with study period shown 
– study periods are shown on the plot (P = Pre-feeding, A1 = Active group 1, A2 = Active 
group 2, W = Washout) and variation explained shown for each axis. PCoA was carried out 
using calculated Euclidean distances of NPPARs. 
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Figure 3.10| PCoA through distance of all PROHEMI LHPCR samples with study centre 
shown – study centres are shown on the plot (C = Cardiff/Port Talbot, S = Sheffield) and 
variation explained shown for each axis. PCoA was carried out using calculated Euclidean 
distances of NPPARs. 
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3.3.2.3 LHPCR analysis of all PROHEMI samples from Cardiff/Port Talbot and Sheffield 
based upon study centre and study period 
Cluster analysis of all samples from both study centres suggests that samples cluster 
together due to the study centre and not study period (Fig. 3. 11). It is possible to see that 
Sheffield samples cluster together to the right hand side of the dendrogram, while 
Cardiff/Port Talbot samples cluster together to the left of the dendrogram. There are a few 
samples from Sheffield which cluster with the Cardiff/Port Talbot samples and vice versa. 
This would explain the slight overlap in clusters generated through PCoA (Fig. 3. 10). In 
addition a heatmap, generated through LHPCR analysis, was applied to the cluster analysis. 
The observed study centre clustering is driven by a difference in the community profiles of 
participants from the two study centres (Fig. 3. 12). Sheffield samples appear to have high 
proportional abundance of two to three peaks, as represented by the deep red colour. 
However, Cardiff/Port Talbot samples show a far lower proportional abundance of a range 
of peaks. This observation was further investigated through the generation of a heatmap 
from selected samples from different portions of the dendrogram (Fig. 3. 13). Sheffield 
samples cluster together and have a high proportional abundance of a peak at 356 base-
pairs (bp). Cardiff/Port Talbot samples have a range of peaks at a lower proportional 
abundance. Samples from Cardiff/Port Talbot also have peaks at 365-367 bp which are 
absent to low in the Sheffield samples. Furthermore, it is possible to see that samples which 
cluster with samples from the other centre, do so due to similar NPPARs e.g. 6PH36 and 
11PH7 (Fig. 3. 13). This information was combined with an in silico LHPCR experiment. 
Through the combination of these two methods, I hypothesise that the major driver for the 
separate clustering of Sheffield samples from Cardiff/Port Talbot samples, is the high peak 
area proportion seen in these samples at 356 bp. According to my in silico LHPCR experiment 
this fragment corresponds to the Bacteroidetes group of bacteria. Low and sometimes non-
existent proportional peak area abundances at 363-367 bp in the Sheffield samples were 
also observed. The in silico LHPCR experiment suggest that the Firmicutes group of bacteria 
would generate fragments of this size. The high abundance of the 356 bp fragment coupled 
with the low and sometimes non-existent proportional peak area abundance observed 
between 365-367 bp, drives the separate clustering of these two study centres (Appendix I).  
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Figure 3.11| Cluster analysis of all PROHEMI LHPCR samples with study centre and study 
period shown – study centre is shown on the inner ring (Cardiff/Port Talbot = blank and 
Sheffield = black) while study period is shown on the outermost ring (Pre-feeding = red, 
Active = green and Washout = blue). 
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Figure 3.12| Cluster analysis of all PROHEMI LHPCR samples with a heatmap of the 
community profile, generated through LHPCR, applied – electropherograms, generated 
through LHPCR, for a given sample were converted into a heatmap and applied to the cluster 
analysis. Proportional abundance is represented through a colour continuum from yellow 
(lowest) to orange to red (highest). Sheffield samples are represented by a black line on the 
inner side of the heatmap while Cardiff samples have been left blank. 
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Figure 3.13| Heatmap of selected samples from different study centres – generated 
through LHPCR analysis of PROHEMI samples. Participant sample is shown (Cardiff/Port 
Talbot = red and Sheffield = blue) with LHPCR fragment size and a key for proportional 
abundance.  
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It is also possible to see this difference in centre proportional peak abundances in another 
heatmap, where all the treatment groups and study periods are represented along with the 
study centre (Fig. 3. 14). It is once again possible to see a high proportional abundance of 
the fragments at 356 bp and also 358 bp in the Sheffield samples with little to no 
proportional abundance of fragments between 365-367 bp. Cardiff/Port Talbot samples 
exhibit an increased distribution of fragment sizes at lower abundance levels. The 
proportional abundances of 356, 363, 365, 366 and 367 fragments were plotted in a box-plot 
(Fig. 3. 15) In order to determine whether there was a significant difference in these 
proportional abundances the Kruskal-Wallis H test was utilised. The data were not normally 
distributed therefore, this test was used. The ranked mean of the 356 bp fragment was 
significantly higher in Sheffield samples than Cardiff samples [χ2 (1) = 42.349, p < 0.001]. 
Conversely, the mean rank of fragments, at 365-367 bp, were significantly higher in the 
Cardiff samples than Sheffield samples ([χ2 (1) = 113.763, p<0.001], [χ2 (1) = 64.285, p<0.001) 
and [χ2 (1) = 53.753, p<0.001] respectively). 
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Figure 3.14| Heatmap of all PROHEMI LHPCR samples – study centre is shown (C = Cardiff/Port Talbot and S = Sheffield) with study period (P = Pre-feeding, 
A = Active Sheffield, A1 = Active group 1 Cardiff/Port Talbot, A2 = Active group 2 Cardiff/Port Talbot and W = Washout) and proportional abundance key. 
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Figure 3.15| The abundance of NPPARs from PROHEMI LHPCR samples – the fragment size 
is shown in bp with a key for the centre where the sample came from. Box-plots represent 
the median, first and third quartiles of a given group of samples while outliers are 
represented by black dots. *denotes a significantly higher mean rank (p<0.05) 
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3.3.2.4 LHPCR analysis of Sheffield faecal samples and comparison with pervious LHPCR 
data 
Stored faecal samples from Sheffield participants were obtained and DNA was extracted 
from these samples at Cardiff University. LHPCR analysis was carried out on the newly 
extracted DNA. Repeat fragment analysis was also carried out on LHPCR products obtained 
from the corresponding original Sheffield DNA extractions, which were stored at -20°C. The 
newly generated LHPCR profiles were compared to the original LHPCR profiles generated 
from Sheffield DNA extractions, and also the LHPCR profiles generated from stored LHPCR 
products. Therefore, there are 3 repeats of LHPCR analysis for participants from the same 
time point. The results show a stark difference between the samples. Freshly extracted DNA 
clustered separately from the stored LHPCR products and original LHPCR profiles (Fig. 3. 16). 
Further inspection through the generation of a heatmap shows the driver for separate 
clustering (Fig. 3. 17). While the original Sheffield extractions showed a high proportional 
abundance of the fragments at 365-367 bp, this is not seen in the later LHPCR analysis of 
DNA extracted from the same samples at Cardiff. In this instance what there appears to be 
little to no proportional abundance of these fragments. Instead there is a high proportional 
abundance of the 365 bp fragment. This is a complete reverse to what was originally seen. 
Fragment analysis of stored LHPCR products from the same original Sheffield samples cluster 
with the original Sheffield LHPCR profiles. This is likely as a result of the stability of the 6-
FAM molecule as previously discussed. 
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Figure 3.16| PCoA of multiple LHPCR analyses on the same samples after storage – samples 
are clustered together based on the condition (1 = original LHPCR profiles from DNA 
extracted at Sheffield, 2 = LHPCR products of DNA extracted at Sheffield after storage at -
20°C and 3 = LHPCR profiles obtained from DNA extracted at Cardiff University after storage 
of the faecal sample). The variation explained for each axis is shown. 
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Figure 3.17| Heatmap of multiple LHPCR analyses carried out on the same samples after 
storage – the heatmap shows the proportional abundance of fragments within a sample. 
Conditions for each sample are indicated by colour with black = original LHPCR profiles from 
DNA extracted at Sheffield, red = LHPCR profiles of LHPCR products from DNA extracted at 
Sheffield after storage at -20°C and green = LHPCR profiles obtained from DNA extracted at 
Cardiff University after storage of the faecal sample. 
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3.3.2.5 Percentage changes in LHPCR profiles of all PROHEMI samples from Sheffield based 
upon study period 
The average percentage change between LHPCR profiles within a given study period was 
calculated. One-way ANOVA showed no significant difference [F (2, 799) = 0.411, p=0.663] 
between the Pre-feeding, Active and Washout periods was observed (Fig. 3. 18). Percentage 
changes for Pre-feeding, Active and Washout periods were 19.61%, 19.3% and 16.39% 
respectively. The average percentage change was also calculated on an individual basis for 
each study period (Fig. 3. 19). There were different observed responses to probiotic 
administration. Participants PH6 and PH9 showed a lower percentage change during the 
Active period which increased upon cessation of the probiotic. However, participants PH1, 
PH4 and PH17 showed an increase in percentage change during the Active period which 
decreased upon cessation of the probiotic. In addition, some participants such as PH5 and 
PH16, showed little response to probiotic administration with similar percentage changes for 
all study periods. It was not possible to calculate percentage changes for some participants, 
such as PH12 and PH18, due to a lack of samples. 
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Figure 3.18| Percentage change between Sheffield LHPCR samples within a given study 
period – the average percentage change between LHPCR profiles from Sheffield within a 
given study period is shown with error bars representing the standard deviation from the 
mean. 
 
Figure 3.19| Percentage change between Sheffield participants’ LHPCR samples within a 
given study period – the average percentage change in LHPCR profiles of individuals from 
Sheffield within a given study period is shown.  
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3.3.3 Ribosomal Intergenic Spacer Analysis (RISA) of faecal DNA 
RISA profiles of 3 individuals at two different time points (before the feeding study and one 
week into the study) were tested along with an extra individual’s sample from before the 
commencement of the study (Fig. 3. 20). Three DNA extractions from a single sample (PH27 
1, PH27 2 and PH27 3) were also compared. The RISA products obtained were bunched 
closely at the 700-1000bp region, making it difficult to identify inter and intra individual 
differences (Fig. 3. 21). The RISA products were then loaded onto a 7500 chip and the 
products were once again bunched (Fig. 3. 22). Pearson's correlation coefficient analysis of 
the two chips shows ≥95% similarity with the 1000 chip and ≥98% with the 7500 chip. Both 
inter and intra individual differences are highly similar. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20| RISA of faecal DNA from the PROHEMI study - lanes 1-5 show the RISA profiles 
participants PH25, PH26, PH27, PH29 and PH30 respectively at the beginning of the feeding 
study. Lanes 6-9 show the RISA profiles participants PH25, PH26, PH27 and PH29 
respectively following one week of probiotic supplementation. While lanes 10-12 show the 
RISA profiles of 3 DNA extractions from one homogenised faecal sample. 
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Figure 3.21| Composite dendrogram generated through RISA of PROHEMI samples using the Bioanalyzer 1000 chip – samples are clustered based on 
percentage similarity where P = Pre-feeding and A= Active. The analysis also contains three sets of RISA products from a single DNA extraction of DNA 
obtained from participant PH27. The figure shows the RISA profile generated for each sample also. 
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Figure 3.22| Composite dendrogram generated through RISA of PROHEMI samples using the Bioanalyzer 7500 chip – samples are clustered based on 
percentage similarity where P = Pre-feeding and A= Active. The analysis also contains three sets of RISA products from a single DNA extraction of DNA 
obtained from participant PH27. The figure shows the RISA profile generated for each sample also. 
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Table 3.3| Pearson's correlation coefficient analysis of RISA products obtained from a Bioanalyzer 1000 chip  
The table contains 5 Pre-feeding samples from different participants (P), 4 Active samples (A) from different participants and 3 RISA products from different DNA 
extractions from PH27 at a single time-point (PH27 1, PH27 2 and PH27 3). 
 Sample 
 
PH27A PH30P PH25P PH29P PH26P PH27P PH29A PH25A PH27 1 PH27 2 PH27 3 PH26A 
PH27A 1.000 
           
PH30P 0.994 1.000 
          
PH25P 0.993 0.991 1.000 
         
PH29P 0.99 0.993 0.988 1.000 
        
PH26P 0.985 0.989 0.981 0.984 1.000 
       
PH27P 0.989 0.991 0.988 0.989 0.991 1.000 
      
PH29A 0.989 0.986 0.98 0.985 0.983 0.98 1.000 
     
PH25A 0.979 0.987 0.977 0.986 0.984 0.98 0.966 1.000 
    
PH27 1 0.988 0.993 0.985 0.986 0.987 0.989 0.977 0.99 1.000 
   
PH27 2 0.99 0.999 0.986 0.977 0.983 0.989 0.977 0.976 0.993 1.000 
  
PH27 3 0.988 0.985 0.985 0.971 0.976 0.982 0.977 0.967 0.988 0.996 1.000 
 
PH26A 0.974 0.974 0.974 0.968 0.955 0.964 0.965 0.951 0.966 0.97 0.97 1.000 
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Table 3.4| Pearson's correlation coefficient analysis of RISA products obtained from a Bioanalyzer 7500 chip 
 Sample 
 PH29P PH30P PH26P PH25P PH27P PH25A PH27 1 PH27 3 PH27A PH27 2 PH29A PH26A 
PH29P 1.000 
           PH30P 0.996 1.000 
          PH26P 0.996 0.995 1.000 
         PH25P 0.996 0.994 0.993 1.000 
        PH27P 0.995 0.994 0.995 0.997 1.000 
       PH25A 0.99 0.987 0.989 0.993 0.989 1.000 
      PH27 1 0.995 0.996 0.992 0.991 0.991 0.986 1.000 
     PH27 3 0.992 0.993 0.999 0.993 0.988 0.984 0.997 1.000 
    PH27A 0.994 0.993 0.99 0.992 0.991 0.987 0.995 0.996 1.000 
   PH27 2 0.999 0.988 0.988 0.991 0.99 0.989 0.99 0.993 0.993 1.000 
  PH29A 0.987 0.983 0.985 0.987 0.985 0.986 0.982 0.987 0.993 0.995 1.000 
 PH26A 0.986 0.979 0.98 0.984 0.982 0.983 0.981 0.981 0.986 0.986 0.985 1.000 
The table contains 5 Pre-feeding samples from different participants (P), 4 Active samples (A) from different participants and 3 RISA products from different DNA 
extractions from PH27 at a single time-point (PH27 1, PH27 2 and PH27 3). 
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3.3.3.1 Automated Ribosomal Intergenic Spacer Analysis (ARISA) of faecal DNA 
RISA profiles were successfully generated from faecal DNA using the newly 6-FAM labelled forward primer 
(Fig. 3. 23). However, analysis using GeneMarker and analysis using the ADAPT system was not possible due 
to the generation of incomplete fragment analysis files. 
 
 
 
 
 
 
 
 
Figure 3.23|. Gel electrophoresis of ARISA products using a 6-FAM labelled forward primer – successful 
amplification of 16 faecal DNA samples with a negative control and 2-log ladder. 
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3.4 Discussion 
3.4.1 Length heterogeneity PCR (LHPCR) 
LHPCR has previously been used as a community fingerprinting method using faecal DNA as 
the template material. However, studies such as these are often short-term and often have a 
limited number of subjects, e.g. one patient and only 3 samples (Bjerketorp et al. 2008), or 
sampling only occurs once (Suzuki et al. 1998). The long-term PROHEMI study scrutinised the 
suitability of LHPCR as a viable fingerprinting method for long-term use and for multiple 
individuals. While all LHPCR primer combinations showed promise, with the exception of the 
DT-LHPCR primers, it was decided that the primer combination of 27F and 358R would be 
used. This primer combination has previously been applied to the human gut (Bjerketorp et 
al. 2008). Pearson's correlation coefficient analysis of multiple DNA extractions from one 
individual, shows that the extraction method can impact upon the LHPCR profile obtained. 
However, LHPCR analysis itself appears to be highly reproducible as intra-sample similarity is 
higher than inter-sample similarity. This is provided that LHPCR samples are subjected to 
fragment analysis as soon as possible due to stability of the 6-FAM label.  
Following primer and reproducibility testing, LHPCR was applied in order to monitor the 
community fingerprints of individuals' faecal DNA samples during the course of the study. 
The results show no gross change in the LHPCR profiles when samples are analysed within 
distinct period groups. Samples from each period and group (Pre-feeding, Active Sheffield, 
Active group 1, Active group 2 and Washout) cluster together through AGNES clustering and 
PCoA. Percentage change analysis was also carried out on Sheffield samples alone and 
showed no significant difference between the Pre-feeding, Active and Washout periods. This 
suggests that probiotic supplementation does not alter the gross bacterial community of a 
healthy individual. In order to scrutinise the dataset further, information from my in silico 
LHPCR experiment, fragment sizes of the probiotic organisms and LHPCR data from the 
PROHEMI samples were combined. There was no increase in fragment abundance at 372 bp 
or 351 bp, the fragment sizes expected to be generated by L. acidophilus (Cul 21 and 60) and 
B. infantis (Cul 20) respectively from my analyses, while probiotic supplementation takes 
place. It must be noted that the dendrogram generated through AGNES clustering of LHPCR 
samples shows clustering of Active Sheffield samples. However, I do not believe that this is 
due to probiotic supplementation. Instead, I believe this is due to geographical differences in 
the distal gut bacterial community of individuals and this will be discussed later. 
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Analysis was also carried out on an individual basis using Sheffield samples alone. This was in 
order to ensure that participants who potentially showed a response to probiotic treatment 
were not masked by those who did not. Varied responses to the consumption of the 
probiotic were observed. Some participants, such as PH4, show an increase in percentage 
change while consuming the probiotic supplement suggesting a bacterial modulating effect. 
However some participants, such as PH6, show a decrease in percentage change while 
consuming the probiotic suggesting a potential stabilising effect. This observed duality in 
responses is further complicated by participants, such as PH16, who show little change in 
response to probiotic supplementation. It is therefore difficult to draw any conclusions from 
this particular analysis. It may be that there is a case of responders to supplementation 
against non-responders. The incidence of responders and non-responders to probiotic 
treatment is not unheard of (Reid et al. 2010). This phenomenon is often seen when the 
infirm are treated with probiotics. However, these results suggest that this occurs in healthy 
individuals also. The responders group is further complicated by different responses. This 
suggests that the response to probiotic supplementation is individual and differs from 
person to person. While some individual changes were observed during probiotic treatment, 
there is no clear response across the whole probiotic taking cohort. This makes the role of 
probiotic supplementation in modulating the gut bacterial community difficult to elucidate. 
Analysis of LHPCR data was carried out based upon study period also, with Cardiff/Port 
Talbot samples being compared to Sheffield samples. The analyses show separate clustering 
of samples based upon study centre. PCoA shows separate clustering of the two study 
locations in agreement with the dendrogram generated through AGNES clustering. In order 
to ascertain the driving force between the observed clustering a heatmap was applied to the 
dendrogram. There is a large abundance of a few fragments in the Sheffield samples while 
there is a lower abundance of a larger range of fragments in the Cardiff/Port Talbot samples. 
Where samples from Cardiff/Port Talbot cluster with Sheffield samples, it is possible to see a 
similar fingerprint profile in Cardiff/Port Talbot samples to the Sheffield samples and vice 
versa. Samples from each cluster were selected and a heatmap generated in order to 
determine the fragment sizes observed. This data was once again combined with my in silico 
LHPCR experiment in order to assign an approximate taxonomic identity to the fragment of a 
given size. Following the in silico LHPCR experiment I believe that the Sheffield samples have 
a high abundance of Bacteroidetes fragments as shown by the significantly high proportional 
abundance of the 356 bp fragment. The Sheffield samples show a significantly lower 
proportional abundance of fragments at 365-367 bp than the Cardiff samples. The in silico 
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LHPCR experiment suggests that the Firmicutes would generate fragments of this size and 
are therefore present at low numbers in the samples obtained from Sheffield (Appendix I). 
Investigation of the samples obtained from Cardiff/Port Talbot shows a greater distribution 
of fragments at lower proportional abundance. In addition, the putative fragment sizes 
generated by the Bacteroidetes and Firmicutes are generally evenly represented in samples 
from Cardiff/Port Talbot.  
It has been noted previously that the ratio of Firmicutes/Bacteroidetes alters with age 
(Mariat et al. 2009). The authors show that the level of Firmicutes is lower in infants than in 
adults and the elderly. However, Bacteroidetes levels remain fairly uniform in infants, adults 
and the elderly. The participants in the study were all adults and not elderly. Therefore, the 
results suggest geographical differences between the gut bacterial community of individuals 
as Cardiff and Port Talbot are in Wales, while Sheffield is in the north of England. It has been 
shown previously that geographical differences can drive changes in the gut bacterial 
community of an individual, usually with diet being the major driver. The gut bacterial 
community of children from the European Union (EU) has been compared to children from 
Burkina Faso (De Filippo et al. 2010). Children from the EU had a significantly higher level of 
Firmicutes than children from Burkina Faso (63.7% vs. 27.3% respectively, p = 7.89 x 10-5). 
The expected reverse was shown in children from Burkina Faso as a significantly higher level 
of Bacteroidetes was observed compared to children from the EU (57.7% vs. 22.4%, p = 1.19 
x 10-6). The believed reasons behind this difference are different diet habits. In another study 
PCoA of unweighted Unifrac distances derived from 16S rRNA datasets, show separate 
clustering of USA adults from Malawians and Amerindians. The Malawian and Amerindian 
populations clustered together (Yatsunenko et al. 2012). These studies show differences 
between very different populations, with different ethnicities and from very different 
countries.  
CHAPTER 3 – COMMUNITY PROFILING OF FAECAL DNA FROM THE PROHEMI STUDY 
106 
 
However, my results suggest a possible difference in the gut bacterial community of 
individuals based on geographical location in the UK. I believe that the 
Firmicutes/Bacteroidetes ratio is responsible for the clustering of Active Sheffield samples. 
During the Active period of the study a larger number of samples were provided. Therefore, 
the Firmicutes/Bacteroidetes ratio difference gives the appearance of clustering due to 
probiotic supplementation. While a geographical difference in gut microbiota composition is 
an interesting conclusion it would be prudent to meet this conclusion with some scepticism. 
Due to the nature of this study, DNA extractions were carried out at the two study centres 
and not at one alone. However, the apparent lack of Firmicutes in the Sheffield samples 
immediately raises the question of whether DNA extraction protocol was followed correctly; 
particularly the need to bead beat the samples. In order to ensure that there were no lab 
generated differences, I carried out DNA extractions on faecal samples from Sheffield which 
had DNA extracted previously. When compared, there was a completely different 
community fingerprint from the original extracted DNA observed. That is to say that the DNA 
extraction which I carried out generated different results to the DNA which was originally 
extracted at Sheffield. When the more recent DNA extractions were compared to their 
respective original DNA extractions, a difference in the fragments and abundances 
generated was seen. The recent extractions showed a high proportional abundance of 
fragments at 365-367 bp, putatively Firmicutes, and a low proportional abundance of the 
356 bp, putatively Bacteroidetes. This observable antithesis between community fingerprints 
obtained from the same faecal samples is most likely due to the effect of storage on the 
faecal sample. The effect of storage and the effect of DNA extraction method on the 
bacterial community acquired has been discussed in Chapter 6. It is difficult to say with 
complete certainty that there is a geographical difference in the gut bacterial community of 
individuals in this study. Unfortunately, the possibility of a methodological artefact in this 
instance cannot be ruled out.  
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LHPCR has been successfully applied to a range of complex ecosystems. The technique has 
been applied to monitor changes in bacterial composition of industrial processes. Tiirola and 
colleagues monitored the change in bacterial composition of a thermophilic biofilm process 
for the treatment of pulp and paper ill white-water lining (Tiirola et al. 2003). For this study, 
a different primer combination was used. The primer fD1 (5'-AGAGTTTGATCCTGGCTCAG-3'), 
which was designed to amplify the majority of eubacteria (Weisburg et al. 1991) was used as 
a forward primer in combination with 518R (5'-ATTACCGCGGCTGCTGG-3') (Muyzer et al. 
1993). In this instance the reverse primer was labelled with the fluorescent molecule IRD-
800. Differences in LHPCR profiles were observed between attached and suspended 
biomass. Furthermore, LHPCR profiles altered following pH shocks in the biofilm. This shows 
that LHPCR can discern differences in communities and also can detect differences in the 
bacterial community community following perturbations. LHPCR has also been applied in 
order to monitor the succession of LAB during the ensiling of maize (Brusetti et al. 2006). In 
this study, the universal primer 27F was used in conjunction with 338R primer (Rogers et al. 
2003). The technique showed changes in the microbial composition as the fermentation 
process progressed from day 0 to day 30. This study shows that the technique can be used in 
order to measure the differences in a microbial community temporally.  
While LHPCR is a useful technique for comparing microbial communities in terrestrial 
ecosystems and industrial processes, it has also been applied to assess changes within the 
human body. Sputum from cystic fibrosis patients was compared using this technique 
(Rogers et al. 2003). The previously mentioned reverse primer 338R was used in conjunction 
with 8F (5'-AGAGTTTGATCCTGGCTCAG-3'), which was labelled with 700IR. The technique 
showed differences in the bacterial community community of individuals. The technique 
showed 10 distinct LHPCR profiles for 14 cystic fibrosis individuals. The technique has also 
been utilised in order to assess whether alcoholism affects the colonic microbiome (Mutlu et 
al. 2012). Faecal material was not the source of DNA in this study instead; biopsies of the 
colonic tissue were taken. The study use the universal primer 27F labelled with 6-FAM in 
conjunction with 355R (5'-GCTGCCTCCCGTAGGAGT-3') in order to generate LHPCR profiles. 
PCoA and plotting of the first, second and third components showed that alcoholics with and 
without alcoholic liver disease clustered away from the healthy controls. The results show 
that LHPCR is a suitable technique in order to determine lifestyle driven differences in the 
composition of the mucosa-associated bacterial community.  
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Mutlu and colleagues used colonic biopsy material as a source of DNA (Mutlu et al. 2012). 
However, faecal material has also been used as a source of DNA. Bjerketorp and colleagues 
used faecal samples of a healthy man before, during and after antibiotic intervention as a 
source of DNA for LHPCR analysis (Bjerketorp et al. 2008). The primers used, 27F and 358R, 
were utilised in this study. The reproducibility of this primer pair was tested and also applied 
in order to determine differences in the bacterial community composition following 
antibiotic therapy. The technique shows differences in the LHPCR profiles between the three 
samples from different times of treatment. Preliminary testing of this primer combination 
during the PROHEMI study also showed that the technique is reproducible. While the 
technique itself is highly reproducible, variability in LHPCR profiles was generated through 
DNA extraction. Researchers should be aware of this before drawing biological conclusions 
on a low sample dataset. This method can be applied to a large study in order to assess 
changes in bacterial community composition of the human distal microbiome. The method is 
relatively high-throughput and inexpensive to carry out. Researchers may use the technique, 
as Mutlu and colleagues (Mutlu et al. 2012) have, in order to select samples of interest for 
next generation sequencing. 
 
3.4.2 Ribosomal Intergenic Spacer Analysis (RISA) and Automated Ribosomal 
Intergenic Spacer Analysis (ARISA) 
RISA has been successfully applied to monitor changes in complex ecosystems such as the 
soil (Ranjard et al. 2001) and freshwater (Fisher and Triplett 1999). The technique has also 
been applied to monitor gut bacterial DNA in faecal material, obtained from colorectal 
cancer patients (n=20) (Scanlan et al. 2008). Patients were followed for a period of 3 
months, showing the suitability of the technique to monitor bacterial community 
fingerprints over a period of time. Due to its precedent of use in complex ecosystems, the 
aim was to use RISA/ARISA as another community fingerprinting method to complement 
LHPCR. Initially RISA samples were separated using the Bioanalyzer 1000 chip. The chip used 
in this instance provided poor fragment separation as samples from different individuals 
showed ≥95% similarity. I therefore separated the RISA fragments through the use of a 
Bioanalyzer 7500 chip. Inspection of the composite dendrogram shows that the 7500 chip 
also provided poor fragment separation. Further analysis through Pearson’s correlation 
coefficient analysis shows that samples from different individuals show ≥98% similarity 
when RISA products are separated using the 7500 chip. Therefore this chip was poorer than 
the 1000 chip in terms of fragment separation. Due to the encountered problems with poor 
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separation of bands using the Bioanalyzer microfluidics platform I experimented with the 
use of ARISA. The forward RISA primer was labelled with the fluorescein molecule 6-FAM 
with the aim to carry out fragment analysis in a similar manner to LHPCR. Unfortunately, 
fragment analysis of these samples generated incomplete files which did not contain the size 
standard in its entirety and did not contain complete ARISA profiles. Therefore, downstream 
processing of the samples could not be carried out. I believe that the size of fragments 
generated from ARISA exceeds the capabilities of the ABI 3130xl machine and through this 
generates incomplete files.  
Owing to the results from RISA and ARISA, it was decided not to apply this technique to the 
dataset. RISA profiles generated through the use of the Bioanalyser microfluidics platform 
were too similar, due to poor fragment separation, to discern small differences. LHPCR 
showed a greater amount of inter-sample variation than RISA and was therefore seen as a 
more viable method to use in the study. It was hoped that ARISA could be used in 
conjunction with LHPCR as fragment analysis using the ABI 3130xl machine would have 
provided greater fragment separation than the Bioanalyser. However, the generation of 
incomplete fragment analysis files ensured that this technique could not be utilised in this 
study. 
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3.5 Conclusions 
The main conclusions for this chapter are as follows: 
1. LHPCR can be used successfully in order to monitor gross changes in the community 
fingerprint of faecal DNA; 
 
2. probiotic supplementation does not appear to modify the gross community 
fingerprint of faecal DNA; 
 
3. there appears to be a geographical difference in the community fingerprint of faecal 
DNA of PROHEMI participants with a difference in the ratio of Bacteroidetes to 
Firmicutes observed; 
 
4. through an in silico LHPCR experiment it is possible to assign broad taxonomic 
identities to peaks in LHPCR profiles. 
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4. CULTURE DEPENDENT ANALYSIS OF FAECAL MATERIAL AND FAECAL 
WATERS FROM THE PROHEMI STUDY 
4.1 Introduction 
In recent years there has been more of a focus on the use of culture independent methods 
in order to analyse complex ecosystems. These ecosystems include the soil (Janssen 2006), 
freshwater (Glöckner et al. 2000) and humans (The Human Microbiome Consortium 2012). 
While 16S rRNA gene cataloguing of ecosystems has become fairly routine, due to the 
reduction in sequencing costs, the technique does not directly show the functions expressed 
within an ecosystem. In order to meet this requirement PICRUSt was developed in order to 
predict the functions present within a community using only 16S rRNA genes as the starting 
point (Langille et al. 2013). However, the technique only infers possible expression and 
presence of functions. Metagenomic libraries may be screened for functions of a particular 
interest, through functional metagenomics in a surrogate host. This technique has been 
applied to identify functional bile salt hydrolases (BSH) in the human gut (Jones et al. 2008). 
Studies such as this hint at the functions which may be expressed within a given community. 
Alternatively, RNA can be converted into complementary DNA (cDNA) in order to create a 
metagenomic library of expressed genes. The technique has been applied in order to analyse 
ocean surface waters (Frias-Lopez et al. 2008). Drawbacks with the use of metagenomic 
interrogation strategies have previously been discussed (de Lorenzo 2005), and include the 
inability of a host to correctly express the gene of interest. 
While the importance of community profiling of 16S rRNA gene sequencing cannot be 
overlooked, it is also important to understand the functions which are being expressed. With 
regards to our microbiome, it is estimated that 100-fold more unique genes are expressed 
by this virtual organ (Qin et al. 2010). Bacterial encoded enzymes, which may have 
previously seemed insignificant, are now beginning to attract attention. Polysaccharides, 
including starch and pectin, have been shown to be broken down by bacterial glycosidases 
and polysaccharidases (Englyst et al. 1987). Recent research has also shown that bacterial 
encoded β-glucuronidases are also important. These enzymes, expressed in the gut, are 
responsible for a high level of free catecholamines in the gut lumen (Asano et al. 2012). -
glucuronidases in the gut free catecholamines from their conjugated inactivated forms, with 
dopamine the highest catecholamine produced. Furthermore, bacterial β-glucuronidases 
affect the body's excretion of toxic compounds, undoing the process of glucuronidation. It 
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has been shown that the glucuronide form of bisphenol A, an oestrogen which has been 
shown to damage the reproductive system of animals, is deconjugated in the cecum of rats 
(Sakamoto et al. 2002). It has also been shown that the glucuronidation of the carcinogen 2-
amino-3-methylimidazo[4, 5-f] quinioline is reversed by bacterial β-glucuronidase (Humblot 
et al. 2007). Deconjugation of its inActive form releases the Active carcinogen in the gut 
lumen. Research such as this shows the pivotal role that bacterial β-glucuronidases have 
upon the body's excretion of toxic compounds. 
As well as producing enzymes to break down carbohydrates, gut bacteria also produce 
proteases. Proteases have been implicated in the progression of IBS and IBD. Research has 
shown that proteolytic activity was 2-3 and 6-fold higher in IBS and IBD patients respectively, 
than healthy patients (Cenac et al. 2007). Metalloproteinases, including collagenases, have 
been implicated in the progression of IBD. UC patients have a significantly (p = 0.0051) 
higher level of metalloproteinase activity at inflamed areas of the mucosa than unaffected 
areas. Furthermore, the unaffected mucosal areas of UC patients had a significantly (p < 
0.001) higher level of metalloproteinase activity than unaffected areas in control patients. 
The proteases implicated in the progression of these two inflammatory conditions were 
thought to be host-derived. However, the importance of bacterial proteases in the 
progression of these two conditions is now being researched. The bacterial gelatinase 
enzyme GelE has been shown to contribute to the development of experimental colitis in a 
murine model (Steck et al. 2011). GelE is produced by the abundant gut commensal 
Enterococcus faecalis, suggesting a role for our resident commensal microbiota in the 
progression of this disease. Bacterially encoded proteases, such as elastase-like enzyme 
from Pseudomonas spp. and mirabilysin of Proteus mirabilis, are also capable of degrading 
immunoglobulin G1 (IgG1) (Brezski and Jordan 2010). It is thought that these proteases act as 
virulence factors and may be an evasion tactic employed by these bacteria. 
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Cholesterol, a sterol produced by our own bodies and obtained from our diet, is a major risk 
factor for cardiovascular disease development (British Heart Foundation 2013). It has been 
shown that bacteria, such as soil dwelling Streptomycetes, express a cholesterol oxidase 
enzyme (choA) and has been expressed in E. coli (Solaiman and Somkuti 1991). Earlier 
research hinted that the ability to degrade cholesterol is not limited to Streptomycetes. The 
feeding of milk fermented with Streptococcus thermophilus lowered the plasma levels of 
cholesterol in male rats and also lowered liver cholesterol levels (Rao et al. 1981). In a more 
recent study, faecal bacteria of healthy individuals were shown to assimilate cholesterol 
(Pereira and Gibson 2002). Amongst the cholesterol assimilators were bifidobacteria, 
lactobacilli and enterococci. The lactobacilli and bifidobacteria shown to exhibit cholesterol 
assimilation were isolated from faecal material and commercial probiotic products. 
Cholesterol assimilating enterococci were isolated from faecal material. The results highlight 
the ability of our resident microbiota to degrade and assimilate cholesterol as well as 
bacteria used in commercial products. 
Gastric and pancreatic lipases break down complex lipids into monoglycerides for intestinal 
absorption (Carriere et al. 1993). These enzymes also play a pivotal role in essential 
mammalian processes such as non-shivering thermogenesis. This is where thermogenin 
(uncoupling protein), produced in the mitochondrion, produces heat in brown adipose 
tissue. Within brown adipose tissue the expression of lipoprotein lipase is upregulated, 
increasing triglyceride turnover and therefore making more energy available for heat 
production (Cannon and Nedergaard 2004). Bacteria also produce lipases; this has been 
previously discussed in detail (Jaeger et al. 1994). These enzymes are used as colonisation 
factors by Propionibacterium acnes and Staphylococcus epidermidis (Jaeger et al. 1994) and 
are thought to act as a virulence factors in some instances. Research has shown that the 
ExoU cytotoxin, produced by Pseudomonas aeruginosa, is a lipase (Sato et al. 2003). 
Furthermore, the cytotoxin appears to require activation or modification by Eukaryotic 
factors. 
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Probiotic administration has been shown to affect functions, provided by our resident gut 
microbiota. The multi-probiotic VSL-3 (3 x 1011 CFU/g) was fed daily to 10 patients with IBS 
and 4 patients with functional diarrhoea for 20 days. Urease activity was significantly (p < 
0.01) decreased and β-galactosidase activity was significantly (p < 0.01) increased through 
probiotic administration (Brigidi et al. 2001). Colon cancer model mice were fed daily with 
yoghurt containing S. thermophilus and Lactobacillus delbrueckii subsp. bulgaricus (2 x 108 
cells/mL), yoghurt supernatant or milk. Results showed that the probiotic yoghurt 
consuming mice had a significantly (p < 0.01) lower level of β-glucuronidase activity than 
mice consuming yoghurt supernatant or milk (De Moreno et al 2005). Research such as this 
suggests that probiotic administration can have a significant impact on the functions 
expressed in our gut. 
Changes to human diet in recent years have been implicated in the increase of diseases such 
as chronic kidney disease (Pecoits-Filho 2007), obesity and cardiovascular disease (CVD) 
(Fung et al. 2001). The "Western diet" has also been implicated in increasing the 
genotoxicity of faecal water (Rieger et al. 1999). Genotoxic compounds can cause DNA 
damage in the host and have been linked with colorectal cancer (Hughes et al. 2000). 
Genotoxicity testing was classically carried out using the Ames tester strain through 
screening for histidine reversion (Ames et al. 1975). Efforts have been made in order to 
make screening quantitative as opposed to qualitative e.g. the E. coli SOS test (Quillardet et 
al. 1982). This organism utilises β-galactosidase as a measurable colorimetric indicator of 
SOS induction and therefore, by proxy determines the genotoxicity of a given compound. 
Genotoxicity testing protocols, such as the comet assay, have been developed in order to 
make the process more biologically relevant to eukaryotic cells (Collins 2004).  
With regards to probiotic administration, it has been shown that probiotics can decrease the 
genotoxicity of faecal water (Oberreuther-Moschner et al. 2004). The genotoxicity of faecal 
waters of individuals who consumed a daily dose of ~109 L. acidophilus 145 and B. longum 
913 were compared to faecal waters of individuals who consumed control yoghurt. The 
probiotic yoghurt significantly (p < 0.05) reduced the induction of DNA strand breaks, as 
measured through a comet assay of HT-29 stem cells. There is therefore a precedent for 
probiotic organisms to modulate genotoxicity levels of faecal waters in humans. The 
research not only highlights the ability of the organisms to survive passage through the GIT 
but also their ability to exert anti-genotoxic effects. 
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4.1.2 Chapter Aims 
The aims of this chapter are as follows: 
 
1. to determine whether the numbers of bacteria expressing functions including protease, 
esterase/lipase, β-galactosidase, β-glucuronidase and cholesterol degrading activity are 
affected by probiotic administration; 
 
2. to determine whether there is a difference in the numbers of bacteria expressing 
functions including protease, esterase/lipase, β-galactosidase, β-glucuronidase and 
cholesterol degrading activity between the two study centres; 
 
3. to determine whether probiotic administration affects the genotoxicity of faecal waters 
from healthy individuals. 
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4.2 Methods and materials  
4.2.1 Culture conditions and bacterial strains used for culture dependent analysis 
During the course of the PROHEMI study many bacterial strains were used (Table 4.1 and 
Table 4.2). These strains were used in the development of functional media and genotoxicity 
testing. 
4.2.2 Functional screening media 
4.2.2.1 Development of the screening media 
4.2.1.1.1 Skimmed milk agar for the detection of extracellular protease activity 
This agar was made as previously described (Jones et al. 2007a). Briefly, sterile skimmed milk 
was added to the appropriate base medium at a final concentration of 1% (w/v) after 
sterilising through autoclaving at 121°C for 15 min. B. subtilis MY2016 was used as a positive 
control for protease activity while B. subtilis WB800N was used as a negative control (Table 
4.1). Tryptone soya agar (TSA) (see section 4.2.3) was used as the base medium for B. 
subtilis. 
4.2.1.1.2 Buffered Protease Agar (BPA) for the detection of extracellular protease activity 
Skimmed milk agar was made as previously described (Jones et al. 2007b). The pH of the 
medium was adjusted to 7.2 and buffered through the addition of a phosphate buffer to the 
agar base at a final concentration of 0.01 M. Phenol red, at a concentration of 100 mg/L, was 
also added to the agar base before sterilising through autoclaving at 121°C for 15 min. The 
phenol red served as a pH indicator changing from red to yellow when it becomes acidified. 
BPA plates were also made with a concentration of 0.1 M phosphate buffer, while all other 
components remained unchanged. In order to develop the agar B. subtilis MY2016 and B. 
subtilis WB800N were used as protease positive and negative controls respectively (Table 
4.1). TSA was used as the base medium for B. subtilis. The 0.01 M phosphate BPA plate was 
also incubated following the spread of a faecal slurry. Luria Bertani (LB) agar (see section 
4.2.3) was used as the base medium for the faecal slurry. 
The ability of the 0.1 M BPA agar to withstand acidification of the medium was tested 
through hydrochloric acid. A 10-fold serial dilution of concentrated hydrochloric acid (~11.65 
M) (Sigma-Aldrich company Ltd. Dorset, UK) was made and applied to the agar in a single 
drop. 
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Table 4.1| Bacterial strains and culture conditions used in the PROHEMI study 
 
 
 
Species Strain Notable feature Growth conditions Reference 
Escherichia coli 
EPI300 
(pCCFOS110 clone) 
β-galactosidase activity 
Luria Bertani (LB) broth + 
12.5µg/mL chloramphenicol 
at 37°C 
(Jones et al. 2007b) 
 
 
EPI300 
 
Lipase/esterase activity 
 
(Jones et al. 2007b) 
 
EPI300 
(choA) 
 
Cholesterol degrading 
activity 
 
(Jones et al. 2007b) 
 
Nissle 
 
β-glucuronidase activity 
 
Lab collection 
Saccharomyces cerevisiae BY4741 Genotoxicity testing strain 
TGA + 50 µg/mL ampicillin at 
37°C 
(Zhang et al. 2008) 
Bacillus subtilis 
MY2016 Protease activity 
TSA/TSB at 30°C 
Lab collection 
WB800N No protease 
Activity 
(Murashima et al. 2002) 
Bifidobacterium bifidum CUL 20 β-galactosidase activity 
MRS agar 
or MRS-X agar at 37°C 
(Allen et al. 2012) 
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Table 4.2| Bacterial strains and culture conditions (continued from Table 4.1) 
 
 
 
Species Strain Notable feature Growth conditions Reference 
Bifidobacterium lactis CUL 34 
 MRS agar or MRS-X agar at 
37°C 
(Allen et al. 2012) 
 
Lactobacillus acidophilus 
 
CUL 21 
 
β-galactosidase activity 
 
MRS agar or MRS-X agar at 
37°C 
(Allen et al. 2012) 
CUL 60 β-galactosidase activity (Allen et al. 2012) 
Salmonella typhimurium TA1535/pSK1002 
 
Genotoxicity testing strain 
 
TGA + 50 µg/ml ampicillin (Reifferscheid et al. 1991) 
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4.2.1.2.3 X-Gal (5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside) agar for the detection 
of extracellular β-galactosidase activity 
The appropriate medium was prepared and sterilised by autoclaving at 121°C for 15 min. 
The sterile medium was allowed to cool to 50°C before the addition of sterile X-Gal (Melford 
Laboratories Ltd, Ipswich, Suffolk, UK) at a final concentration 40 µg per mL of agar. In order 
to develop the agar E. coli was used. The strain, from a metagenomic study, contained an 
EPI300 plasmid expressing β-galactosidase activity (Table 4.1). This strain was used as a 
positive control. LB agar (see section 4.2.3) was used as the base medium for E. coli. 
4.2.1.3 X-Gluc (5-bromo-4-chloro-3-indolyl-β-D-glucuronic acid) agar for the detection of 
extracellular β-glucuronidase activity 
The appropriate medium was prepared and sterilised by autoclaving at 121°C for 15 min. 
The sterile medium was allowed to cool to 50°C before the addition of sterile X-Gluc (Apollo 
Scientific Ltd, Stockport, Cheshire, UK) at a final concentration 40 µg per mL of agar. The 
agar was developed through the use of E. coli Nissle. This strain expresses β-glucuronidase 
activity and was used as a positive control (Table 4.1). LB agar (see section 4.2.3) was used 
as the base medium for E. coli. 
4.2.1.4 Cholesterol agar for the detection of extracellular cholesterol degrading enzymes 
Cholesterol (1 g) (Sigma-Aldrich Company Ltd. Dorset, UK) was dissolved in 100 mL of 
ethanol to make a 1% w/v solution. This solution was added to the prepared appropriate 
medium at a concentration of 0.1% v/v. This was sterilised by autoclaving at 121°C for 15 
min before the plates were poured. The agar was developed through the use of an E. coli 
strain from a metagenomic study. The strain contained an EPI300 plasmid expressing the 
cholesterol oxidase gene choA (Solaiman and Somkuti 1991) (Table 4.1). This strain is able to 
degrade cholesterol and was therefore used as a positive control. LB agar (see section 4.2.3) 
was used as the base medium for E. coli. 
4.2.1.5 Tributyrin agar for the detection of extracellular lipases/esterases 
Tributyrin agar consists of neutral tributyrin and a tributyrin agar base (Sigma-Aldrich 
company Ltd. Dorset, UK). The tributyrin agar base was prepared by following the 
manufacturer’s guidelines and 10 g/L of neutral tributyrin was added to the base. The 
mixture was blended together for 1 min using a food processor before sterilisation by 
autoclaving at 121°C for 15 min. The agar was developed through the use of a 
lipase/esterase producing E. coli, from a metagenomic study (Jones et al. 2007b). This was 
used as a positive control as it contained an EPI300 plasmid expressing a lipase/esterase 
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gene (Table 4.1). E. coli expressing β-galactosidase activity was used as a negative control 
(Table 4.1). LB agar (see section 4.2.3) was used as the base medium for E. coli. 
 
4.2.2 Application of functional screening media 
4.2.2.1 Functional screening of the probiotic organisms used in the PROHEMI study 
The probiotic organisms used in the PROHEMI study were screened for expressed functions. 
The base media and culture conditions used to screen for these functions are shown in Table 
4.3. 
4.2.2.2 Functional screening of faecal samples from the PROHEMI study 
Serial dilutions to 10-9 of faecal samples were made in maximum recovery diluent (MRD) 
containing L-cysteine (see section 4.2.4). These dilutions were plated out onto the functional 
media. The base medium used for the functional media, growth conditions and dilutions 
plated are shown in Table 4.4. Colonies expressing the function of interest were counted 
and expressed as CFU/g of faeces at Cultech Ltd. 
4.2.4 Media used in the study 
4.2.4.1 TSA 
TSA was prepared according to the manufacturer's guidelines (Oxoid Ltd, Hampshire, UK). 
The medium was sterilised by autoclaving at 121°C for 15 min. 
4.2.4.2 LB agar 
LB agar was prepared according to the manufacturer's guidelines (Sigma-Aldrich Company 
Ltd. Dorset, UK). The medium was sterilised by autoclaving at 121°C for 15 min. 
4.2.4.3 de Man, Rogosa, Sharpe (MRS) agar 
MRS agar was prepared following manufacturer's guidelines (Oxoid Ltd, Hampshire, UK). The 
medium was sterilised by autoclaving at 121°C for 15 min. 
4.2.4.4 MRS agar with polymyxin 
MRS agar was prepared following manufacturer's guidelines (Oxoid Ltd, Hampshire, UK). The 
medium was sterilised by autoclaving at 121°C for 15 min. Media was allowed to cool to 
50°C in a waterbath before sterile polymyxin B was added at 120 units/mL of agar. 
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4.2.4.5 MRS-X agar 
MRS agar was prepared following manufacturer's guidelines (Oxoid Ltd, Hampshire, UK). 
However, Lithium chloride, Sodium propionate and L-cysteine hydrochloride (Sigma-Aldrich 
Company Ltd. Dorset, UK) were added at 2 g/L, 3 g/L and 0.5 g/L respectively before 
sterilisation by autoclaving at 121°C for 15 min. The medium was allowed to cool to 45°C 
before the addition of defibrinated Sheep's blood (Oxoid Ltd, Hampshire, UK) at a final 
concentration of 5% v/v. 
4.2.4.6 Plate count agar  
Plate count agar was prepared following manufacturer's guidelines (Oxoid Ltd, Hampshire, 
UK). The medium was sterilised by autoclaving at 121°C for 15 min. 
4.2.4.5 Maximum recovery diluent (MRD) containing 0.5% L-cysteine 
MRD was prepared following manufacturer's guidelines (Oxoid Ltd, Hampshire, UK). L-
cysteine hydrochloride (Sigma-Aldrich Company Ltd. Dorset, UK) was added at a 
concentration of 0.5% w/v before sterilisation by autoclaving at 121°C for 15 min.  
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Table 4.3| Culture conditions used for functional screening of the probiotic organisms used 
in the PROHEMI study 
 
 
 
 
 
 
 
 
 
 
 
Organism Medium 
Incubation 
conditions 
L. acidophilus 
(Cul 21) 
MRS agar 
37°C for 72 h in aerobic 
and anaerobic 
conditions 
L. acidophilus 
(Cul 60) 
MRS agar 
37°C for 72 h in aerobic 
and anaerobic 
conditions 
B. bifidum 
(Cul 20) 
MRS and MRS – X 
agars 
37°C for 72 h in 
anaerobic conditions 
B. lactis 
(Cul 34) 
MRS and MRS – X 
agars 
37°C for 72 h in 
anaerobic conditions 
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Table 4.4| Culture conditions used for functional screening of PROHEMI faecal samples 
 
 
Functional screening plate 
Base medium used for functional 
screening 
Faecal dilutions plated Culture conditions 
BPA 
(Protease activity) 
LB agar 10-1 to 10-6 37°C for 48 h 
X-gal agar 
(β-galactosidase activity) 
Plate count agar 10-1 to 10-6 37°C for 48 h 
X-gluc agar 
(β-glucuronidase activity) 
Plate count agar 10-1 to 10-6 37°C for 48 h  
Tributyrin agar 
(Lipase/esterase activity) 
Tributyrin agar base 10-1 to 10-6 37°C for 48 h  
Cholesterol agar 
(Cholesterol degrading activity) 
Plate count agar 10-1 to 10-6 37°C for 5 days 
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4.2.5 Genotoxicity testing 
Genotoxicity testing was carried out with  
4.2.5.1 Genotoxicity testing using Saccharmomyces cerevisiae BY4741 
A genotoxicity testing protocol for this organism was followed (Jia and Xiao 2004; Zhang et 
al. 2008). S. cerevisiae BY4741 (0.5 mL) over-night culture was added to separate aliquots of 
2.5 mL fresh YPD medium (20 g/L peptone, 10 g/L yeast extract and D-glucose 20 g/L) and 
incubated for a further 2 h. Methyl methanesulfonate (MMS) was added to the separate 
aliquots at final concentrations of 0.01 - 0.1% v/v; a control with no MMS was also used. 
These aliquots were further incubated for 4 h. 1 mL was taken from each of the aliquots and 
the cell density measured at OD600nm. Remaining cells were collected by centrifugation at 
13,000 g for 5 s and washed twice using distilled water. Supernatant was discarded and cells 
were resuspended in 1 mL of buffer Z (16.1 g/L Na2HPO4∙7H2O, 5.5 g/L NaH2PO4∙H2O, 0.75 
g/L KCl, 0.246 g/L MgSO4∙7H2O, 2.7 mL β-mercaptoethanol, pH 7.0) (Miller 1972) To this 50 
µL of a 0.1% w/v SDS solution and 50 µL of chloroform were added before being vortexed for 
10 s at high speed. To the now permeabilized cells 200 µL of a 4 mg/mL o-nitrophenyl-β-
galactoside (ONPG) in dimethyl sulfoxide (DMSO) solution was added followed by incubation 
in an orbital shaker set at 150 rpm for 20 min at 30°C. The reaction was stopped by the 
addition of 1 M Na2CO3. Aliquots were centrifuged at 1,500 g for 5 min in order to obtain the 
supernatant, which was measured at OD420nm. The level of β-galactosidase activity was 
determined by following the equation: 
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4.2.5.2 Genotoxicity testing using Salmonella typhimurium (TA1535/pSK1002) 
The initial SOS/umuC test (Oda et al. 1985) using this organism was further developed 
(Reifferscheid et al. 1991) and this protocol was followed. The known mutagens methyl 
methanesulfonate (MMS) and 4-nitroquinoline-N-oxide (4-NQO) were used as mutation 
inducing agents to test the protocol. Briefly, S. typhimurium was revived from a freezer stock 
onto a TGA agar plate containing 50 µg/mL ampicillin (Amp). From this an over-night culture 
was set-up in TGA broth supplemented with 50 µg/mL Amp. The following morning the over-
night culture was centrifuged at 3000 g for 5 min. The supernatant was discarded and the 
remaining bacterial pellet was resuspended in 1 mL of TGA. 20 mL of TGA broth was 
inoculated with 0.5 mL of the resuspended pellet and incubated at 37°C over-night until an 
optical density of 1.5 was obtained (OD600). The over-night culture was diluted, through the 
addition of fresh TGA broth, and incubated at 37°C until an optical density of 0.15 (OD600) 
was reached. The tester culture (290 μL) was distributed into microplates (Fisher Scientific 
UK Ltd, Loughborough, UK). Two-fold serial dilutions of MMS and 4-NQO in DMSO (10 - 
0.15625 % v/v) were added to the tester culture and incubated at 37°C for 2 h in an orbital 
shaker. Absorbance at 420 nm and 600 nm was determined using a Tecan Infinite M200 Pro 
plate reader (Tecan UK Ltd, Reading, UK). The β-galactosidase activity was calculated as 
previously described (Miller 1972). 
4.2.5.3 Genotoxicity testing using the SOS – Chromo Test™ system 
The SOS – Chromo Test™ system was purchased from Environmental Bio-Detection Products 
Inc. (EBPI, Ontario, Canada). The test was carried out according to the manufacturer's 
protocol with faecal water as the test chemical. Genotoxicity of faecal waters was tested 
using faecal waters which were made as previously described (Marchesi et al. 2007). In order 
to ensure that the faecal water cytotoxicity was not masking its genotoxicity, faecal waters 
were also diluted 10-fold in PBS and tested. Test faecal waters and controls were incubated 
with the test organism in duplicate plates. The layout of the test plate is shown in Fig. 4.1. 
Induction of the SOS system in test plates was measured for the through the use of a Tecan 
Infinite M200 Pro plate reader (Tecan UK Ltd, Reading, UK) at 600 nm with the addition of 
faecal waters before (pre-incubation) and after (post-incubation) incubation at 37°C. 
Following SOS system induction measurement alkaline phosphatase activity was measured 
at 420 nm. This measure was achieved through the addition of a colorimetric substrate. 
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 Figure 4.1| Layout of test samples and controls for the SOS ChromoTest™ system – faecal water of participants are denoted by their respective PH 
numbers followed by the sample number. The period of the study is also shown, P = Pre-feeding, A = Active and W = Washout.  
 
 
1 2 3 4 5 6 7 8 9 10 11 12 
 
Control 
4-NQO (μg/mL)            
A 10 
PH1 1 
(P) 
PH2 2 
(P) 
PH6 9 
(A) 
PH11 1 
(P) 
PH24 7 
(A) 
PH26 11 
(A) 
PH1 16 
(W) 
PH2 17 
(W) 
PH9 2 
(P) 
PH11 16 
(W) 
PH26 1 
(P) 
B 5 
PH1 2 
(P) 
PH2 9 
(A) 
PH6 13 
(A) 
PH11 2 
(P) 
PH24 11 
(A) 
PH26 14 
(W) 
PH1 17 
(W) 
PH6 1 
(P) 
PH9 13 
(A) 
PH11 17 
(W) 
PH26 2 
(P) 
C 2.5 
PH1 9 
(A) 
PH2 13 
(A) 
PH6 16 
(W) 
PH11 9 
(A) 
PH24 14 
(W) 
PH26 15 
(W) 
PH2 1 
(P) 
PH6 2 
(P) 
PH9 17 
(W) 
PH24 2 
(P) 
PH26 7 
(A) 
D 1.25 
PH1 13 
(A) 
PH2 16 
(W) 
PH9 1 
(P) 
PH11 13 
(A) 
PH24 15 
(W) 
PH1 1 
(P) 
PH2 2 
(P) 
PH6 9 
(A) 
PH11 1 
(P) 
PH24 7 
(A) 
PH26 11 
(A) 
E 0.625 
PH1 16 
(W) 
PH2 17 
(W) 
PH9 2 
(P) 
PH11 16 
(W) 
PH26 1 
(P) 
PH1 2 
(P) 
PH2 9 
(A) 
PH6 13 
(A) 
PH11 2 
(P) 
PH24 11 
(A) 
PH26 14 
(W) 
F 0.313 
PH1 17 
(W) 
PH6 1 
(P) 
PH9 13 
(A) 
PH11 17 
(W) 
PH26 2 
(P) 
PH1 9 
(A) 
PH2 13 
(A) 
PH6 16 
(W) 
PH11 9 
(A) 
PH24 14 
(W) 
PH26 15 
(W) 
G 0.16 
PH2 1 
(P) 
PH6 2 
(P) 
PH9 17 
(W) 
PH24 2 
(P) 
PH26 7 
(A) 
PH1 13 
(A) 
PH2 16 
(W) 
PH9 1 
(P) 
PH11 13 
(A) 
PH24 15 
(W) 
Blank 
H DMSO 
Blank Blank Blank Blank Blank Blank Blank Blank Blank Blank Blank 
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4.2.6 Statistical analysis 
Box-plots of total bacterial counts, counts obtained from functional media and absorbances 
for genotoxicity screening were generated in R statistical software (R-Core-Team 2012). The 
plots were generated through a custom scripts which utilised gglpot2 (Wickham 2009) and 
reshape2 (Wickham 2007) packages (Appendix II). Box-plots show the median, 1st and 3rd 
quartiles and outliers of a sample or study period. 
Normality testing, Kruskal-Wallis H tests and single pair-wise comparisons were carried out 
in IBM SPSS statistics 20 (IBM, Portsmouth, UK). 
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4.3 Results 
4.3.1 Functional media testing 
The media used in the study were developed and tested using positive and negative control 
organisms (Fig. 4.2 A-G).   
4.3.1.1 Cholesterol degrading activity 
Relevant media containing cholesterol were used as a screen for this activity. E. coli 
expressing the gene choA was used as a positive control (Fig. 4.2 A). It was possible to see 
zones of clearing around this organism where the cholesterol has been degraded. In order to 
ensure that the observed function was cholesterol degradation, a negative control was used. 
For this purpose E. coli was once again used. However, a frame-shift mutation was 
previously introduced into the inserted choA gene. Therefore, the gene was no longer 
expressed and the organism was no longer able to degrade cholesterol, producing no zone 
of clearing (Fig. 4.2 B).  
4.3.1.2 β-galactosidase activity 
The indoxyl glycoside X-gal was added to the relevant media in order to screen for β-
galactosidase activity. E. coli expressing β-galactosidase activity was used as a positive 
control. Colonies which are positive for β-galactosidase activity appear blue in colour (Fig. 
4.2 C). 
4.3.1.3 β-glucuronidase activity 
The indoxyl glucuronide X-gluc was added to the relevant media in order to screen for β-
glucuronidase activity. In order to develop the medium E. coli Nissle 1917 was used. This 
organism expresses β-glucuronidase activity. Colonies which are positive for β-glucuronidase 
activity appear blue in colour (Fig. 4.2 D). 
4.3.1.4 Lipase/esterase activity 
The lipid tributyrin with a carbon chain length of 15 was used in order to screen for 
lipase/esterase activity. The suitability of the medium was tested through the use of a 
lipase/esterase expressing E. coli. Bacterial colonies which are positive for lipase/esterase 
activity produce a zone of clearing (Fig. 4.2 E). 
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Figure 4.2| Functional media screens – (A) Cholesterol LB agar with E. coli expressing choA 
as shown by the zones of clearing around the colonies. (B) Cholesterol LB agar with no zones 
of clearing around the colonies. E. coli with a frame-shift mutation in the choA gene was 
used. (C) X-gal LB agar with two different E. coli strains expressing β-galactosidase activity as 
shown by the blue colour of the colonies. (D) X-gluc agar with blue colonies of E. coli due to 
the expression of β-glucuronidase. (E) Tributyrin agar with two strains of E. coli. The strain in 
the bottom half expresses a lipase/esterase gene and therefore produces zones of clearing 
around the colonies. The strain in the top half expresses a β-galactosidase gene and 
therefore does not produce a zone of clearing. 
 
A B C 
D E 
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4.3.1.5 Protease activity 
4.3.1.5.1 Skimmed milk agar 
The protease positive B. subtilis MY2016 showed zones of clearing around its colonies on 
skimmed milk agar (Fig. 4.3 A). However, the agar was further developed in order to avoid 
false positives. 
4.3.1.5.2 BPA  
B. subtilis MY2016 was once again used in order to test the medium with a phosphate buffer 
at 0.01 M. The organism showed zones of clearing around its colonies, indicative of protease 
activity. The agar at 0.01 M buffering was also tested through the plating of a faecal slurry 
(Fig. 4.3 B). Some colonies showed zones of clearing suggesting protease activity. However, 
the colour of the pH indicator phenol red changed to orange-yellow. This suggests that the 
pH has dropped and therefore false positives are difficult to rule out.  
To this end, the concentration of the phosphate buffer was increased to 0.1 M. The clearing 
of the plate, following the spread of an over-night culture of B. subtilis MY2016, shows that 
the plate detects protease activity (Fig. 4.3 C). Furthermore, the plate remains bright red and 
therefore shows that no drop in pH occurs. In contrast, the spreading of an over-night 
culture of B. subtilis WB800N does not clear the plate (Fig. 4.3 D). Therefore, for correct 
assignment of protease production in an organism or sample using BPA plates, a zone of 
clearing needs to be produced while the plate remains red. These plates show a strong 
colour change when concentrated hydrochloric acid (11.65 M) is placed on a BPA plate (Fig. 
4.3 E). Colour change is also observable when a 1/10 dilution (~1.165 M) is dropped onto a 
BPA plate. However, there is no colour change when more dilute acid (~0.1165 M) is 
dropped onto the BPA plates. This further highlights the buffering capacity of the phosphate 
buffer. 
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Figure 4.3| Functional media for the detection of extracellular proteases – (A) Skimmed 
milk LB agar with zones of clearing produced by B. subtilis MY2016. (B) BPA with 0.01 M 
phosphate buffer. The plates have been incubated with a faecal slurry and show a 
yellow/orange colour as well as zones of clearing around some of the colonies. (C) BPA with 
0.1 M phosphate buffer. The plate was incubated with an over-night culture of the protease 
positive B. subtilis MY2016, clearing the plate while it remains red in colour. (D) BPA with 0.1 
M phosphate buffer. The plate was incubated with an over-night culture of the protease 
deficient B. subtilis WB800N, producing no clearing. (E) Serial dilution of hydrochloric acid 
and drop application onto a 0.1 M BPA plate. 
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4.3.2 Functional screening of the probiotic mixture 
The results of functional screening of the probiotic mixture are shown in Table 4.5. From the 
experiment it is possible to observe that both stains of L. acidophilus (Cul21 and Cul60) and 
B. bifidum (Cul20) produce extracellular β-galactosidase activity (Fig. 4.4 A-C). However, 
none of the other tested functions are exhibited by these probiotic organisms. 
 
Table 4.5| Functions expressed by the probiotic organisms used in the PROHEMI study 
 Organism 
Function 
expressed 
B. bifidum 
(CUL20) 
B. lactis 
(CUL34) 
L. acidophilus 
(CUL21) 
L. acidophilus 
(CUL60) 
 
Protease 
activity 
- - - - 
 
Lipase/esterase 
activity 
- - - - 
 
Cholesterol 
degrading 
activity 
- - - - 
 
β-galactosidase 
activity 
+* - +** +** 
 
β-glucuronidase 
activity 
- - - - 
* denotes that the function was positive when MRS and MRS-X were used as the base 
media. 
**denotes the function was positive when L. acidophilus was cultured aerobically and 
anaerobically. 
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Figure 4.4|β-galactosidase activity exhibited by the probiotic organisms used in the 
PROHEMI study – (A) shows B. bifidum (Cul20) growing on MRS-X and MRS (left to right). 
(B) shows L. acidophilus (Cul21) growing on MRS agar following anaerobic and anaerobic 
incubation (left to right). (C) shows L. acidophilus (Cul60) growing on MRS agar following 
aerobic and anaerobic incubation (left to right) 
A B
 
C  
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4.3.3 Functional media screening of faecal samples 
The functions expressed, based on which study centre the samples come from,  have been 
plotted. Box-plots show that there are outliers for the expression of tested functions (Fig. 
4.5). It is possible to see that there are samples which express high levels of β-galactosidase 
and β-glucuronidase activity in both study centres. There are also outliers for protease 
production in both study groups and there are outliers also for lipase/esterase production 
but to a lesser extent. Cholesterol degrading bacteria were not detected in either of the 
study groups. Bacterial counts for functions expressed were not normally distributed 
therefore, a Kruskal – Wallis H test was carried out on the data. The test showed no 
significant difference between the mean ranks the two centres in terms of bacterial 
numbers expressing protease activity [χ2 (1) = 0.569, p = 0.451] and lipase/esterase activity 
*χ2 (1) = 0.05, p = 0.946]. However, there were significant differences between the mean 
ranks of the two centres in terms of β-galactosidase activity *χ2 (1) = 33.36, p < 0.001+ and β-
glucuronidase activity *χ2 (1) = 26.74, p < 0.001]. 
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Figure 4.5| Box-plot of functions expressed by PROHEMI samples based upon the study 
centre – there are two box-plots for each tested expressed function, with Cardiff samples on 
the left of the two and Sheffield samples on the right. The box-plot shows the median, 1st 
and 3rd quartiles. Outliers are represented by •. The numbers of bacteria expressing each 
function are shown in CFU/g of faecal material. *denotes a significant difference between 
the ranked means of the two centres (p < 0.001). 
 
* * 
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Functions expressed by bacteria were also analysed by study period separately for each 
study centre. Box-plots of the tested functions expressed by Sheffield samples show outliers 
once again (Fig. 4.6). Due to the outliers it is difficult to discern differences between the 
study periods. It is especially difficult as outliers for a given function such as β-galactosidase 
activity are much higher than outliers from other functions such as esterase/lipase activity. 
Therefore, box-plots were generated for protease (Fig. 4.7), β-galactosidase and β-
glucuronidase activity (Fig. 4.8). Bacterial counts for functions expressed from Sheffield were 
not normally distributed so a  Kruskal – Wallis H test was carried out on the data. The test 
showed significant differences between the mean ranks of the three study periods in terms 
of protease [χ2 (2) = 10.27, p = 0.006], β-galactosidase *χ2 (2) = 9.85, p = 0.007] and β-
glucuronidase *χ2 (2) = 30.15, p < 0.001] expression by bacteria. Post-hoc analysis through 
single pairwise comparisons showed that the mean rank of bacteria expressing protease 
activity was significantly higher in the Pre-feeding group than both the Active and Washout 
groups at the 0.05 level. This difference can be viewed in the box-plot (Fig. 4.7) where the 
median and 3rd quartile are higher in the Pre-feeding period than the Active and Washout 
periods. Through post-hoc analysis it was shown that the mean ranks of bacteria expressing 
β-galactosidase and β-glucuronidase activities were significantly higher in the Active and 
Washout groups than the Pre-feeding group at the 0.05 level. Box-plots show that the 
medians and 3rd quartiles for β-galactosidase and β-glucuronidase activities are higher in the 
Active and Washout periods than the Pre-feeding period (Fig. 4.8). Furthermore, the 
numbers of bacteria expressing these activities are highest during the Active period.  
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Figure 4.6| Box-plot of functions expressed by PROHEMI samples obtained from Sheffield 
based upon study period - there are three box-plots for each tested expressed function, 
with Pre-feeding, Active and Washout samples shown left, middle and right respectively for 
each function. The box-plot shows the median, 1st and 3rd quartiles. Outliers are represented 
by •. The numbers of bacteria expressing each function are shown in CFU/g of faecal 
material. 
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Figure 4.7| Box-plot of protease activity expressed by PROHEMI samples obtained from 
Sheffield based upon study period – three boxplots are shown with a corresponding key. 
The median, 1st and 3rd quartiles and outliers are represented by •. The numbers of bacteria 
expressing each function are shown in CFU/g of faecal material. *denotes a significantly 
higher ranked mean than the Active and Washout period (p<0.05). 
 
* 
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Figure 4.8| Box-plot of β-galactosidase and β-glucuronidase activity expressed by 
PROHEMI samples obtained from Sheffield based upon study period – three boxplots are 
shown for each function with a corresponding key. The median, 1st and 3rd quartiles and 
outliers are represented by •. The numbers of bacteria expressing each function are shown 
in CFU/g of faecal material. *denotes a significantly higher ranked mean than the Pre-
feeding period (p<0.05). 
 
* * 
* 
* 
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Samples from Cardiff were also analysed separately. In a similar fashion to Sheffield samples, 
outliers for expressed functions were observed (Fig. 4.9). These outliers made it difficult to 
discern difference in bacterial counts expressing functions between the study periods. 
Therefore, box-plots of protease activity (Fig. 4.10), β-galactosidase and β-glucuronidase 
activities (Fig. 4.11) were plotted separately. Bacterial counts for functions expressed were 
not normally distributed. Therefore, a Kruskal-Wallis H test was carried out on the data. The 
test showed significant differences between the mean ranks of the four study periods in 
terms of protease [χ2 (3) = 13.67, p = 0.003+, and β-glucuronidase activities gluc *χ2 (3) = 
28.06, p < 0.001]. Through post-hoc analysis it was shown that the Pre-feeding group had a 
significantly higher mean rank of bacteria expressing protease activity than Active group 1, 
Active group 2 and Washout periods at the 0.05 level. It is possible to see that the median 
and 3rd quartile are higher in the Pre-feeding group in the box-plot (Fig 4.10). Post-hoc 
analysis showed that the mean rank of bacteria expressing β-glucuronidase activity was 
significantly higher in the Active group 1, Active group 2 and Washout periods than the Pre-
feeding period at the 0.05 level (Fig 4.11). 
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Figure 4.9|Box-plot of functions expressed by PROHEMI samples obtained from Cardiff 
based upon study period - there are four box-plots for each tested expressed function, with 
Pre-feeding, Active group 1, Active group 2 and Washout samples shown left, middle left, 
middle right and right respectively for each function. The box-plot shows the median, 1st and 
3rd quartiles. Outliers are represented by •. The numbers of bacteria expressing each 
function are shown in CFU/g of faecal material 
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Figure 4.10| Box-plot of protease activity expressed by PROHEMI samples obtained from 
Cardiff based upon study period – four boxplots are shown for each function with a 
corresponding key. Pre-feeding, Active group 1, Active group 2 and Washout samples are 
shown from left to right respectively. The median, 1st and 3rd quartiles and outliers are 
represented by •. The numbers of bacteria expressing each function are shown in CFU/g of 
faecal material. *denotes a significantly higher ranked mean than the Active group 1, Active 
group 2 and Washout periods (p<0.05). Active group 1 and Active group 2 cannot be seen as 
the protease level is significantly lower than the Pre-feeding period. 
* 
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Figure 4.11| Box-plot of β-galactosidase and β-glucuronidase activity expressed by 
PROHEMI samples obtained from Cardiff based upon study period – four boxplots are 
shown for each function with a corresponding key. The median, 1st and 3rd quartiles and 
outliers are represented by •. The numbers of bacteria expressing each function are shown 
in CFU/g of faecal material. *denotes a significantly higher ranked mean than the Pre-
feeding period (p<0.05). 
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4.3.4 Genotoxicity testing of faecal waters 
Genotoxicity testing was carried out using Saccharmomyces cerevisiae BY4741 and 
Salmonella typhimurium (TA1535/pSK1002). However, the results were inconclusive and will 
not be discussed in this thesis. 
 
4.3.4.3 Genotoxicity testing using the E. coli SOS – ChromoTest™ system 
The genotoxic agent 4-NQO was used as a positive control and illustrated the SOS induction 
response of this E. coli strain (Fig. 4.12). The absorbance at 605 nm increased as the 
concentration of 4-NQO increased. However, the curve begins to plateau between 5-10 
μg/mL of 4-NQO.  
 
Figure 4.12| The response of the SOS system and alkaline phosphatase activity to 
increasing concentrations of 4-NQO – the absorbance at 605 nm is plotted, before and after 
incubation, against 4-NQO at increasing concentrations.  
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Analysis of the data through comparison of study periods shows that faecal waters from Pre-
feeding, Active and Washout period induce a response from the SOS system. Neat and 
diluted faecal waters from the 3 study periods show no significant difference in SOS 
induction from the control, prior to incubation (Fig. 4.13 and Fig 4.14 respectively). 
However, a significant difference in SOS induction was observed post-incubation (Fig. 4.13 
and Fig. 4.14 respectively). The data were not normally distributed; therefore, a Kruskal-
Wallis H test was carried out on the data. Analysis of neat samples in this manner showed 
that there was a significant difference in the mean ranks of the 3 study periods and the 
control group [χ2 (3) = 23.653, p < 0.001]. Post-hoc analysis through pairwise comparison 
showed that Pre-feeding, Active and Washout periods had a significantly higher ranked 
mean than the control samples at the 0.05 level. Although not statistically significant, 
analysis showed that the median absorbance at 605 nm was higher in the Active and 
Washout groups than the Pre-feeding group (0.518, 0.514 and 0.463 respectively). Kruskal-
Wallis H test analysis of the diluted faecal waters showed a similar pattern; with no 
significant difference between the study periods and control samples prior to incubation. 
However, there was a significant difference between the 3 study groups and control samples 
following incubation *χ2 (3) = 19.774, p < 0.001]. Pairwise comparison post-hoc analysis 
showed that the ranked means of Pre-feeding, Active and Washout samples were 
significantly higher than the control groups at the 0.05 level. The observation of higher 
absorbance medians was emulated in this dataset; with the Active and Washout groups 
exhibiting a higher median absorbance than the Pre-feeding group (0.454, 0.437 and 0.422 
respectively).  
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Figure 4.13| The effect of neat faecal waters on SOS induction in the SOS ChromoTest™ 
system – a box-plot of the absorbance at 605 nm pre-incubation and post-incubation is 
shown. The absorbance of neat faecal waters from the 3 study periods is shown along with 
the absorbance of control samples. Outliers are represented by •.*denotes a significant (p = 
0.05) difference between the study period and control.  
 
* * * 
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Figure 4.14| The effect of diluted faecal waters on SOS induction in the SOS ChromoTest™ 
system - a box-plot of the absorbance at 605 nm pre-incubation and post-incubation is 
shown. The absorbance of diluted faecal waters from the 3 study periods is shown along 
with the absorbance of control samples. Outliers are represented by •*denotes a significant 
(p = 0.05) difference between the study period and control. 
 
* * 
* 
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Neat and diluted faecal waters were also analysed by individual (Fig.4.15 and Fig. 4.16). The 
data was not normally distributed; therefore a Kruskal-Wallis H test analysis was carried out. 
Analysis of neat faecal water prior to incubation showed that there was a significant 
difference between the absorbance of participants' faecal water and the controls at 605 nm 
*χ2 (7) = 26.327, p <0.001] (Fig. 4.15). Post-hoc analysis through pairwise comparison showed 
that the ranked mean absorbance, at 605 nm, of PH11, PH26 and PH6 was significantly 
higher than the control ranked means at the 0.05 level. Analysis of neat faecal waters, 
following incubation, showed a significant difference between participants and control 
faecal waters *χ2 (7) = 40.073, p < 0.001]. Pairwise comparison post-hoc analysis showed that 
PH26 and PH11 had a significantly higher ranked mean absorbance at 605 nm than the 
controls at the 0.05 level. Furthermore, PH11 had a significantly higher ranked mean than 
PH1 at the 0.05 level. Analysis of the diluted faecal waters (Fig 4.16) gave different results to 
the neat faecal water (Fig 4.15). There was no significant difference between the ranked 
means of participants and controls at 605 nm prior to incubation. However, there was a 
significant difference between the ranked mean absorbance at 605 nm of participants and 
controls following incubation *χ2 (7) = 38.204, p < 0.001]. Post-hoc analysis through pairwise 
comparison showed that PH1, PH24 and PH26 had a significantly higher ranked mean 
absorbance, at 605 nm, than controls. In addition, PH1 and PH24 had a significantly higher 
ranked mean absorbance at 605 nm than PH11. The results of the 1/10 dilution show that 
the faecal waters of PH1 are genotoxic while the SOS system was not induced by its 
respective neat faecal water. 
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Figure 4.15| The effect of neat faecal waters on SOS induction in the SOS ChromoTest™ 
system - a box-plot of the absorbance at 605 nm pre-incubation and post-incubation is 
shown. The absorbance of neat faecal waters from PROHEMI participants is shown along 
with the absorbance of control samples. Outliers are represented by •. *denotes a 
significant (p = 0.05) difference between the study period and control, †denotes a significant 
difference between the sample and PH1. 
* * * 
* 
* 
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Figure 4.16| The effect of diluted faecal waters on SOS induction in the SOS ChromoTest™ 
system - a box-plot of the absorbance at 605 nm pre-incubation and post-incubation is 
shown. The absorbance of diluted faecal waters from PROHEMI participants is shown along 
with the absorbance of control samples. Outliers are represented by •. *denotes a 
significant difference between the study period and control, †denotes a significant 
difference between the sample and PH11. 
 
* 
† * 
† * 
CHAPTER 4 - CULTURE DEPENDENT ANALYSIS OF FAECAL MATERIAL AND FAECAL WATERS 
FROM THE PROHEMI STUDY 
151 
 
4.4 Discussion 
Culture dependent methods provide a means to interrogate a microbial community for 
functions of interest. Through the use of specialised agars, we have screened faecal material 
and the probiotic organisms used in the PROHEMI study for such functions. It has previously 
been shown that B. bifidum and some strains of L. acidophilus express β-galactosidase 
activity (de Vrese et al. 2001; Møller et al. 2001). Furthermore, the consumption of a 
probiotic organism, capable of increasing β-galactosidase activity, has been linked with 
alleviating clinical symptoms of lactose maldigestion (de Vrese et al. 2001). Previous studies 
are in accordance with my results, whereby B. bifidum (Cul20, NCIMB 30153) and L. 
acidophilus (Cul21, NCIMB 30156) and (Cul60, NCIMB 30157), express β-galactosidase 
activity. The results show a significant difference in β-galactosidase activity following 
probiotic administration in the Sheffield cohort, where activity increased. This difference 
may be due to expression of β-galactosidase activity by the two strains of L. acidophilus and 
B. bifidum. It has previously been shown that the consumption of L. acidophilus and B. 
bifidum for a 3 week period, in healthy individuals, did not increase β-galactosidase 
expression (Marteau et al. 1990). On the one hand the results suggest that probiotic 
consumption, for a much longer period, does increase β-galactosidase expression. However, 
in agreement with the findings of Marteau and colleagues Active Group 1, Active Group 2 
and Washout period, from the Cardiff cohort did not show an increase in β-galactosidase 
activity. This result seems counter-intuitive. I would expect to see an increase in the activity 
of this enzyme in one of the groups, as one of the groups received the Active treatment. 
While there appears to be no evidence for geographical differences in response to probiotic 
administration, this may be the underlying reason for a differential response.  
Bacterial β-glucuronidases are now receiving more attention, as they are becoming 
increasingly recognised as problem enzymes during drug therapy. Bacterial forms of the 
enzyme can have a significant impact upon the human body's efforts to excrete toxic 
compounds. The Phase I clinical trial of the anti-cancer compound CPT-11 (irinotecan) was 
linked with granulocytopenia, nausea, vomiting and diarrhoea (Shinkai et al. 1994). It has 
since been argued that the toxicity of this compound in the GIT, and therefore its side-effect 
of diarrhoea, is due to bacterial β-glucuronidase activity (Takasuna et al. 1996). Following 
this finding, research published this year determined the efficacy of an E. coli β-
glucuronidase inhibitor in the prevention of CPT-11 induced diarrhoea (Roberts et al. 2013). 
One such inhibitor was found to protect against CPT-11 induced diarrhoea in mice. The 
probiotic strains used in the PROHEMI study do not express β-glucuronidase activity. 
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However, all Active groups from Sheffield and Cardiff as well as both Washout groups 
showed a significant increase in β-glucuronidase activity compared to their respective Pre-
feeding levels. It has previously been shown that the feeding of L. acidophilus and B. bifidum, 
in the short-term, non-significantly increased β-glucuronidase activity (Marteau et al. 1990). 
The PROHEMI study used a longer Active feeding period of 6 months. Therefore, if B bifidum 
and L. acidophilus have the means to increase β-glucuronidase activity, the longer feeding 
period may explain the significant increase. The diet of the individual can impact the level of 
β-glucuronidase activity. Through the use of a murine model, it has been shown that a diet 
high in fat and/or protein can significantly increase β-glucuronidase activity (Reddy et al. 
1977). The authors further suggest the toxicity, excretion and reabsorption of carcinogens 
can be impacted by an increase in β-glucuronidase activity. Bacterial encoded 
glucuronidases can deconjugate these carcinogenic substances from inActive glucuronide 
conjugates bound for excretion. The role of probiotic administration in protection against 
colorectal cancer has recently been reviewed (Uccello et al. 2012). One discussed 
mechanism of protection was the ability of some probiotic bacteria to decrease β-
glucuronidase activity. Uccello and colleagues discussed the potential for L. acidophilus to 
decrease β-glucuronidase activity in humans. However, my results show the potential for an 
increase in the activity of this enzyme; with the potential to detrimentally affect host-health. 
Furthermore, probiotic administration in patents receiving particular drug therapies will 
need to be considered carefully, as an increase in β-glucuronidase activity may lead to drug 
toxicity.  
Bacterially encoded proteases can be detrimental to human health. These enzymes have 
been implicated in the progression of IBD and IBS (Steck et al. 2012). It has been shown that 
the metalloproteinase gelitinase (GelE) from Enterococcus faecalis contributes to the 
development of colitis in an experimental mouse model (Steck et al. 2011). It is believed that 
GelE cleaves E-cadherin leading to loss of epithelial barrier function. In addition, bacterial 
proteases are believed to play a pivotal role in immune evasion by pathogenic bacteria. The 
proteases produced to this end are various, numerous and have been discussed previously 
(Potempa and Pike 2009). One such mechanism is the resistance of pathogens to 
antimicrobial peptides through the degradation of such compounds by proteases (Nizet 
2006). The importance of proteases in the progression of inflammatory disease of the gut is 
now being recognised. Through this recognition it has been suggested that the inhibition of 
proteases should be used as a novel therapy for inflammatory diseases of the GIT (Sałaga et 
al. 2013). The effect of probiotic consumption on the protease activity of the distal gut is 
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sparse. My results suggest that probiotic consumption can decrease protease activity with 
the potential to positively affect host health. The positive effects of some probiotic species 
and strains in the treatment of IBD and IBS have been discussed in Chapter 1. In addition to 
this discussion, the results hint at a potential mechanism for the beneficial effects exerted in 
this disease state. Probiotic bacteria may decrease the inflammatory potential of pathogenic 
bacteria through decreasing their pro-inflammatory effector molecules.  
The potential for modulation of the gut microbiota to promote degradation of dietary 
cholesterol has attracted attention. L. plantarum has been shown to exhibit 
hypocholesterolemic effects (Jeun et al. 2010). Following a 4 –week intervention, where 6-
week old C57BL/6 mice were fed 109 CFU/day, total cholesterol levels were significantly (p < 
0.05) lower in the probiotic group than the control. The authors suggest that this lowering is 
not as a direct result of cholesterol degradation by the bacteria. It was suggested that the 
cholesterol lowering potential of this probiotic organism is mediated through elevation of 
bile acid excretion and decreased cholesterol uptake in the intestine. As previously 
discussed, some bacterial species possess cholesterol degrading enzymes. The 
Streptomycete cholesterol oxidase enzyme ChoA has been expressed in E. coli (Solaiman and 
Somkuti 1991). Further to this work, this enzyme has also been expressed in B. longum (Park 
et al. 2008). The authors suggest that the system used to express choA in this organism can 
be used in order to produce dairy products with useful proteins in them. Whether the 
authors aim to produce dairy products containing ChoA is unclear. Throughout the PROHEMI 
study, no cholesterol degrading activity was observed from any sample, at any time-point. 
This hints at the rarity/non-existence of direct cholesterol degradation, at least at a 
detectable level, in the human gut. 
The importance of lipase/esterase activity has been discussed previously and probiotic 
administration can affect the expression of these enzymes also. Research has shown that in 
children receiving ceftriaxone treatment probiotic administration with a range of 
organisms/strains increased lipase/esterase activity (Zoppi et al. 2001). The data, however, 
were not shown. Furthermore, to what extent probiotic administration in this cohort 
increased lipase/esterase was not discussed either. My results show that lipase/esterase 
activity was unaffected by probiotic consumption. The general level of this activity was low 
throughout samples from all study periods.  
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Assessing the genotoxicity of compounds through a bacterial strain has been used for many 
years. Ames developed histidine auxotrophic Salmonella typhimurium strains in order to 
screen compounds for mutagenic properties (Ames et al. 1975). Three published strains 
were used in order to screen for different types of mutagenic potential. Strain TA1535 was 
utilised to screen for base-pair substitutions while strains TA1537 and TA1538 detected 
frameshift mutations. In addition, an E. coli strain, which is auxotrophic for tryptophan, has 
also been used in order to screen for mutagenic compounds (Tarmy et al. 1973). While these 
tester strains were useful for qualitative purposes, a given compound has mutagenic 
potential or not, they were not useful for direct quantification of the mutagenic/genotoxic 
potential of a compound. To this end, new bacterial strains with a means to directly quantify 
the genotoxic potential of a compound were developed. Quillardet and colleagues 
developed the PQ37 strain of E. coli (Quillardet et al. 1982). This strain contained a sifA::lacZ 
fusion operon, whereby the expression of β-galactosidase was regulated by the cell division 
inhibitor SfiA (also known as SulA) (Huisman and D'Ari 1981). The sfiA/sulA gene is part of 
the SOS response in E. coli and is expressed when DNA is damaged (Mizusawa et al. 1983). 
Quillardet and colleagues utilised this strain to screen for genotoxic compounds. This was 
achieved through the induction of β-galactosidase activity, and its measurement through the 
enzymatic cleavage of the colorimetric substrate ONPG, by genotoxic agents. Sensitivity to 
genotoxic agents was further increased by making E. coli PQ37 deficient for the gene uvrA 
and therefore, unable to carry out excision repair. It can be argued that the genotoxic 
potential of a compound in a prokaryote model is not directly applicable to eukaryotic cells 
With this in mind, a yeast genotoxicity reporter strain was developed (Jia et al. 2002). This 
strain once again utilises lacZ, in conjunction with the ribosomal component encoding RNR3 
gene, for colorimetric determination of the genotoxic potential of a compound. The authors 
argue that this system is a more "faithful" model of the genotoxic effect of compounds in 
mammalian cells. The responses of a single-cell eukaryote will be closer to a mammalian cell 
than the responses of a prokaryotic cell. Sensitivity of this model was further increased 
through the deletion of cwp genes encoding cell wall mannoproteins (Zhang et al. 2008). In 
addition to the utilisation of β-galactosidase activity as a proxy measurement for the 
genotoxic potential of a compound, lux genes have also been used. Yagur-Kroll and 
colleagues have developed a sulA::luxCDABE E. coli strain (Yagur-Kroll et al. 2010). For their 
experiments the SOS inducing quinolone nalidixic acid was used. In response to the induced 
DNA damage, E. coli become bioluminescent and this bioluminescence acts as a proxy for 
the quantification of genotoxic potential of a compound.  
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Bacterial reporter strains allow high-throughput and relatively simple screening of 
compounds in order to determine their genotoxic potential. While efforts have been made 
in order to make the results of these experiments applicable to humans, studies using 
human and animal cell populations are difficult to surpass. The comet assay and its 
methodological variations have previously been discussed (Fairbairn et al. 1995). One 
advantage of this assay is the ability to test the genotoxicity of a compound on a particular 
cell-line of interest. The immortal cell-line HT-29 was first isolated from a colon tumour in 
1964 (Fogh et al. 1977) and can be used in the comet assay. Faecal water genotoxicity has 
been tested using HT-29 cells in the comet assay. It is possible to argue that detected 
genotoxic potentials of faecal waters in this system are biologically relevant to humans, as 
genotoxic faecal waters will come into contact with cells of the colon.  
Reviewing the literature highlights the impact on diet upon the cytotoxicity and genotoxicity 
of faecal water. It has been shown that a reduction in dairy product consumption is linked 
with a significant lower HT-29 cell survival (34% vs. 20% respectively, p = 0.025) in the HT-29 
cytotoxicity test (Glinghammar et al. 1997). However, the genotoxicity of faecal waters 
following dairy rich and dairy free diets was not significantly different. Other research 
however, has shown that a diet high in fat but low in dietary fibre increases the genotoxic 
potential of faecal water (Rieger et al. 1999). Tail intensity, following the incubation of faecal 
waters from two diets (rich in fat and low in fibre vs. high in dietary fibre and low in fat) with 
HT-29 cells in a comet assay, were significantly different (28.7% vs. 17.5% respectively, p = 
0.02). In an effort to negate the potential of diet induced faecal water genotoxicity, the 
effect of probiotic supplementation has been studied. AD sufferers and healthy subjects 
received a placebo yoghurt drink or a probiotic drink containing L. paracasei Lpc-37, L. 
acidophilus 74-2 and B. lactis 420 (7.8 x 1010, 5.8 x 106 and 1.2 x 107 CFU/day respectively) 
for 8 weeks. While there was no significant difference in the genotoxic activity of faecal 
waters of healthy individuals, there was a significant difference between AD sufferers. 
Patients with AD who received the probiotic yoghurt had a significantly (p = 0.029) lower 
level of faecal water genotoxicity (Roessler et al. 2012).  
While the genotoxicity experiment used only a limited number of samples, probiotic 
administration showed no significant effect upon faecal water genotoxicity. Neat and diluted 
faecal waters from all study periods showed significant SOS induction compared to the 
control. In a study where various LAB strains were incubated with faecal water prior to 
incubation with HT-29 cells in a comet assay, a significant difference was observed (Burns 
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and Rowland 2004). Burns and colleagues did not incubate the HT-29 cells directly with the 
bacterial faecal water suspension due to bacterial cell interference with the comet assay. B. 
bifidum BB12, B. lactis 420, L. plantarum and L. bulgaricus showed a significant reduction in 
genotoxicity compared to control faecal water incubated with PBS (68%, 24%, 63% and 37% 
reduction respectively, p < 0.05). While this research shows that probiotic organisms can 
decrease the genotoxicity of faecal water, it is not entirely clear how applicable the results 
are to probiotic supplementation. The authors selected the bacterial strains as previous 
research showed that these strains could survive GIT transit. However, their effects in vivo 
still need to be corroborated as my results suggest that probiotic supplementation in vivo 
does not decrease the genotoxic potential of faecal water. 
My results highlight that there are inter-individual differences in the genotoxicity of faecal 
water. This has previously been shown where the genotoxic potential of faecal waters from 
6 individuals induced varying levels of genotoxicity (Oßwald et al. 2000). Furthermore, faecal 
waters from one individual over 6 weeks showed varying levels of genotoxicity with 
significant differences ranging from no significant difference to the control to highly 
significant (p < 0.001). Results from the PROHEMI study show that the neat faecal waters of 
PH1, PH2, PH6, PH9 and PH24 are not statistically different from the controls while PH11 and 
PH26 are different. However, once diluted the faecal waters of PH1 and PH24 do become 
significantly more genotoxic than controls. This suggests that while neat, the faecal waters 
of PH1 and PH24 were too cytotoxic for the SOS ChromoTest™ reporter strain and therefore, 
the SOS system was not induced. However, once diluted the cytotoxicity of the samples 
decreased and therefore, SOS system induction could take place. The SOS ChromoTest™ 
system utilises the E. coli PQ37 strain developed by Quillardet and colleagues (Quillardet et 
al. 1982). This strain is constitutive for alkaline phosphatase activity and can be measured 
through the use of a colorimetric substrate. Spill-over from the colour produced through the 
β-galactosidase reaction interferes with this readout and therefore, makes it difficult to 
attribute whether absorbance is linked with alkaline phosphatase activity (viability) or β-
galactosidase activity (genotoxicity). The concept of responders to a treatment has been 
discussed previously. Due to the inter-participant variation seen, it would be of interest to 
stratify the results based on participant and to then determine whether probiotic 
administration has a genotoxic reducing effect. It would be particularly interesting to 
determine the effect of probiotic administration on those with particularly high genotoxic 
faecal water. Unfortunately, the effect of probiotic administration on faecal water 
genotoxicity in this instance was underpowered. While there are enough numbers to carry 
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out study period and participant analysis, I was unable to stratify the results based upon 
individual in a given study period. However, repeating the experiment with faecal waters 
from participants with high genotoxicity alone may give rise to a responder response to 
probiotic administration. 
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4.5 Conclusions 
The main conclusions for this chapter are as follows: 
1. screening for β-galactosidase, β-glucuronidase, protease, esterase/lipase and cholesterol 
degrading activities can be carried out on faecal material using functional media; 
 
2. probiotic administration reduces the numbers of bacteria expressing protease activity in 
healthy males; 
 
3. the numbers of bacteria expressing β-galactosidase and β-glucuronidase activity in 
healthy males increases during probiotic supplementation; 
 
4. there are geographical differences between the two study centre in terms of the 
numbers of bacteria expressing β-galactosidase and β-glucuronidase activity 
 
5. the genotoxicity of faecal waters are unaffected by probiotic supplementation in healthy 
males; 
 
6. there are individual differences in faecal water genotoxicity levels in healthy males. 
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5. CULTURE INDEPENDENT ANALYSIS OF FAECAL MATERIAL AND FAECAL 
WATERS FROM THE PROHEMI STUDY 
5.1 Introduction 
While microbiology has historically utilised classical culture dependent techniques, there has 
been a shift in recent years to the use of culture independent techniques. Researchers have 
been aware of the bias that culture dependent analysis can introduce since Staley and 
Konopka coined the phrase, "the great plate count anomaly" (Staley and Konopka 1985). 
This notion has previously been discussed by Rappé and Giovannoni. Meta-analysis of 
published GenBank 16S rRNA gene sequences from 1993 – 2002 showed that deposition of 
sequences from culture independent studies were over 2-fold greater than those from 
culture dependent studies (Rappe and Giovannoni 2003).  
Many culture independent techniques rely on the use of the 16S rRNA gene as a molecular 
chronograph (Woese 1987) and biomarker for organisms through their subsequent 
sequencing. With regards to sequencing, there have been significant advances since the 
advent of Sanger sequencing by Frederick Sanger (Sanger et al. 1977). The NGS technology 
454 pyrosequencing, through the use of emulsion PCR, has been applied to sequence and 
assemble the genome of Mycoplasma genitalium (Margulies et al. 2005). The method has 
also been applied to analyse complex microbial communities such as the deep sea "rare 
biosphere" (Sogin et al. 2006), the soil (Roesch et al. 2007) and the gut microbiome in obese 
and lean twins (Turnbaugh et al. 2009). NGS technologies are still evolving with sequencing 
platforms such as the Ion Torrent, which utilises protons (Rothberg et al. 2011) and the 
further development of optical based platforms such as Illimina-Solexa sequencing (Bentley 
et al. 2008). Illumina-Solexa sequencing, through the use of HiSeq2000 and MiSeq platforms, 
has been applied to sequence complex microbial communities (Caporaso et al. 2012). These 
complex communities included the human oral cavity, the skin and faecal material. 
Sequencing technologies allow researchers to interrogate the importance of both culturable 
and as yet uncultivated unculturable bacteria that make up the human distal gut 
microbiome. 
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Metabonomics, as defined by Nicholson and colleagues, is "the quantitative measurement of 
the dynamic multiparametric metabolic response of living systems to pathophysiological 
stimuli or genetic modification" (Nicholson et al. 1999). This technique can be considered 
culture independent as biological fluids are generally the source of information and are 
analysed through spectroscopic methods. The technique has been applied in order to 
analyse urine and plasma (Beckonert et al. 2007) and has been successfully applied in the 
detection of epithelial ovarian cancer (Odunsi et al. 2005). 
With regards to the gut, it is understood that the commensal gut microbiota play a pivotal 
role in the metabolism of compounds. Therefore, it follows that the dysbiosis of the gut 
microbial community, and the subsequent impact upon host health, will give rise to different 
metabonomic signatures. Antibiotic treatment with enrofloxacin in mice affected their faecal 
and urinary metabonomic profiles (Romick-Rosendale et al. 2009). Analysis through principal 
component analysis (PCA) showed that samples prior to antibiotic treatment clustered 
separately from post-treatment samples. In humans 1H nuclear magnetic resonance (NMR) 
analysis of faecal waters obtained from IBD patients, showed significant differences to 
healthy controls. Namely, there was a significant (p < 0.05) depletion in the SCFAs acetate 
and butyrate in UC patients (Marchesi et al. 2007). This research highlights that disruptions 
in normal gut function can have pronounced effects upon the metabonomic profiles of an 
individual. 
Novel high-throughput methods such as NGS and metabonomic analysis shed light on our 
complex gut microbial ecosystem. However, there is very little in the literature as to the 
effect of probiotic administration on metabonomic profiles in humans. In addition there is 
very little research into the effect of probiotic administration into the gut bacterial 
community of healthy individuals. The response of the infirm to various probiotic strains and 
prebiotics has been well documented (Tuohy et al. 2003). However, there is a gap in 
knowledge with respect to the changes, if any, in the gut microbiota of healthy individuals 
during probiotic intervention.  
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5.1.1 Chapter Aims 
The aims of this chapter are as follows: 
 
1. to determine whether probiotic administration affects the bacterial community of 
healthy males; 
 
2. to determine whether there is a difference between the bacterial community of healthy 
males from the two study centres; 
 
3. to answer whether the gross metabonomic profiles of healthy individuals are affected 
by probiotic administration; 
 
4. to answer whether probiotic administration in healthy males affects chemical shifts 
associated with SCFAs; 
 
5. to determine whether there are differences in the gross metabonomic profiles and 
SCFA profiles of healthy individuals from the two study centres. 
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5.2 Methods and materials 
5.2.1 Illumina MiSeq sequencing of PROHEMI faecal DNA 
Previously extracted faecal DNA from the PROHEMI study was diluted to a concentration of 
5 ng/μL.. The primers, 515F (5'- GTGCCAGCMGCCGCGGTAA) and 806R (5'- 
GGACTACHVGGGTWTCTAAT), were synthesised with the necessary Illumina adapters as 
previously described (Caporaso et al. 2012) in order to amplify the V4 region of the 16S rRNA 
gene. Multiplex sequencing of the DNA samples was achieved through the synthesis of a 
unique sample barcode in the reverse primer. Each DNA sample was amplified in triplicate 
25 μL reactions through the PCR. Briefly, each reaction contained 5 ng of template DNA, 0.7 
μM of total primers, 0.7 μM mixed dNTPs, 2.5 U KAPA HiFi Taq DNA polymerase (Kapa 
Biosystems Inc., Boston, US) and 1 X accompanying reaction buffer (2 mM MgCl2). The 
thermal cycler (Bioer Gene Pro, Bioer Technology, China) was programmed with an initial 
denaturing step of 95°C for 5 min, followed by 25 cycles of 98°C for 20 s, 60°C for 30 s and 
72°C for 40 s with a final extension step of 72°C for 1 min. Triplicate reactions were pooled 
and visualised through gel electrophoresis. Visualised bands of correct size were excised and 
purified using the QIAquick gel extraction kit (QIAGEN, Crawley, West Sussex, UK) following 
manufacturer's guidelines. Product concentration was quantified using the Qubit® 2.0 
fluorometer system (Life Technologies Ltd, Paisley, UK) following manufacturer's guidelines. 
All samples were diluted to a final concentration of 2.5 ng/μL and were pooled in equal 
volumes. One final visual check was carried out through gel electrophoresis, where the 
desired result was a single clear product. Following the final visual check, the equimolar 
pooled samples were subjected to 250 bp paired end Illumina MiSeq sequencing (Illumina 
United Kingdom, Essex, UK) following manufacturer's guidelines. 
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5.2.2 Bioinformatic analysis of MiSeq results 
Mothur, an open-source programme was used for the majority of the analysis (Schloss et al. 
2009). In order to carry out the analysis a tab separated file, which contained the sample ID 
and file names of both paired end reads for a given sample, was created (Appendix III). This 
served to associate the relevant sequence files with the correct sample. 
Sequences were processed using Mothur through custom batch files (Appendix IV) based 
upon a protocol developed by Schloss and colleagues (Schloss et al. 2011). Mothur utilised a 
current version of the RDP training set (training set 9) and the Silva 16S rRNA gene FASTA 
reference sequences (Pruesse et al. 2007) in order to carry out the analysis. Briefly, contigs 
were constructed from the two paired-end reads for a given sample and associated with the 
respective sample. Sequences were shortened to a maximum length of 275 bp and any 
sequences with ambiguous bases removed. In order to reduce the computational power 
needed to carry out the analysis, unique sequences were kept and multiples of unique 
sequences removed. Unique sequences were aligned to the reference Silva 16S rRNA FASTA 
sequences. The need for computational power was once again reduced by selecting unique 
sequences and discarding multiples of the unique sequence. Chimeras were identified and 
removed before an OTU table was generated using an 80% cut-off. Sequences which were 
not bacterial, including archaeal, mitochondrial and chloroplast DNA, were removed. OTUs 
were classified using a 97% similarity cut-off to the genus level. Normalisation of OTUs was 
achieved through sub-sampling to 1370 and 10197 sequences. Samples were initially sub-
sampled to 1370 sequences in order to maintain a high level of samples for analysis. Sub-
sampling to 10197 sequences was carried out to maintain a higher level of sequences for 
analysis. However, sub-sampling to 10197 sequences removed some samples with sequence 
counts below 10197 from further analyses. Computations including the inverse Simpson's 
diversity and Jaccard similarity coefficient indices, Yue and Clayton θ similarity coefficients, 
weighted and unweighted UniFrac  (Lozupone and Knight 2005) distances were carried out 
in Mothur. Ordination through non-metric multi-dimensional scaling (nMDS) and principal 
co-ordinate analysis (PCoA) of some of the previous indices were also carried out in Mothur. 
Generated axes from the ordination techniques were plotted using R statistical software (R-
Core-Team 2012) through the use of a custom script (Appendix II). The script utilised the R 
packages, labdsv (Roberts 2010), vegan (Oksanen et al. 2011) and calibrate (Graffelman 
2012) packages. Normality, homogeneity of variance testing and Kruskal – Wallis H tests 
were carried out in IBM statistics 20 (IBM, Portsmouth, UK). 
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Extended error bar plots of mean proportions of phyla and families were created using 
STAMP: Statistical Analysis of Metagenomic Profiles v2.0.0 software (Parks and Beiko 2010). 
Study centres and periods were analysed through a two-sided Welch's t-test with Bonferroni 
multiple test correction.  
 
5.2.3 Metabonomic analysis of PROHEMI faecal waters 
5.2.3.1 Generation of faecal waters from PROHEMI faecal samples 
Faecal waters were generated as previously described (see Chapter 2.5).  
5.2.3.2 1H NMR analysis of PROHEMI faecal waters 
Metabonomic analysis of faecal waters was carried out through proton NMR spectroscopy at 
Imperial College London. The protocol followed has previously been described (Marchesi et 
al. 2007). Briefly, 180 μL of faecal water was added to 320 μL of deuterium oxide and 100 μL 
of 0.2 M sodium phosphate buffer (pH 7.4). This buffer contained 100% deuterium oxide, for 
the magnetic field lock, and 0.01% 3-(trimethylsilyl)-[2,2,3,3-2H4] propionic acid sodium salt, 
for the spectral calibration. The buffer also contained 3 mM of sodium azide as a 
precautionary antibacterial measure. The faecal water, deuterium oxide and sodium 
phosphate buffer mixture was centrifuged at 10,000 g for 5 min before 580 μL was 
dispensed into 5 mm thickness, 7 inch borosilicate NMR tubes (Cortecnet , France). These 
tubes were subjected to NMR analysis. 1H NMR spectra of faecal waters were obtained using 
a Bruker 600 MHz spectrometer (Bruker, Rheinstetten, Germany) at the operating 1H 
frequency of 600.13 MHz at a temperature of 300 K. A standard NMR pulse sequence 
(recycle delay -90°-t1-90°-tm-90°-acquisition) was applied to acquire one-dimensional 
1H 
NMR spectral data, where t1 was set to 3 μs and tm (mixing time) was set to 100 ms. The 
water peak suppression was achieved using selective irradiation during a recycle delay of 2 s 
and tm. A 90° pulse was adjusted to 10 μs. A total of 256 scans were collected into 64 k data 
points with a spectral width of 20 ppm. 
5.2.3.3 Assignment of SCFAs to chemical shifts 
Chemical shifts for acetate, propionate, butyrate and valerate were obtained from the 
Madison Metabolomics Consortium Database (Cui et al. 2008). Chemical shifts 
corresponding to these compounds were manually selected from the dataset and exported. 
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5.2.3.4 Statistical analysis of the 1H NMR data 
The proportional abundances of the chemical shifts for NMR spectra were calculated. 
AGNES, using Ward's method, of the calculated Euclidean distances of the proportional 
abundances of NMR chemical shifts and export in Newick format was carried out in R 
statistical software. In order to carry out AGNES a custom script was used. The script utilised 
the R packages, ape (Paradis et al. 2004), BiodiverstiyR (Kindt  and Coe 2005) and cluster 
(Maechler et al. 2005) packages (Appendix II). Once exported in Newick format, the tree was 
manipulated using iTol software online (Letunic and Bork 2011). PCoA, using calculated 
Euclidean distances of the proportional abundances of chemical shifts, was carried out in R 
statistical software. A custom script was used which utilised vegan (Oksanen et al. 2011) 
calibrate (Graffelman 2012) and labdsv (Roberts 2010) R packages (Appendix II). 
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5.3 Results 
5.3.1 Illumina MiSeq DNA sequencing of 16S rRNA genes obtained from PROHEMI 
DNA samples 
5.3.1.1 The effect of normalisation on the dataset 
Sequence counts for a given sample are shown in Appendix V. The lowest number of 
sequences was 33 while the highest was 279,029 sequences. Samples were sub-sampled to 
1370 and 10197 with sequence counts below the two cut-offs removed from β-diversity, 
phylum and family level analyses.  
5.3.1.2 α – diversity of samples 
Samples were compared by study centre and study period. Inverse Simpson diversity results 
were plotted based upon the study period (Fig. 5.1) and study centre (Fig. 5.2) prior to and 
following normalisation. Analysis through the Kruskal – Wallis H test showed no significant 
difference between the Simpson diversity indices of non-normalised and both sets of 
normalised sequences. Furthermore, there was no significant difference in the Simpson 
diversity indices of samples based upon study period. However, Kruskal – Wallis H test 
analysis showed a significant difference between the mean ranks of samples based upon 
study centre, *χ2 (1) = 33.104, p<0.001].  
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Figure 5.1| Study period inverse Simpson diversity indices of PROHEMI faecal DNA – non – 
normalised, normalised through sub-sampling to 10197 sequences and 1370 sequences are 
shown based upon study period 
 
 
 
 
 
 
 
 
 
Figure 5.2| Study centre inverse Simpson diversity indices of PROHEMI faecal DNA – non – 
normalised, normalised through sub-sampling to 10197 sequences and 1370 sequences are 
shown based upon study centre. * denotes a significant difference between Sheffield and 
Cardiff samples (p<0.05). 
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5.3.1.2 β – diversity analysis of PROHEMI faecal DNA samples 
β-diversity ordination plots for the 1370 sub-sample are not shown as the results were 
similar to those obtained from sub-sampling to 10197 sequences. 
 
5.3.1.2.1 Analysis of all PROHEMI faecal DNA samples by study period 
PROHEMI faecal samples were subjected to PCoA analysis of Jaccard similarity coefficient 
indices and Yue and Clayton θ similarity coefficients. Data, which were normalised through 
sub-sampling to 1370 and 10197 sequences, showed no separate clustering of Pre-feeding, 
Active and Washout periods (Fig. 5.3 A-B ).  
In addition, nMDS analysis of both unweighted and weighted UniFrac distances of the two 
sub-samples showed no separate clustering of samples based upon study period (Fig. 5.4 A-
B).  
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Figure 5.3| The effect of probiotic administration on the faecal DNA β-diversity of all individuals from the PROHEMI study following normalisation 
through sub-sampling to 10197 sequences – In both plots P = Pre-feeding, A = Active and W = Washout periods. The percentage of variation explained is 
shown for each axis. (A) shows PCoA of Jaccard similarity coefficient indices of PROHEMI samples. (B) shows PCoA of Yue and Clayton θ similarity 
coefficients of PROHEMI samples. 
A B 
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Figure 5.4| The effect of probiotic administration on the faecal DNA UniFrac distances of all individuals from the PROHEMI study following normalisation 
through sub-sampling to 10197 sequences – In both plots P = Pre-feeding, A = Active and W = Washout periods. (A) shows nMDS of unweighted UniFrac 
distances of PROHEMI samples. (B) shows nMDS of weighted UniFrac distances of PROHEMI samples. 
A B 
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5.3.1.2.2 Analysis of Cardiff PROHEMI faecal DNA samples by study period 
β-diversity analysis was also carried out by study period through splitting the data into their 
respective study centres. With respect to the Cardiff study centre, PCoA of Jaccard similarity 
coefficient indices, using both sub-sample sets, shows samples clustered together regardless 
of the study period (Fig. 5.5 A). Analysis through PCoA of Yue and Clayton θ similarity 
coefficients of the two sub-sample sets showed similar results (Fig. 5.5 B). However, the Pre-
feeding group did not cluster tightly with the other groups as was observed in PCoA analysis 
of the Jaccard similarity coefficient indices.  
Analysis through nMDS of weighted and unweighted UniFrac distances was also carried out. 
Through analysis of the 1370 sequence and 10197 sequence sub-samples it was shown that 
samples from all 4 study periods clustered together (Fig. 5.6 A-B). 
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Figure 5.5| The effect of probiotic administration on the β-diversity of Cardiff/Port Talbot faecal DNA from the PROHEMI study following normalisation 
through sub-sampling to 10197 sequences – In both plots P = Pre-feeding, A1 = Active group 1, A2 = Active group 2 and W = Washout periods. The 
percentage of variation explained is shown for each axis. (A) shows PCoA of Jaccard similarity coefficient indices of Cardiff/Port Talbot PROHEMI samples. 
(B) shows PCoA of Yue and Clayton θ similarity coefficients of Cardiff/Port Talbot PROHEMI samples.  
A B 
CHAPTER 5 –  CULTURE INDEPENDENT ANALYSIS OF FAECAL MATERIAL AND FAECAL WATERS FROM THE PROHEMI STUDY 
173 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6| The effect of probiotic administration on the faecal DNA UniFrac distances of Cardiff/Port Talbot individuals from the PROHEMI study 
following normalisation through sub-sampling to 10197 sequences – In both plots P = Pre-feeding, A1 = Active group 1, A2 = Active group 2 and W = 
Washout periods. (A) shows nMDS of unweighted UniFrac distances of Cardiff/Port Talbot PROHEMI samples. (B) shows nMDS of weighted UniFrac 
distances of Cardiff/Port Talbot PROHEMI samples. 
A B 
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5.3.1.2.3 Analysis of Sheffield PROHEMI faecal DNA samples by study period 
Analysis of Sheffield samples alone through PCoA analysis of Jaccard similarity coefficient 
indices of the two sub-sample datasets showed no effect of probiotic administration (Fig. 5.7 
A). Samples from the Pre-feeding, Active and Washout periods clustered together. PCoA 
analysis of Yue and Clayton θ similarity coefficients also showed no effect of probiotic 
administration on the β-diversity of Sheffield PROHEMI faecal DNA, as samples from all 3 
study periods clustered together (Fig 5.7B).  
Through nMDS analysis of unweighted and weighted UniFrac distances of both sub-samples, 
no probiotic driven change in β-diversity of Sheffield samples was observed (Fig. 5.8 A-B). 
Samples from all three study periods clustered together once again. 
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Figure 5.7| The effect of probiotic administration on the faecal DNA β-diversity of Sheffield individuals from the PROHEMI study following normalisation 
through sub-sampling to 10197 sequences – In both plots P = Pre-feeding, A= Active and W = Washout periods. The percentage of variation explained is 
shown for each axis. (A) shows PCoA of Jaccard similarity coefficient indices of Sheffield PROHEMI samples. (B) shows PCoA of Yue and Clayton θ similarity 
coefficients of Sheffield PROHEMI samples.  
A B 
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Figure 5.8| The effect of probiotic administration on the faecal DNA UniFrac distances of Sheffield individuals from the PROHEMI study following 
normalisation through sub-sampling to 10197 sequences – In both plots P = Pre-feeding, A= Active and W = Washout periods. The percentage of variation 
explained is shown for each axis. (A) shows nMDS of unweighted UniFrac distances of Sheffield PROHEMI samples. (B) shows nMDS of weighted UniFrac 
distances of Sheffield PROHEMI samples. 
A B 
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5.3.1.2.4 Analysis of all PROHEMI faecal DNA samples by study centre 
In addition to analysis by study period, DNA samples from the PROHEMI study were also 
analysed by study centre. PCoA analysis of Jaccard similarity coefficient indices and Yue and 
Clayton θ similarity coefficients of 1370 and 10197 sequence sub-samples was carried out 
(Fig. 5.9 A-B). Results showed samples clustering based upon study centre, with Sheffield 
and Cardiff samples clustering relatively separately. However, there is a degree of overlap 
between the two study centres with samples from Cardiff clustering with Sheffield samples 
and vice versa.  
Analysis through nMDS of unweighted and unweighted UniFrac distances based on study 
period showed similar results. Results of weighted and unweighted UniFrac distances of the 
1370 and 10197 sequence sub-samples showed separate clustering of the samples based 
upon study centre (Fig. 5.10 A-B). It must be noted that both sub-samples show a degree of 
overlap between the two study centres, with samples from Cardiff clustering with Sheffield 
samples and vice versa.  
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Figure 5.9| The β-diversity of PROHEMI study faecal DNA samples by study centre following normalisation through sub-sampling to 10197 sequences – 
In both plots C = Cardiff and S= Sheffield study centres. The percentage of variation explained is shown for each axis. (A) shows PCoA of Jaccard similarity 
coefficient indices of PROHEMI samples. (B) shows PCoA of Yue and Clayton θ similarity coefficients of PROHEMI samples. 
A B 
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Figure 5.10| UniFrac distances of PROHEMI study faecal DNA samples by study centre following normalisation through sub-sampling to 10197 sequences 
– In both plots C = Cardiff and S= Sheffield study centres. The percentage of variation explained is shown for each axis. (A) shows nMDS of unweighted 
UniFrac distances of PROHEMI samples. (B) shows nMDS of weighted UniFrac distances of PROHEMI samples. 
A B 
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5.3.1.2.5 Phylum level analysis of all PROHEMI faecal DNA samples by study period 
Although there was no observed separate clustering of samples based upon study period, 
the samples were analysed at the phylum level. Extended error bar plots of phyla from each 
study period, after sub-sampling to 1370 and 10197 sequences, were compared (Fig. 5.11 A-
C and Fig. 5.12 A-C). Comparisons of the 1370 sequence sub-sample showed a significant 
difference. The Proteobacteria were significantly (p < 0.05) higher in the Active group than 
the Pre-feeding group (Fig. 5.11 A). No significant differences in the mean proportions of all 
other phyla were observed between study periods in both sets of sub-samples.  
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Figure 5.11| Extended error bar plot of phylum level abundance in PROHEMI samples 
based upon study period from the 1370 sequence sub-sample – for each plot the mean 
proportional abundances are shown for the phyla and the differences between the mean 
proportions of phyla with 95% confidence interval error bars are shown. Respective p-values 
for a given phylum have been displayed with * denoting a significant (p < 0.05) difference 
through Welch's t-test with Bonferroni correction for multiple comparisons. (A) shows the 
mean proportional abundances of phyla in both Pre-feeding and Active groups as well as the 
differences in the mean proportions of phyla between Pre-feeding and Active groups. (B) 
shows the mean proportional abundances of phyla in both Active and Washout groups as 
well as the differences in the mean proportions of phyla between Active and Washout 
groups. (C) shows the mean proportional abundances of phyla in both Pre-feeding and 
Washout groups as well as the differences in the mean proportions of phyla between Pre-
feeding and Washout groups. 
A 
B 
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Figure 5.12| Extended error bar plot of phylum level abundance in PROHEMI samples 
based upon study period from the 10197 sequence sub-sample – for each plot the mean 
proportional abundances are shown for the phyla and the differences between the mean 
proportions of phyla with 95% confidence interval error bars are shown. Respective p-values 
for a given phylum have been displayed with * denoting a significant (p < 0.05) difference 
through Welch's t-test with Bonferroni correction for multiple comparisons. (A) shows the 
mean proportional abundances of phyla in both Pre-feeding and Active groups as well as the 
differences in the mean proportions of phyla between Pre-feeding and Active groups. (B) 
shows the mean proportional abundances of phyla in both Active and Washout groups as 
well as the differences in the mean proportions of phyla between Active and Washout 
groups. (C) shows the mean proportional abundances of phyla in both Pre-feeding and 
Washout groups as well as the differences in the mean proportions of phyla between Pre-
feeding and Washout groups 
A 
B 
C 
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5.3.1.2.6 Phylum and family level analysis of all PROHEMI faecal DNA samples by study 
centre 
Due to the observed separate clustering of samples based upon study centre, as previously 
discussed in section 5.3.1.2.4, samples were analysed at the phylum and family level. 
Analysis of the 1370 sub-sample showed that Cardiff samples have a significantly (p < 0.05) 
higher mean proportion of Firmicutes and Actinobacteria than Sheffield samples (Fig. 5.13). 
However, Sheffield samples have a significantly (p < 0.05) higher mean proportion of 
Bacteroidetes and Proteobacteria than Cardiff samples (Fig 5.13). Family level analysis of the 
1370 sub-sample shows that in terms of the significant difference observed in the mean 
proportions of Bacteroidetes from the two study centres there are differences. The mean 
proportion of Prevotellaceae and Porphyromonadaceae are significantly higher in the 
Sheffield samples than Cardiff samples (Fig. 5.14). However, no significant difference was 
observed in the mean proportions of Bacteroidaceae and Rikenellaceae between the two 
study centres (Fig. 5.14). In terms of the difference in the mean proportions of Firmicutes 
differences were also observed at the family level. There was a significantly higher 
proportion of Ruminococcaceae, Lachnospiraceae, Peptostreptococcaceae and 
Streptococcaceae in Sheffield samples than Cardiff samples (Fig. 5.14). However, no 
significant difference in the mean proportions of Clostridiaceae, Veillonellaceae nor 
Acidaminococcaceae was observed between the two study centres (Fig. 5.14). 
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Figure 5.13| Extended error bar plot of phylum level abundance in PROHEMI samples 
based upon study centre from the 1370 sequence sub-sample – the mean proportional 
abundances of phyla are shown for Cardiff/Port Talbot and Sheffield samples. The 
differences in the mean proportions of phyla between Cardiff/Port Talbot and Cardiff with 
95% confidence interval error bars are also shown. Respective p-values for a given phylum 
have been displayed, calculated using Welch's t-test with Bonferroni correction for multiple 
comparisons. All differences in mean proportions were highly significant (p < 0.001).  
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Figure 5.14| Extended error bar plot of family level abundance in PROHEMI samples based 
upon study centre from the 1370 sequence sub-sample – the mean proportional 
abundances of families are shown for Cardiff/Port Talbot and Sheffield samples. The 
differences in the mean proportions of families between Cardiff/Port Talbot and Cardiff with 
95% confidence interval error bars are also shown. Respective p-values for a given family 
have been displayed, calculated using Welch's t-test with Bonferroni correction for multiple 
comparisons where * denotes a significant difference (p < 0.05). 
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Analysis of the 10197 sub-sample at the phylum level shows the same trend as the 1370 sub-
sample. Cardiff samples show a significantly (p < 0.05) higher mean proportion of Firmicutes 
than the Sheffield samples (Fig. 5.15). The mean proportion of Bacteroidetes is significantly 
higher in the Sheffield samples than Cardiff samples (Fig. 5.15). Analysis at the family level 
showed that there were differences in the mean proportions of members of the Firmicutes 
and Bacteroidetes at the family level. The mean proportion of Ruminococcaceae, 
Lachnospiraceae, Peptostreptococcaceae, Streptococcaceae, Erysipelotrichaceae and 
Clostridiaceae families were significantly (p < 0.05) higher in the Cardiff group than the 
Sheffield group (Fig. 5.16). This finding is slightly different as the mean proportion of 
Clostridiaceae was not significantly higher in the Cardiff group than the Sheffield group in 
the 1370 sub-sample. However, there was no significant difference between the mean 
proportions of Veillonellaceae, Acidaminococcaceae, Peptococcaceae, Lactobacillaceae nor 
Leuconostocaceae of the two study centres (Fig. 5.16). In a similar fashion to the Firmicutes, 
family level differences were observed in the Bacteroidetes. The mean proportions of the 
Prevotellaceae, Porphyromonadaceae and Bacteroidaceae were significantly (p < 0.05) 
higher in the Sheffield samples than Cardiff samples. Unlike the 1370 sub-sample, the 10197 
sub-sample showed a significantly (p < 0.05) higher mean proportion of Bacteroidaceae in 
Sheffield samples. The mean proportions of both Rikenellaceae and Flavobacteriaceae 
showed no significant difference between the two study centres (Fig. 5.16). 
While there are observable differences in the phyla and families of bacteria within samples 
from Cardiff and Sheffield, differences were also observed between the two sub-samples. 
Differences in the mean proportions of families, such as the Clostridiaceae and 
Bacteroidaceae, which did not reach significance in the 1370 sub-sample, reach significance 
in the 10197 sub-sample. Furthermore, the mean proportion of Proteobacteria between the 
two study centres does not exhibit a significant difference in the 10197 sub-sample while the 
phylum does in the 1370 sub-sample. Through sub-sampling to 10197 sequences, there is an 
increase in observable families over sub-sampling to 1370 sequences e.g. the 
Lactobacillaceae and Leuconostocaceae families.  
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Figure 5.15| Extended error bar plot of phylum level abundance in PROHEMI samples 
based upon study centre from the 10197 sequence sub-sample – the mean proportional 
abundances of phyla are shown for Cardiff/Port Talbot and Sheffield samples. The 
differences in the mean proportions of phyla between Cardiff/Port Talbot and Cardiff with 
95% confidence interval error bars are also shown. Respective p-values for a given phylum 
have been displayed, calculated using Welch's t-test with Bonferroni correction for multiple 
comparisons. All differences in mean proportions were highly significant (p < 0.001).  
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Figure 5.16| Extended error bar plot of family level abundance in PROHEMI samples based 
upon study centre from the 10197 sequence sub-sample – the mean proportional 
abundances of families are shown for Cardiff/Port Talbot and Sheffield samples. The 
differences in the mean proportions of families between Cardiff/Port Talbot and Cardiff with 
95% confidence interval error bars are also shown. Respective p-values for a given family 
have been displayed, calculated using Welch's t-test with Bonferroni correction for multiple 
comparisons where * denotes a significant difference (p < 0.05)..  
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5.3.2 Metabonomic analysis of PROHEMI faecal waters 
5.3.2.1 Analysis of gross metabonomic profiles 
Cluster analysis of all gross metabonomic profiles, obtained from the faecal waters of 
PROHEMI participants, appears to show no effect of probiotic administration (Fig. 5.17). 
Samples from all 3 study periods appear to cluster together randomly. Furthermore, analysis 
of the gross metabonomic profiles through PCoA showed no separate clustering between 
the 3 study periods (Fig. 5.18) 
In order to ensure that a response to probiotic administration was not being masked by 
differential study centre responses, gross metabonomic profiles were also analysed 
separately. Analysis, through PCoA, of Cardiff/Port Talbot faecal water metabonomic profiles 
showed no separate clustering due to study period (Fig. 5.19). The figure shows that samples 
from the Pre-feeding, Active group 1, Active group 2 and Washout periods cluster together. 
PCoA of Sheffield faecal water metabonomic profiles showed a similar result, with Pre-
feeding, Active and Washout periods clustering together (Fig. 5.20). Therefore, the results 
suggest that probiotic administration has no effect on the gross faecal metabonomic profiles 
of healthy individuals. 
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Figure 5.17| Cluster analysis of PROHEMI faecal metabonomic profiles based on study 
period – the study period is represented by a coloured ring on the outside of the 
dendrogram. Samples from the Pre-feeding period are red, Active period are green and 
Washout period are blue. 
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Figure 5.18| PCoA through Euclidean distance of all PROHEMI faecal metabonomic profiles 
based on study period – the first two principal co-ordinates have been plotted with the 
percentage of variation explained shown. Pre-feeding samples are shown in red, Active 
samples are shown in green and Washout samples are shown in black. 
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Figure 5.19| PCoA through Euclidean distance of Cardiff PROHEMI faecal metabonomic 
profiles based on study period – the first two principal co-ordinates have been plotted with 
the percentage of variation explained shown. Pre-feeding samples are shown in green, 
Active group 1 samples are shown in black, Active group 2 samples in red and Washout 
samples are shown in blue. 
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Figure 5.20|PCoA through Euclidean distance of Sheffield faecal metabonomic profiles 
based on study period – the first two principal co-ordinates have been plotted with the 
percentage of variation explained shown. Pre-feeding samples are shown in red, Active 
samples are shown in black and Washout samples are shown in green. 
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In contrast to cluster analysis of PROHEMI faecal metabonomic profiles by study period, 
analysis by study centre shows a degree of clustering by study centre (Fig. 5.21). The 
dendrogram shows large clusters of samples from a given study centre interspersed with 
samples from the other study centre.  
Gross faecal metabonomic profiles were also subjected to PCoA analysis by study centre 
(Fig. 5.22). Through plotting the first two components it is possible to see that the 
metabonomic profiles of the two study centres cluster separately. It is likely that the 
observed interspersed study centre samples observed in Fig. 5.21 are those samples which 
appear close together in Fig. 5.22. These results suggest a geographical difference in the 
gross metabonomic profiles of PROHEMI participants as Sheffield and Cardiff/Port Talbot 
samples appear to cluster separately.  
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Figure 5.21| Cluster analysis of PROHEMI faecal metabonomic profiles based on study 
centre – the study centre is represented by a ring on the outside of the dendrogram with 
Sheffield in black  and Cardiff samples with no colouring. 
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Figure 5.22| PCoA through Euclidean distance of all PROHEMI faecal metabonomic profiles 
based on study centre – the first two principal co-ordinates have been plotted with the 
percentage of variation explained shown. Sheffield samples are shown in red and Cardiff 
samples are shown in black. 
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5.3.2.2 Analysis of SCFA metabonomic profiles 
Exported chemical shifts of acetate, propionate, butyrate and valerate were analysed by 
study period through cluster analysis. Samples appeared to cluster together irrespective of 
study period (Fig. 5.23). The data were also analysed through PCoA based upon study period 
(Fig. 5.24). However, samples from all 3 study periods clustered together once again.  
SCFA metabonomic profiles were also analysed by study period for each study centre. 
Analysis through PCoA showed no separate clustering due to probiotic administration in the 
Cardiff/Port Talbot samples (Fig. 5.25). In accordance with this observed result, samples 
from Sheffield clustered together irrespective of study period also (Fig. 5.26). These results 
suggest that probiotic administration has no effect upon the SCFA profiles of healthy male 
subjects. 
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Figure 5.23| Cluster analysis of PROHEMI faecal SCFA metabonomic profiles based on 
study period – the study period is represented by a coloured ring on the outside of the 
dendrogram. Samples from the Pre-feeding period are red, Active period are green and 
Washout period are blue. 
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Figure 5.24| PCoA through Euclidean distance of all PROHEMI faecal SCFA metabonomic 
profiles based on study period – the first two principal co-ordinates have been plotted with 
the percentage of variation explained shown. Pre-feeding samples are shown in red, Active 
samples are shown in black and Washout samples are shown in green. 
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Figure 5.25| PCoA through Euclidean distance of Cardiff PROHEMI faecal SCFA 
metabonomic profiles based on study period – the first two principal co-ordinates have 
been plotted with the percentage of variation explained shown. Pre-feeding samples are 
shown in green, Active group 1 samples are shown in black, Active group 2 samples in red 
and Washout samples are shown in blue. 
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Figure 5.26| PCoA through Euclidean distance of Sheffield faecal SCFA metabonomic 
profiles based on study period – the first two principal co-ordinates have been plotted with 
the percentage of variation explained shown. Pre-feeding samples are shown in red, Active 
samples are shown in black and Washout samples are shown in green. 
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The SCFA metabonomic profiles of PROHEMI samples were also analysed by study centre 
through cluster analysis and PCoA. Cluster analysis of the samples showed a degree of 
clustering based upon study centre (Fig. 5.27). However, unlike the cluster analysis of gross 
faecal metabonomic profiles (Fig. 5.21), there appeared to be a greater degree of sample 
interspersing.  
PCoA analysis of SCFA metabonomic profiles based upon study centre appeared to show 
separate clustering (Fig. 5.28). However, unlike PCoA analysis of the gross faecal 
metabonomic profiles of PROHEMI participants by study centre (Fig. 5.22), there was a 
larger degree of overlap between the two clusters. This overlap is the probably reason for 
the observed greater degree of Cardiff/Port Talbot and Sheffield sample interspersing 
observed in Fig.5.27. The results suggest that there is a geographical difference in the SCFA 
metabonomic profiles of participants, with Cardiff/Port Talbot and Sheffield samples 
showing a degree of separate clustering. However, it must be noted that the separate 
clustering observed in analysis of SCFA metabonomic profiles of PROHEMI participants is not 
as distinct as the separation observed in their respective gross metabonomic profiles.  
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Figure 5.27| Cluster analysis of PROHEMI faecal SCFA metabonomic profiles based on 
study centre – the study period is represented by a ring on the outside of the dendrogram. 
Samples from the Cardiff study centre are blank while samples from the Sheffield study 
centre are black. 
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Figure 5.28| PCoA through Euclidean distance of all PROHEMI faecal SCFA metabonomic 
profiles based on study centre – the first two principal co-ordinates have been plotted with 
the percentage of variation explained shown. Sheffield samples are shown in red and Cardiff 
samples are shown in black. 
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5.4 Discussion 
5.4.1 Illumina MiSeq NGS of PROHMI faecal DNA 
There appears to be a need for research into the effect of probiotic administration on the 
gut bacterial community and its effect on the metabonomic profiles of individuals needs to 
be carried out. I have shown that long-term probiotic administration does very little with 
respect to the alteration of the gut bacterial community of healthy individuals. In addition, 
gross metabonomic profiles and profiles associated with SCFA are also unaffected. 
 
Analysis through Mothur showed there was a high degree of variability in terms of sequence 
counts for a given sample. This is due to methodological issues prior to and during the 
sequencing run. Normalisation, through sub-sampling to 1370 and 10197 sequences, was 
carried out in order to avoid sequencing bias (Schloss et al. 2011). Sub-sampling to the 
lowest possible number of sequences would have severely lowered the number of 
sequences in all samples to 33 sequences. The dataset would have been severely reduced 
with a loss of 278996 sequences from the highest sample. Sub-sampling to 1370 sequences 
and 10197 sequences removed 3 and 42 samples respectively from subsequent analysis. 
While this was not ideal, the samples were from all study periods and centres. Therefore, it 
is unlikely that bias was introduced from sub-sampling.  
 
Inverse Simpson diversity indices show that there was no significant difference in the 
diversity of samples following sub-sampling and no significant difference between study 
periods. However, there was a significant difference between the two study centres, with 
Sheffield samples showing a decreased level of diversity in non-normalised and both 
normalised datasets. It has recently been shown that the α-diversity of the faecal microbiota 
of infants differs as they age with the highest diversity seen at 2 years and the lowest 
diversity seen at 4 months (Avershina et al. 2013). Differences in α-diversity have not only 
been observed across different ages. In a recent study, the distal gut microbiome diversity of 
healthy Bangladeshi children was compared to healthy children from the US. Bangladeshi 
children were shown to have a significantly (p < 0.001) higher α-diversity than US children 
(Lin et al. 2013). My results highlight a geographical difference in the α-diversity of the distal 
gut microbiota of healthy male subjects within the UK and should be researched further. 
There appears to be a discrepancy in knowledge regarding inter-centre differences in gut 
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bacterial diversity. Published studies seem to focus on a single study centre alone and when 
comparisons are carried out they are often comparisons of disparate locations. To my 
knowledge there are no comparisons between locations in the UK in terms of differences in 
the diversity of the gut bacterial community of individuals. Therefore, I cannot say whether 
this is in line with other research in this area or not.  
β-diversity measurements were carried out using Mothur (Schloss et al. 2009). This open-
source software utilises Jaccard similarity coefficient indices in order to determine the 
dissimilarity between communities in question (Schloss et al. 2009). The technique was 
developed and applied by Jaccard in order to describe the diversity of plants in the Alps 
(Jaccard 1912). Effectively, the technique takes the presence/absence of an OTU into 
account and not its abundance. Conversely however, the Yue and Clayton θ similarity 
coefficient analysis takes the abundance of a given OTU into account. Analysis through these 
two measurements showed no clustering due to probiotic administration. The results of 
PCoA on these two measures showed that all samples clustered together, regardless of 
study period, for each sub-sample. Furthermore, when the two study centres were analysed 
separately all study periods still clustered together.  
 
UniFrac distance analysis, a comparatively new technique, has been applied in order to 
analyse complex microbial communities (Lozupone and Knight 2005). In a similar manner to 
Jaccard similarity coefficient indices analysis, the unweighted method of UniFrac does not 
take in to account the abundance of a given OTU. This form of the metric measures the 
presence/absence of a given OTU instead. It is therefore ideal in order to compare differing 
microbial communities as the OTU composition is likely to be different. However, the 
weighted method takes the abundance of a given OTU into account, in a similar fashion to 
the Yue and Clayton θ similarity coefficient analysis. Analysis through both unweighted and 
weighted UniFrac distance analysis emulated the results obtained from Jaccard similarity 
coefficient indices and Yue and Clayton θ similarity coefficient analysis. Ordination through 
nMDS of weighted and unweighted UniFrac distances showed no effect of probiotic 
administration as all samples clustered together, irrespective of study period. In addition, 
samples clustered together regardless of study period once both study centres were 
analysed separately. All four β-diversity measurements used suggested that probiotic 
administration did not affect the presence/absence or abundance of OTUs. 
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The data were analysed by study centre also and while probiotic administration showed no 
effect on β-diversity, there were observable differences between the two study centres. 
PCoA of Jaccard similarity coefficient indices and Yue and Clayton θ similarity coefficients 
showed separate clustering of samples from the two study centres. There was an observable 
overlap between samples from the two study centres however, in general separate 
clustering was observed. Ordination of weighted and unweighted UniFrac distances through 
nMDS showed similar results for both sub-samples. PROHEMI samples appeared to cluster 
separately due to study centre with some sample overlap between the two study centres. 
The results suggest a geographical difference between the presence/absence and 
abundance of OTUs.  
 
Sequence data were analysed at the family and phylum level also. Analysis of the 1370 sub-
sample showed a significant increase in the mean proportion of Proteobacteria between the 
Active and Pre-feeding periods. However, this was not shown in the 10197 sub-sample. This 
result suggests that the difference seen is probably due to a bias introduced from sub-
sampling as opposed to a real biological effect. There were no other observed significant 
differences at the phylum level between the study periods.  
 
Phylum level analysis of the sequence data showed a significant difference between the two 
study centres in both sub-samples. Sheffield samples were shown to have a higher mean 
proportion of Bacteroidetes while Cardiff/Port Talbot samples had a higher mean proportion 
of Firmicutes. Significant differences were also observable at the family level. However; in 
contrast to the phylum level analysis both sub-samples showed differences in the families 
exceeding significance. It is interesting to note that sub-sampling affected the number of 
bacterial families which exceeded significance with 9 families and 14 families reaching 
significance in the 1370 sub-sample and the 10197 sub-sample respectively. The observed 
difference between the two sub-samples is likely to be due to a sub-sampling artefact. 
Families which exceeded significance in the 1370 sub-sample also exceeded significance in 
the 10197 sub-sample. The evaluation of different sub-sampling methods has previously 
been researched and was shown to impact upon the sequence dataset in question (Carcer et 
al. 2011). 
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Analysis at the phylum leads us to believe that Cardiff/Port Talbot samples have a higher 
mean proportion of Firmicutes than Sheffield. However, family level analysis shows that not 
all mean proportions of the Firmicutes are significantly higher. Similarly, phylum level 
analysis leads us to believe that Sheffield samples have a higher mean proportion of 
Bacteroidetes than Cardiff/Port Talbot samples. However, family level analysis once again 
shows that not all mean proportions of Bacteroidetes are significantly higher.  
My results suggest that probiotic administration does not impact upon the bacterial 
community of healthy individuals. It has recently been shown that the ratio of Bacteroidetes 
to Firmicutes was significantly (p < 0.05) increased following administration of L. salivarus 
(1010 CFU/day) for 12 weeks in obese adolescents (Larsen et al. 2013). Research into the 
effect of the administration of B. longum in combination with an inulin-based prebiotic in 
older healthy individuals has recently been carried out (Macfarlane et al. 2013). In this 
cohort, the consumption of 2 x 1011 B. longum with 6 g of the prebiotic twice daily 
significantly increased Bifidobacteria, Actinobacteria and Firmicutes (p < 0.0001, p < 0.0004 
and p < 0.0001 respectively). This recent research suggests that probiotic administration can 
impact the composition of the gut microbiota. However, one study cohort was not healthy, 
as the participants were obese (Larsen et al. 2013), and the age of participants from the 
other study group ranged from 65-90 (Macfarlane et al. 2013). These two study cohorts are 
not indicative of the general population who take probiotic supplements daily. In accordance 
with my results, it has recently been shown that probiotic yoghurt consumption did not 
impact the gut microbiota of healthy subjects. Filteau and colleagues showed that the daily 
consumption of L. acidophilus LA-5 (109 CFU/day) with increasing doses of B. animalis ssp. 
lactis BB-12 (109 and 10
10 CFU/day) and 40 mg/day green tea extract for 4 weeks did not 
affect the distal gut microbiota of healthy individuals. Vanhoutte and colleagues have also 
shown that the consumption of S. boulardii (2.5 x 109 viable cells/day) for 4 weeks did not 
impact upon the DGGE profiles of healthy volunteers. Therefore, my research is in 
accordance with these studies; it seems probiotic administration, in healthy individuals, does 
not impact upon the distal gut microbiota. The reasons behind this observation are unclear. 
However, there is a possibility that the probiotic organisms used in the PROHEMI study do 
not possess the ability to modulate the gut bacterial community of individuals. It has 
previously been shown that the feeding of B. longum 46 and B. longum 2C (total of 109 
CFU/mL) for 6 months gave rise to a bifidogenic response (Lahtinen et al. 2009). The 
organisms used were different to the organisms used in the PROHEMI study and the 
observed differences were in an elderly cohort. This gives rise to another possible reason for 
CHAPTER 5 –  CULTURE INDEPENDENT ANALYSIS OF FAECAL MATERIAL AND FAECAL WATERS 
FROM THE PROHEMI STUDY 
209 
 
the lack of distal gut bacterial modulation observed. PROHEMI participants were healthy 
males and were not elderly. Perhaps modulation cannot be achieved in this healthy cohort 
as the distal gut microbiota is established and not under dysbiosis. It is also possible that not 
all of the probiotic mixture given to PROHEMI participants reaches the large intestine. While 
previous research has shown that the L. acidophilus strains used in the PROHEMI can be 
detected in the faecal material of healthy individuals following feeding (Mahenthiralingam et 
al. 2009), the same has yet to be shown for the bifidobacteria used in the study. The 
bifidobacteria used in the PROHEMI study may possess bifidogenic properties however; they 
may not reach the large intestine in sufficient numbers to exert these effects.  
Analysis by study centre suggests that there are geographical differences in the gut bacterial 
community of individuals across the UK. There is a significant difference between the 
proportional abundances of the two major distal gut phyla, the Bacteroidetes and 
Firmicutes, across the two study centres. Previous research by Gordon and colleagues using 
obese mice suggests that the abundance of Firmicutes are significantly (p < 0.05) higher in 
obese mice while the abundance of Bacteroidetes are significantly (p < 0.05) lower (Ley et al. 
2005). This observation was strengthened by analysis of obese and lean human twins by 
Turnbaugh and colleagues (Turnbaugh et al. 2009). Once again there was a significant (p = 
0.003) reduction in the abundance of Bacteroidetes in obese subjects. However, there was 
no significant difference in the abundance of Firmicutes. My research, using healthy 
individuals, suggests a difference in the ratio of Bacteroidetes and Firmicutes due to 
geographical difference. Geographical differences in the composition of the distal gut 
microbiota have previously been discussed. NGS of the V3-V4 16S rRNA genes from the 
faecal DNA of Bangladeshi and USA children showed differences in the relative abundances 
of OTUs corresponding to the Firmicutes and Bacteroidetes (Lin et al. 2013). Bangladeshi 
children showed a higher abundance of Firmicutes to Bacteroidetes (60% vs. 20% 
respectively) while children from the USA showed a more even abundance (46% vs. 43%). 
Interestingly, this observation was extended to Bangladeshi adults also, with a high 
abundance of Firmicutes (50%) and a very low abundance of Bacteroidetes (6%). The authors 
cannot give an exact reason for the observed difference. However, they suggest that 
differences in diet, genetics and environmental factors, including socioeconomic factors, 
may play a role. 
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With regards to the effect of diet on the microbiome, newly published research has shown 
diet can modulate the distal gut microbiome in healthy subjects (David et al. 2013). Healthy 
subjects either followed an animal-based diet or plant-based diet for 5 days. Comparisons 
were made to a pre-diet period and post-diet period, where participants were instructed to 
eat normally. α-diversity analysis of the data showed no significant difference of Shannon 
diversity indices attributable to either diet. However, β-diversity was significantly affected by 
the animal-based diet. Furthermore, it was shown that log2 fold changes of the Firmicutes 
were significantly affected by both diets while log2 fold changes of the Bacteroidetes were 
significantly affected by the animal diet. My results show a difference in the gut bacterial 
community of individuals from the UK. These differences are unlikely to be due to 
socioeconomic factors however, differences in diet and lifestyle are likely drivers for the 
observed differences in the ratio of Bacteroidetes to Firmicutes observed in the samples. 
The differences in the abundances of Firmicutes in the PROHEMI study are not a trivial 
matter. Previous research has shown that members of the Firmicutes phylum, namely 
members of clostridial cluster XIVa, play a pivotal role in the production of butyrate 
(Barcenilla et al. 2000). Of the isolated butyrate producers 80% clustered within clostridial 
cluster XIVa. Barcenilla and colleagues highlighted that the most abundant group of isolates 
(42%) clustered with E. rectale and Roseburia cecicola. Previously published data suggests 
that diet can affect the abundance of clostridial cluster XIVa members. Duncan and 
colleagues have shown that a reduced dietary intake of carbohydrates is linked with a 
reduction in the abundance of Roseburia spp. and the E. rectale subgroup of clostridial 
cluster XIVa in obese subjects (Duncan et al. 2007). Furthermore, the research was 
strengthened as Duncan and colleagues showed a decrease in butyrate concentrations in the 
faecal material. Research by Walker and colleagues has also shown that a diet high in 
resistant starch significantly (p < 0.001) increases the clostridal cluster XIVa member E. 
rectale and Ruminococcus bromii in overweight males (Walker et al. 2011). It is therefore 
apparent that diet can impact upon members of the Firmicutes. With regards to my data 
there is a significantly (p < 0.0001) higher mean proportion of Lachnospiraceae and 
Ruminococcaceae in Cardiff/Port Talbot samples. Both of these families lie within clostridial 
XIVa group and suggest that diet may be the driver for the observed difference. This idea is 
further strengthened by the previously discussed newly published research by David and 
colleagues (David et al. 2013). Healthy participants following an animal-based diet showed a 
significant reduction in E. rectale and Roseburia faecis. However, an animal-based diet 
significantly increased members of the Bactroidetes including the Porphyromonadaceae. 
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5.4.2 1H NMR metabonomic analysis of PROHEMI faecal waters 
Metabonomic analysis of the PROHEMI dataset showed similar results to the NGS results 
from the study. There appeared to be no effect of probiotic supplementation on the gross 
metabonomic and SCFA metabonomic profiles of individuals. The data were analysed by 
period separately for the two study centres with individuals clustering together regardless of 
the study period. There have been studies which have used metabonomic profiling following 
probiotic administration in murine models. In an experimentally induced colitis mouse 
model the efficacy of L. brevis HY7401, Lactobacillus sp. HY7801 and B. longum HY8004 
(combined concentration of 3 x 109 CFU/mL) has been assessed (Hong et al. 2010). Colitis, in 
this model, was induced by dextran sulphate sodium. Probiotic fed mice showed increased 
levels of SCFA than mice which did not receive probiotic treatment. Administration of the 
probiotic species L. acidophilus La5 and B. lactis BB12 (109 CFU/day) for 30 days in aged (16 
months) mice has also been researched (Brasili et al. 2013). Differences in the faecal and 
urinary metabolites were observed between the two study groups. Research into the effect 
of feeding L. paracasei NCC2461 (108/day) in a humanised mouse model has been carried 
out (Martin et al. 2008). Analysis of SCFAs in this model showed a significant (p < 0.001) 
decrease in acetate, a significant (p < 0.001) increase in isobutyrate, a significant (p < 0.001) 
increase in butyrate and a significant (p < 0.01) increase in isovalerate compared to the 
control group. Furthermore, 1H NMR analysis also showed a significant (p < 0.01) decrease in 
acetate following probiotic consumption compared to the control group. My results suggest 
that there is no effect of probiotic administration on faecal metabolites. However, the 
dataset needs to be analysed in more detail in order to ensure that specific changes are not 
being masked by metabolites which do not respond. In addition, branched SCFA were not 
included in my analysis and need to be considered in future analyses. 
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While probiotic administration did not seem to affect the gross metabonomic and SCFA 
metabonomic profiles of individuals, study centre differences were once again observed. 
Samples from Cardiff/Port Talbot and Sheffield clustered separately when gross faecal 
metabolites were analysed. Analysis of SCFA metabolites also showed a degree of separate 
clustering based upon study centre. However, there was a larger degree of sample overlap 
from the two study centres. The effect of diet on the distal gut microbiota has previously 
been discussed (Duncan et al. 2007; Walker et al. 2011). Furthermore, its impact upon the 
production of compounds such as SCFA has also been discussed. My data therefore suggest 
that there is a geographical difference in the metabolite profiles of individuals enrolled in 
the PROHEMI study. The results showed a difference between the gut bacterial community 
of individuals also and from previously published research there is a hint that these two 
observations are intrinsically linked. It is possible that differences in lifestyle or diet are 
driving changes in the distal gut bacterial community of individuals and in turn drives a 
difference in faecal metabolite profiles. 
 
Further research needs to be carried out in order to ensure that the results are a true 
biological phenomenon and not merely methodological driven. With regards to the 
sequencing data, the effect of faecal material storage and the DNA extraction method 
followed on the variability of results has been discussed in Chapter 6. 
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5.5 Conclusions 
The main conclusions for this chapter are as follows: 
1. probiotic administration does not affect the distal gut bacterial community of healthy 
males; 
 
2. there are difference in the distal gut bacterial community of healthy males from the 
two study centres; 
 
3. NGS backs up the observations made following LHPCR analysis and validates the 
technique for use in analysing human faecal DNA; 
 
4. there are no effects of probiotic administration upon the gross metabonomic and SCFA 
profiles of healthy individuals; 
 
5. 1H NMR analysis reveals a difference in the gross and SCFA metabonomic profiles of 
PROHEMI participants from the two studies centres.  
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6. THE EFFECT OF FREEZING FAECAL MATERIAL ON ITS BACTERIAL 
COMPOSITION 
6.1 Introduction 
The ability of the human gut microbiota to influence host health and well-being has become more 
apparent in recent years. Studies are highlighting the link between the host gut microbiota and 
the hypothalamic-pituitary-adrenal (HPA) axis (Ait-Belgnaoui et al. 2012), controversially with 
obesity (Ley et al. 2006b) and autism (Song et al. 2004). Konopka and Staley described the “great 
plate count anomaly” in nonphotosynthetic microorganisms from aquatic and terrestrial 
environments (Staley and Konopka 1985). The anomaly is equally applicable to the human gut, as 
the number of cultivable bacteria is significantly less than the total numbers of bacteria residing 
in the gut. The inability of culture dependent approaches to acquire all of the information has 
recently been highlighted. The impact of diet on the gut bacterial community of 14 overweight 
men was determined through 16S rRNA analysis (Walker et al. 2011). Of the 320 phylotypes 
identified in the study, only 33.4% showed 98% identity with cultured bacteria. The authors 
suggest that this is due to poor culture dependent coverage of less abundant bacterial groups. It 
was further suggested that the culture independent to dependent discrepancy arises through 
poor anaerobic isolation work; and not due to the inability of these organisms to be cultured.  
Faecal material provides a non-invasive alternative for the collection of data on the distal colon. 
Therefore it has been the source of information for many studies from animals (Simpson et al. 
2000) to humans (Eckburg et al. 2005). In order to obtain a snapshot of the distal gut microbiota 
and functions therein, many researchers extract DNA from faeces. The extraction method that 
should be followed has been debated, as the DNA obtained should be a true representation of 
the distal gut microbial community. That is to say that the method followed should not create 
biases in the data generated. Efficacy of commercially available faecal DNA extraction kits 
(McOrist et al. 2002), modified DNA extraction protocols using bead beating (Salonen et al. 2010), 
and modification of commercially available kits (Maukonen et al. 2012) have been evaluated. 
There is no clear consensus from the papers published over the last decade comparing extraction 
methods, which is the correct protocol to follow? 
The confusion regarding which DNA extraction protocol to follow is further complicated by the 
confusion over the correct method for faecal storage prior to the highly variable results obtained 
from DNA extraction. Even in 2012 uncertainty remains (Table. 6.1). When DNA was extracted 
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from the faecal samples of 4 individuals (2 healthy controls and 2 irritable bowel syndrome 
patients) stored at 1, 4, 6, 8 and 24 h, samples clustered based on the individual and not due to 
the storage method or time stored (Carroll et al. 2012). In another piece of work it has also been 
shown that microbial diversity of faecal samples (n=4) is not significantly affected by storage at 
room temperature, up to 24 h. DNA was degraded and a significant change in the proportion of 
bacteria was observed after 2 weeks storage at room temperature (Cardona et al. 2012). 
In order to overcome the effect of DNA degradation and loss of bacterial diversity that arises from 
storage at room temperature, faecal samples are often frozen. However, this in itself cannot 
guarantee the integrity of the DNA information obtained. It has been shown that the ratio of the 
two major phyla of the human gut, the Firmicutes and Bacteroidetes, is altered after faecal 
sample storage at -20°C for 53±5 days. There was a reduction in abundance of Bacteroidetes 16S 
rRNA genes obtained after extraction (Bahl et al. 2012). Faecal samples can also be stored at -
80°C. It has been shown, in a similar manner to storage at room temperature up to 24 h, that 
samples cluster together based upon individual and not due to storage method or time. The 
weighted and unweighted UniFrac values of 16S rRNA gene sequences obtained from samples 
frozen at -80°C up to 6 months show significant similarity to their corresponding fresh samples 
(Carroll et al. 2012). Another layer of complexity is added when the thawing of frozen faecal 
samples is consider. It has been shown that thawing faecal samples from -80°C over an h or 3 h 
both cause DNA degradation. There is also a loss of bacterial 16S rRNA sequences from the 
Bacteroides genus (Cardona et al. 2012). 
The confusion arising from varied results and different storage methods adds to the difficulty of 
carrying out inter study comparisons. It is also difficult to compare results from studies as 
different extraction methods are often followed. In collaborative studies, researchers may decide 
to overcome inter-centre variation by transporting faecal samples to one centre for DNA 
extraction. However, the implications of the effect of thawing frozen faecal samples shows that 
caution should be taken when transporting faecal samples from different locations. The extracted 
DNA may not provide a true representation of the community. While the stability of faecal 
microbial communities appear to be unaffected by storage at -80°C for 6 months, long-term 
storage at -20°C has not been fully researched. However, freezers at -20°C may be more readily 
available than -80°C freezers in developing countries. Therefore, there is a need for further 
research into the effect of storage at -20°C on the faecal bacterial community. It has been shown 
that the storage of faecal material at -20°C affects the ratio of Firmicutes to Bacteroidetes. 
However, it is unclear how long a sample may be stored at this temperature before the microbial 
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community is affected. Lyophilisation of faecal material from pigs prior to extraction has also 
been suggested as a method to increase the DNA recovery, as shown by restriction fragment 
polymorphism (Ruiz and Rubio 2009). However, this has not been applied to human faecal 
samples and there is a need for investigation through next generation sequencing. 
The confusion in the literature highlights the need for further investigation and development of a 
standard operating procedure. There is a need to minimise the variation generated by 
methodological differences. Real biological effects may be masked or false biological effects 
generated through a methodological artefact. 
 
CHAPTER 6 – THE EFFECT OF FREEZING FAECAL MATERIAL ON ITS BACTERIAL COMPOSITION 
217 
 
Table 6.1|The effect of different storage conditions on DNA extraction results 
Storage method Duration Effect Reference 
Freezing at -20°C 53 ± 5 days Shift in the ratio of Firmicutes to Bacteroidetes (Bahl et al. 2012) 
Room temperature* 
(not defined) 
 
 
 
 
Time taken to thaw 
from -80°C before 
re-freezing at 
-80°C 
 
3 h 
 
24 h 
2 weeks 
 
 
1 h 
 
 
 
3 h 
No effect 
 
DNA is degraded 
Reduction in the mean proportion of sequences of uncultured bacteria 
from the Bacteroides, Prevotellaceae and Bifidobacterium taxa 
DNA is degraded 
Reduction in the mean proportion of sequences from an uncultured 
bacterium from the Bacteroides genus 
DNA is degraded 
Reduction in the mean proportion of sequences of uncultured bacteria 
from the Bacteroides, Prevotellaceae and Bifidobacterium taxa 
DNA is degraded 
(Cardona et al. 2012) 
Room temperature** 
(approx. 25°C) 
Freezing at -80°C ** 
1, 4, 6, 8, 24 h 
1 week 
1, 2, 3, 4, 5, and 6 months 
Clustering of faecal samples due to the individual and not storage 
method/time. 
No significant differences in the bacterial group DNA after storage 
(Carroll et al. 2012) 
*when compared to the same sample frozen at -20°C 
**all samples had DNA extracted after 30 min at room temperature prior to storage; this acted as a baseline for comparison 
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6.1.1 Chapter Aims 
The aims of this chapter are as follows: 
 
1. to determine whether the freezing of faecal material at -20°C prior to DNA extraction 
affects its bacterial composition; 
 
2. if the bacterial composition of a faecal sample is affected by freezing at -20°C, I aim to 
determine how long a sample can be stored before it is detrimentally affected. 
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6.2 Methods and materials  
6.2.1 454 FLX Titanium NGS for analysis on the effect of freezing faecal samples and 
the effect of homogenisation 
Faecal samples from 9 individuals were processed and DNA extracted, as previously 
described (see Chapter 2.3.1). DNA was extracted from fresh samples and after samples had 
been frozen at -20°C for 24 h, 2 weeks, 3 months and 6 months. Extracted faecal DNA was 
subjected to 454 FLX Titanium PCR. The forward and reverse primers 338F (5’-
ACTCCTACGGGAGGCAGCAG) and 926R (5’- CCGTCAATTCMTTTRAGT) were synthesised with 
454 FLX Titanium adapters B (5’-CCTATCCCCTGTGTGCCTTGGCAGTCTCAG) and A (5’- 
CCATCTCATCCCTGCGTGTCTCCGACTCAG) respectively (Haas et al. 2011). The reverse primer 
was also synthesised with a unique sample barcode for downstream identification of 
sequences. Each sample was amplified in triplicate 50 µl reactions. Each reaction contained 
50 ng of template DNA, 0.4 µM of total primers , 0.4 µM of mixed dNTPs, 2.5 U of NEB Taq 
DNA Polymerase (New England Biolabs® Inc. Ipswich, MA 01938-2723) and 1X accompanying 
standard reaction buffer (10mM Tris-HCl, 50 mM KCl, 1.5 mM MgCl2, pH 8.3 at 25°C). The 
thermal cycler (C1000™; BIO-RAD, Hertfordshire, UK) was programmed with an initial 
denaturing step of 94°C for 3 min, 20 cycles of 94°C for 30 s, 53°C for 30 s and 72°C for 3 min 
with a final extension step of 72°C for 3 min Products were visualised by gel electrophoresis. 
The triplicate reactions were pooled and concentrated by ethanol precipitation, as 
previously described (see Chapter 2.4). The concentrated products were purified using the 
QIAquick PCR purification kit (QIAGEN, Crawley, West Sussex, UK) and correct sized products 
were selected by gel electrophoresis. The gel bands were purified using the QIAquick gel 
extraction kit (QIAGEN, Crawley, West Sussex, UK). Emulsion PCR and sequencing were 
carried out according to the manufacturer’s protocol. 
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6.2.2 Bioinformatic analysis of NGS results 
Mothur, an open-source programme, was used for the majority of the analysis (Schloss et al. 
2009). The .sff file generated from 454 pyrosequecning was opened in Mothur. This 
generated two files, the sequence file in FASTA format and a quality file. Using the RDP's 
pyrosequencing pipeline, the sequence and quality files were uploaded to the pipeline initial 
process utility (available at: http://rdp.cme.msu.edu/). The utility also required the forward 
and reverse primer sequences as well as the unique sample barcodes used. The minimum 
quality score was set to q20.  
Sequences with a score were then obtained through download. Mothur requires a group file 
whereby sequences are associated with their respective samples. The group file was created 
using Mothur.  
All relevant files were placed in the same directory as the Mothur executable file along with 
a current version of the RDP training set (training set 9) and the Silva 16S rRNA gene FASTA 
refrence sequences (Pruesse et al. 2007). Analysis in Mothur was carried out through the use 
of custom batch files (Appendix VI) based upon a protocol developed by Schloss and 
colleagues (Schloss et al. 2011). Briefly, sequences were shortened to 300bp, in order to 
increase quality, and aligned to the Silva 16S rRNA gene FASTA sequences. Unique 
sequences were selected, in order to reduce computing power, and chimeras were removed. 
The OTU table was generated using a 97% (0.03) cut-off. Normalisation of the OTU table was 
achieved through sub-sampling of the sequence data to the lowest number of sequences 
present in a given sample e.g. PH25 3M contained 699 sequences. Therefore, all other 
samples were sub-sampled in order to contain 699 sequences. This step omitted PH27 2W 
and PH34 3M from further analysis, as the number of sequences within these samples was 
markedly lower than 699. Remaining sample sequences were taxonomically identified using 
the RDP training set. Computations including the Yue and Clayton θ similarity coefficient, 
weighted and unweighted UniFrac distances, inverse Simpson's diversity and Jaccard 
similarity coefficient indices were carried out in Mothur. Non-metric multi-dimensional 
scaling (nMDS) and principal co-ordinate analysis (PCoA), of some of these measures, was 
also carried out in Mothur. The axes generated from nMDS and PCoA were plotted using R 
statistical software (R-Core-Team 2012) through the use of a custom script (Appendix II). 
The script utilised labdsv (Roberts 2010), vegan (Oksanen et al. 2011) and calibrate 
(Graffelman 2012) packages. Normality, homogeneity of variance testing, one-way ANOVA 
and Kruskal-Wallis H tests were carried out on the data in SPSS (IBM, Portsmouth, UK). 
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Bacteroidetes OTU abundances were exported into SPSS (IBM, Portsmouth, UK) statistics 
software. The data were tested for normality and for homogeneity of variance also. One-way 
ANOVA and Tamhane's T2 post-hoc test was also carried out on the data. 
Phylum data, unweighted and weighted UniFrac distances were imported into R statistical 
software (R-Core-Team 2012). AGNES clustering, using Ward's method, of normalised OTU 
abundances and UniFrac distances followed by export in Newick format was carried out in R 
statistical software. This was achieved through a custom script which utilised ape (Paradis et 
al. 2004), BiodiverstiyR (Kindt  and Coe 2005) and cluster (Maechler et al. 2005) R packages 
(Appendix II). Once exported in Newick format, the dendrogram was manipulated using iTol 
software online (Letunic and Bork 2011). The ratio of Bacteroidetes to Firmicutes was also 
applied to the dendrogram in the form of a bar-chart. 
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6.3 Results 
6.3.1 α - diversity of samples 
Samples were compared based upon storage time and the individual also. The inverse 
Simpson diversity indices have been plotted based upon the participant (Fig. 6.1) and time 
stored at -20°C (Fig. 6.2), before and after normalisation. There was no significant difference 
in the diversity between participants before and after normalisation, as shown by one-way 
ANOVA [F (8, 34) = 1.651, p=0.147] and [F (8, 34) = 1.680, p=0.139] respectively. Analysis 
based upon storage time shows a similar pattern. One-way ANOVA shows no significant 
difference in diversity between the samples after varying lengths of storage at -20°C before 
and after normalisation, [F (4, 38) = 0.71 p=0.590) and [F (4, 38) = 0.511, p=0.728]. 
Therefore, the level of diversity is not significantly different after storage at -20°C up to 6 
months. Furthermore, inter-individual diversity also appears to be relatively uniform. 
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Figure 6.1| Inverse Simpson's diversity index of OTUs obtained from 454 pyrosequencing 
of DNA after different storage times – average inverse Simpson's diversity indices are 
shown from all storage times for each participant (n=9). Both normalised and non-
normalised OTU datasets were subjected to the diversity index. Error bars show SD from the 
mean.
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Figure 6.2| Inverse Simpson's diversity index of OTUs obtained from 454 pyrosequencing 
of DNA after different storage times – average inverse Simpson's diversity indices are 
shown for all storage time. Where 24H = 24 h, 2W = 2 weeks, 3M = 3 months and 6M = 6 
months. Both normalised and non-normalised OTU datasets were subjected to the diversity 
index. Error bars show SD from the mean. 
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6.3.2 The effect of storage at -20°C on the bacterial community of a faecal sample 
The similarity in community structure of samples following storage at -20°C for varying 
lengths of time has been analysed. To this end nMDS analysis of Jaccard similarity coefficient 
indices and the Yue and Clayton θ similarity coefficients of samples has been carried out. 
Samples from Fresh, 24H, 2W and 3M groups cluster together through Jaccard similarity 
coefficient index analysis. However, the 6M group shows a degree of separate clustering 
(Fig. 6.3). The results obtained through the Yue and Clayton θ similarity coefficient show a 
more dramatic change (Fig. 6.4). While Fresh, 24H and 2W groups cluster together the 3M 
group begins to cluster separately. The 6M group clusters completely separately from the 
Fresh, 24H and 2W groups. However, there is some overlap between the clusters generated 
from 3M and 6M. 
UniFrac distance analysis was also carried out on the dataset. In a similar manner to the 
Jaccard similarity coefficient, PCoA of unweighted UniFrac distances of the samples show a 
degree of separate clustering following 6 months of storage at -20°C (Fig. 6.5A). The degree 
of separate clustering of 6M samples along with the samples which overlap with other 
storage periods can be seen through AGNES of the unweighted UniFrac distances (Fig. 6.5B). 
Cluster analysis of the unweighted UniFrac distances also shows that samples, with the 
exception of 6M samples, tend to cluster together based upon the individual and not due to 
time stored (Fig. 6.5B). Analysis through PCoA of weighted UniFrac distances shows separate 
clustering of 6M samples, in a similar fashion to the Yue and Clayton θ similarity coefficient 
(Fig. 6.6A). This cluster of 6M samples also appears tighter than its unweighted counterpart 
(Fig. 6.5A). Cluster analysis, through AGNES, of the weighted UniFrac distances shows that 
all but 2 of the 6M samples cluster together (Fig. 6.6B). Furthermore, unlike the unweighted 
iteration, weighted UniFrac distances of samples do not seem to cluster based upon the 
individual any longer. Instead, samples cluster with samples from different individuals at the 
same time-point and different time-points alike. 
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Figure 6.3| nMDS plot of the Jaccard similarity coefficient indices obtained from samples 
following storage at -20°C – samples have been coloured based upon their duration stored 
at -20°C, F = Fresh, 24H = 24 h, 2W = 2 weeks, 3M = 3 months and 6M = 6 months.  
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Figure 6.4| nMDS plot of the the Yue and Clayton θ similarity coefficients obtained from 
samples following storage at -20°C – samples have been coloured based upon their duration 
stored at -20°C, F = Fresh, 24H = 24 h, 2W = 2 weeks, 3M = 3 months and 6M = 6 months. 
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Figure 6.5| Unweighted UniFrac distance analysis of faecal DNA following storage at -20°C – (A) shows PCoA of the unweighted UniFrac distances where, 
the first and second components are plotted with the percentage of variation explained. Samples are colour coded, F = Fresh, 24H = 24 h, 2W = 2 weeks, 
3M = 3 months and 6M = 6 months. (B) shows AGNES clustering of the unweighted UniFrac distances between samples. The samples are colour coded to 
match the PCoA plot. 
(B) (A) 
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Figure 6.6| Weighted UniFrac distance analysis of faecal DNA following storage at -20°C – (A) shows PCoA of the weighted UniFrac distances where, the 
first and second components are plotted with the percentage of variation explained. Samples are colour coded, F = Fresh, 24H = 24 h, 2W = 2 weeks, 3M = 3 
months and 6M = 6 months. (B) shows AGNES clustering of the weighted UniFrac distances between samples. The samples are colour coded to match the 
PCoA plot. 
(A) 
(B) 
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The proportional abundances of assigned OTUs at the phylum level have been plotted (Fig. 
6.7). The majority of the samples contain a high abundance of Firmicutes and Bacteroidetes 
and the Actinobacteria are also abundant. The Proteobacteria are present but to a lesser 
extent. The ratio of Bacteroidetes to Firmicutes decreases as the storage time increases. This 
is further highlighted in a heatmap which clusters the most similar samples (Fig. 6.8). In the 
heatmap it is possible to see that 6 month (black) and the majority of 3 month (purple) 
samples cluster together. The reason for the clustering is due to the high number of OTUs in 
the Firmicutes phylum relative to the number of OTUs in the Bacteroidetes phylum. Cluster 
analysis through AGNES shows that the majority of samples after 6 months and 3 months of 
storage cluster together (Fig. 6.9). It is also possible to observe that the ratio of Firmicutes to 
Bacteroidetes in these samples is higher than in any of the other samples. 
In order to inspect this difference further OTU counts for the Bacteroidetes phylum were 
collected, exported and plotted (Fig. 6.10). The average OTU counts for the Bacteroidetes at 
Fresh, 24 h, 2 weeks, 3 months and 6 months were 141.33, 155.33, 121.75, 65.25 and 16.33 
respectively. The data were not normally distributed so a Log10 transformation was carried 
out. One – way ANOVA showed a highly significant difference between the mean of the 
Bacteroidetes counts [F (4, 38) = 14.504, p<0.001). Although after transformation the data 
were normal, there was no homogeneity of variance [Levene statistic (4, 38) = 4.588, 
p=0.004). Therefore, the Tamhane's T2 post-hoc test, which does not assume homogeneity 
of variance, was used. This post-hoc test showed that the average Bacteroidetes OTU counts 
for 6 months significantly differ from the counts obtained from Fresh, 24 h and 2 weeks 
storage at -20°C at the .05 significance level. There was no significant difference between 
Fresh, 24 h, 2 weeks and 3 months. Similarly there was no significant difference between the 
average Bacteroidetes OTU counts for 3 months and 6 months.  
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Figure 6.7| The effect of faecal material storage at -20°C on the bacterial community at the phylum level – proportional abundances of phyla are shown. 
Participant numbers are followed by the time stored at -20°C. F= fresh, 24H = 24 h, 2W = 2 weeks, 3M = 3 months and 6M = 6 months. Phyla are 
represented by colours and a key is shown. 
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Figure 6.8|Heatmap to show the effect of faecal material storage at -20°C on the bacterial 
community at the phylum level – the heatmap shows absolute numbers of OTUs for a given 
phylum, these are represented by colour. The time stored at -20°C is also represented by 
colour in a horizontal bar at the top of the heatmap. Colour keys are shown and similar 
samples are clustered together. 
 
CHAPTER 6 – THE EFFECT OF FREEZING FAECAL MATERIAL ON ITS BACTERIAL COMPOSITION 
233 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.9|Cluster analysis to show the effect of storage at -20°C on the ratio of Firmicutes 
to Bacteroidetes – AGNES of OTUs at the phylum level was carried out. The inner circle 
shows the time stored at -20°C on a grayscale colour continuum. Blanks represent Fresh 
samples and the shade becomes darker to represent a longer period of storage with Black 
(the darkest) representing 6 months' storage. The proportional abundance of Firmicutes 
(blue) to Bacteroidetes (red) is also shown as a bar chart. 
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Figure 6.10|The effect of storage at -20°C on the number of Bacteroidetes OTUs – the 
absolute number of Bacteroidetes OTUs are shown for each storage time; 24H = 24 h, 2W = 
2 weeks, 3M = 3 months and 6M = 6 months. The error bars represent SD from the mean. 
***denotes a highly significant difference (p<0.001) between the given storage period and 
the 6 months storage period.  
 
*** 
*** 
*** 
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In order to determine whether a specific member of the Bacteroidetes phylum was affected 
by storage at -20°C or not, the dataset was analysed at the family level also. Box-plots of 
OTU abundance for the Bacteroidetes at the family level were therefore plotted (Fig 6.11 
and Fig. 6.12). The data were not normally distributed therefore, Kruskal – Wallis H tests 
were carried out. The ranked means were significantly different between the times stored at 
-20°C for Bacteroidaceae *χ2 (4) = 20.130, p < 0.001], Rikenellaceae *χ2 (4) = 10.393, p = 
0.034], and Porphyromonadaceae *χ2 (4) = 20.494, p < 0.001]. Post-hoc analysis through pair-
wise comparisons shows that the mean ranks of Bacteroidaceae, Rikenellaceae and 
Porphyromonadaceae families were significantly higher at Fresh, 24 h and 2 weeks than 3 
months and 6 months at the 0.05 level. There was no significant difference between the 3 
months and 6 months' time-point in any of families and furthermore there was no significant 
difference between the ranked means of the Prevotellaceae family following storage at -
20°C. 
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Figure 6.11| Box-plot showing the effect of storage at -20°C prior to DNA analysis on 
members of the Bacteroidetes phylum at the family level – the box-plots show the median, 
1st and 3rd quartiles for 3 families at different storage periods, these are represented by 
colour and a key is shown. Outliers are represented by black dots. *denotes a significant 
difference between the rank mean of that given storage period and the ranked mean after 6 
months of storage (p<0.05). 
* * 
* 
*   * 
  
* 
CHAPTER 6 – THE EFFECT OF FREEZING FAECAL MATERIAL ON ITS BACTERIAL COMPOSITION 
237 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.12| Box-plot showing the effect of storage at -20°C prior to DNA analysis on the 
Bacteroidaceae family of the Bacteroidetes phylum - the box-plots show the median, 1st 
and 3rd quartiles for the Bacteroidaceae family at different storage periods, these are 
represented by colour and a key is shown. Outliers are represented by black dots. *denotes 
a significant difference between the rank mean of that given storage period and the ranked 
mean after 6 months of storage (p<0.05). 
 
* * 
 
* 
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6.4 Discussion 
The effect of storage upon the bacterial community of a faecal sample has been shown to be 
significant. Many researchers use faecal material as a proxy for the distal gut and the large 
intestine. It is therefore fundamentally important that this source of information represents 
the community truly. I have shown that the storage of this material at -20°C can affect the 
results.  
The inverse Simpson diversity indices show that there are no significant differences in the 
diversity of the samples after storage. There is also no significant difference in the diversity 
of samples based upon the individual. By plotting the normalised and non-normalised 
diversity indices it is possible to see that sub-sampling has not decreased the diversity. This 
is desirable as sub-sampling should still represent the initial community. Sub-sampling is also 
an essential step in order to negate sequencing generated biases. The effect of storage on 
the diversity of the faecal bacterial community has previously been researched. In 
agreement with my observations, the diversity of the community as a whole was not 
affected by storage conditions (Cardona et al. 2012). It has also been shown that faecal 
samples may be kept at room temperature for 72 h before storage at -80°C, with no 
significant change to the community as a whole (Roesch et al. 2009).  
The effect of storage at -20°C on the bacterial community of a sample becomes apparent 
when the β-diversity of the samples is analysed. nMDS analysis of Jaccard similarity 
coefficients generated from OTUs shows a moderate effect of storage on the community. 
This classical method was initially applied to describe the diversity of plants in the Alps 
(Jaccard 1912). Mothur utilises Jaccard's principle in order to describe the dissimilarity 
between communities (Schloss et al. 2009). This measure uses presence/absence of OTUs 
and does not take into account the abundance of a given OTU. This method shows moderate 
separate clustering of samples following 6 months of storage at -20°C. When the data are 
analysed through nMDS analysis of the Yue and Clayton θ similarity coefficients, a greater 
effect of storage is observed. Through this analysis it becomes apparent that samples cluster 
separately after 6 months of storage at -20°C. These samples show a degree of clustering 
with samples after 3 months of storage at -20°C. Similarity coefficients generated through 
the Yue and Clayton θ method (Schloss et al. 2009) take the abundance of a given OTU into 
account. Therefore, it is possible to surmise that the presence or absence of OTUs are not 
greatly affected by storage. However, the abundance of specific OTUs are affected by 
storage and furthermore, drive separate clustering of samples.  
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UniFrac distance analysis is a relatively new comparative method which has been applied to 
complex microbial communities (Lozupone and Knight 2005). The method determines the 
phylogenetic distance between samples or communities through the use of a phylogenetic 
tree. The unweighted version of the metric was applied in order to compare microbial 
communities from different types marine environments (Lozupone and Knight 2005). The 
unweighted metric does not take into account the abundance of a given OTU when 
comparing samples. Therefore, it is a useful technique in order to compare samples from 
different communities. The application of the unweighted form of this measure to my 
dataset shows that samples tend to cluster together based upon the individual and not time 
stored, with the exception of the 6M samples. This suggests that individuals have their own 
community of OTUs which drives this individual based clustering. With regards to the 
clustering of 6M samples, it appears that the storage of the faecal material negates inter-
individual differences in gut bacterial community and is probably due to the loss of 
Bacteroidetes OTUs. Samples from other time-points generally do not cluster together 
however, the 6M samples do cluster together. The weighted version of UniFrac does take 
into account the abundance of OTUs (Lozupone et al. 2007). When this measure is applied to 
the dataset inter-individual variation becomes less apparent. Samples from different 
individuals cluster with the same time-points from other individuals and different time-
points also. Once again, a large cluster of 6M samples can be observed with some 3M 
samples too. Therefore, I can conclude freezing does not greatly affect the 
presence/absence of OTUs up until 6 months as samples from individuals cluster together. 
However, freezing even for short periods seems to detrimentally affect the abundance of 
OTUs and through this decreases inter-individual variation. However, the abundances are 
not greatly affected until 6M of storage at -20°C. 
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Taxonomic assignment of OTUs at the phylum level show that the bacterial community of 
faecal samples resembles what has been previously shown (Ley et al. 2006a). In the fresh 
samples, the two major phyla are the Firmicutes and Bacteroidetes with Actinobacteria and 
Proteobacteria also present. In addition, the proportion of Bacteroidetes decreases as time 
stored at -20°C increases. This decrease in Bacteroidetes OTU abundance is responsible for 
the clustering observed in the nMDS plot of the Yue and Clayton θ similarity coefficients and 
in the PCoA and AGNES clustering of weighted UniFrac distances. Analysis, through the 
generation of a heatmap, shows that samples after storage for 3 months which cluster with 
samples after 6 months of storage do so due to a similar number of Firmicutes and 
Bacteroidetes OTUs. Analysis of the number of Bacteroidetes OTUs alone shows a highly 
significant reduction after 6 months of storage at -20°C. There was no significant difference 
between the 3 month storage period and 6 month storage period. This suggests that the 3 
month period is a transition point between Fresh, 24 h, 2 weeks and 6 months. Although 
there is a decrease in the numbers of Bacteroidetes OTUs, they do not completely disappear. 
This further explains why separate clustering was not observed through Jaccard similarity 
coefficient and unweighted UniFrac distance analysis. Bacteroidetes OTUs are still present 
and therefore these measures do not show separate clustering of samples from the 6 month 
storage period. The Yue and Clayton θ similarity coefficient and weighted UniFrac distances 
do take into account the abundance of OTUs. Therefore, separate clustering at 6 months is 
observed due to the reduction in the number of Bacteroidetes OTUs 
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My results suggest that storage does not affect the bacterial diversity of a faecal sample as a 
whole. However, storage at -20°C does affect the Bacteroidetes phylum, a major phylum in 
the human gut. Although a significant difference in Bacteroidetes OTU abundance was not 
observed until 6 months of storage, there was a marked reduction after 3 months of 
storage. Due to there being no significant difference between the Bacteroidetes OTU 
abundance at 3 months and 6 months, it is advisable not to store faecal samples at -20°C for 
longer than 2 weeks prior to DNA extraction. It has previously been shown that storage at -
20°C for 53 ± 5 days affects the ratio of Firmicutes to Bacteroidetes (Bahl et al. 2012). This 
period falls between the sampling points of 2 weeks to 3 months in my study where 
observable differences in the Bacteroidetes abundance become apparent. It is difficult to 
assign a reason for this decrease. It has been shown that the Bacteroidetes phylum is 
generally unaffected by freeze thawing in Arctic tundra soil (Männistö et al. 2009). It is 
therefore unlikely that freeze thawing of the faecal sample is directly causing a decrease in 
the Bacteroidetes. Members of this genus have been shown to degrade complex 
polysaccharides, including chitin (McBride et al. 2009). The commensal Bacteroidetes 
thetaiotaomicron has been shown to produce enzymes which degrade complex 
polysaccharides also (Xu et al. 2003). It has also been suggested that Porphyromonas 
gingivalis, a member of the Bacteroidetes phylum, lacks the protein secretion machinery 
which is common to other Gram negative bacteria (Sato et al. 2010). Many members of the 
Bacteroidetes genus contain the outer membrane protein porT. The researchers highlight 
that there are no orthologs of the porT gene in Bacteroides fragilis or B. thetaiotaomicron. 
However, the secretion machinery of Bacteroidetes may be affected by freezing and 
therefore export of the many carbohydrate degrading enzymes these bacteria produce 
cannot take place. My results show that the Bacteroidaceae and Porphyromonadaceae 
families decrease following storage at -20°C. Therefore, it could be possible that members of 
these families are degraded, due to their plethora of complex carbohydrate degrading 
enzymes. The subsequent DNA release may then be degraded from enzymes present within 
the faecal sample. 
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The effect of storage, combined with the already discussed variable results of DNA 
extraction on bacterial community community, gives the researcher much to consider. 
Indeed the effect of storage must be considered while designing experiments. It would 
appear that there is a finite window for the extraction of DNA to obtain a true 
representation of the faecal bacterial community. Roesch and colleagues have highlighted 
concerns that the faecal bacterial community needs to be a true representation of the distal 
gut (Roesch et al. 2009). It is especially important as much research focuses on the effect of 
our gut microbiota on the onset of diseases. New research suggests a link between our gut 
microbiota and the development of obesity. Researchers are especially interested in the 
proportion of Firmicutes to Bacteroidetes (Ley et al. 2006b; Turnbaugh et al. 2009). The 
results of Ley and colleagues’ work have not been emulated in another study (Fleissner et al. 
2010). My research shows that storage can affect the proportion of Firmicutes to 
Bacteroidetes. This raises questions as to how samples from the aforementioned studies 
were treated and stored. It may be prudent to ensure that observed differences in the ratio 
of Firmicutes to Bacteroidetes of already published work are true biological effects and not 
methodologically driven. 
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6.5 Conclusions 
The main conclusions for this chapter are as follows: 
1. freezing faecal material at -20°C gives rise to a significant reduction in the Bacteroidetes 
phylum; 
 
2. significant reductions in the Bacteroidetes phylum occurs between 2 weeks and 3 
months and it is therefore advisable not to store faecal material for longer than 2 weeks 
prior to DNA extraction.  
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7. GENERAL DISCUSSION, PERSPECTIVES AND FUTURE RESEARCH  
7.1 Conclusions 
The effect of long-term probiotic administration in healthy male individuals has been 
researched in the PROHEMI study, a pilot feeding study. Participants' distal gut bacterial 
composition, gut functions, genotoxicity and metabonomic profiles of their faecal waters 
have been researched through the use of a suite of techniques. In addition samples from 
Cardiff/Port Talbot and Sheffield have been compared against one and other. 
Recent research has hinted that the method of faecal material storage and subsequent DNA 
extraction can give rise to variable results. With regards to faecal material, it has been 
shown that storage can detrimentally impact upon the ratio of Bacteroidetes to Firmicutes, 
the two major phyla in the human gut. Therefore a 6 month study was undertaken in order 
to strengthen the body of knowledge in this area. 
The main conclusions of the studies now follow: 
7.1.1 Probiotic administration does not affect the distal gut bacterial community of 
healthy male individuals (Chapters 4 and 5) 
Through the community fingerprinting technique LHPCR it was shown that probiotic 
administration does not appear to affect the gross bacterial community of the distal gut in 
healthy individuals. Ordination techniques showed samples clustered together regardless of 
study period.  
NGS through Illumina-Solexa technology strengthened this finding. Sequencing of the 16S 
rRNA V4 region of PROHEMI faecal DNA showed no change attributable to probiotic 
administration. Ordination techniques once again did not show separate clustering of 
samples due to probiotic supplementation. In addition, phylum analysis showed no 
significant difference between study periods in terms of the abundance of detected phyla. 
Meta-analysis of the literature leads us to believe that modulation of human diet in turn will 
give rise to a change in the gut bacterial community of an individual {Walker, 2011 #813}. 
The efficacy of prebiotic feeding has also been carried out with phylum specific responses to 
given prebiotics shown {Gibson, 1999 #912}{Langlands, 2004 #913}. However, research into 
the effect of long-term probiotic supplementation upon the distal gut microbiota seems to 
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be lacking. Results from the PROHEMI study indicate that long-term probiotic 
supplementation does not affect the distal gut bacterial community of healthy individuals. 
 
7.1.2 Probiotic administration differentially affects functions provided by the 
commensal microbiota of healthy male individuals (Chapter 3) 
Probiotic administration appears to leave some functions provided by our distal gut 
microbiota unchanged while affecting others. Bacterial numbers expressing protease activity 
was reduced during probiotic supplementation in both study centres. The numbers of 
bacteria expressing β-glucuronidase activity in both Cardiff/Port Talbot samples and 
Sheffield samples increased during supplementation. β-galactosidase activity in Sheffield 
samples also increased during probiotic supplementation. Cholesterol degrading activity and 
esterase/lipase activity were low across all study periods and unaffected by probiotic 
supplementation.  
Many studies focus upon metagenomic strategies in order to interrogate the functions 
provided by our resident gut microbiota {Gill, 2006 #892}{Qin, 2010 #51}. However, my 
research utilised functional media and direct culture from faecal material. Through 
functional screening of the faecal microbiota differential responses in gut functions have 
been shown during probiotic treatment. This study gave rise to an agar screening method 
for protease activity which avoids false positives from β-galactosidase producing bacteria 
{Morris, 2012 #295}. Bacterial proteases have been implicated in the onset of intestinal 
inflammation {Steck, 2011 #839} and in the development of IBS and IBD {Steck, 2012 #836}. 
Probiotic supplementation may provide a means to decrease the expression of gut bacterial 
proteases and reduce intestinal inflammation. While there is a potential benefit in probiotic 
supplementation for the reduction of bacteria expressing protease activity, the increase in 
number of bacteria expressing β-glucuronidase activity is alarming. β-glucuronidases are 
responsible for the reversal of glucuronidation, uncoupling inactive toxic compounds so they 
become active once more. The results from this study suggest that further research needs to 
be carried out into the effect of probiotic supplementation on β-glucuronidase activity in the 
gut. These findings pose questions as to whether probiotic supplementation should be given 
to individuals receiving drug therapy as drug toxicity may be increased. 
CHAPTER 7 – GENERAL DISCUSSION, PERSPECTIVES AND FUTURE RESEARCH 
246 
 
7.1.3 Probiotic administration does not affect the genotoxicity and metabonomic 
profiles of faecal waters of healthy male individuals (Chapters 3 and 5) 
 
Research into the effect of probiotic consumption on the reduction of carcinogen 
genotoxicity has previously been carried out. Meta-analysis by Burns and Rowland has 
shown that probiotic supplementation can reduce the genotoxic effect of carcinogens in vivo 
and in vitro {Burns, 2000 #916}. More recent research by Burns and Rowland has shown that 
the genotoxic potential of faecal water of a healthy individual was decreased in HT-29 cell 
comet assay {Burns, 2004 #151}. In this study, probiotic LAB bacteria were incubated with 
HT-29 cells directly prior to administration of faecal water. While this study showed the anti-
genotoxic potential of probiotic bacteria, their effects following passage through the human 
GIT needs to be researched. 
With this in mind, the aim was to determine whether long-term probiotic administration 
gives rise to anti-genotoxic effects. My research showed that the levels of genotoxicity 
across all study periods remained relatively uniform. Genotoxicity levels neither increased 
nor decreased upon induction of probiotic supplementation. The protocol followed for 
genotoxicity testing served as a pilot experiment. The results showed significant differences 
in the faecal water of individuals. It would therefore have been interesting to analyse 
PROHEIMI participants individually throughout the course of the pilot feeding study in order 
to determine whether there are responders and non-responders to probiotic treatment.  
Metabonomic analysis has been applied in order to screen faecal water for metabolites 
indicative of disease {Marchesi, 2007 #205}{Odunsi, 2005 #897}. The technique has also 
been applied in order to determine whether LAB modify the metabonomic profiles of an 
experimental colitis mouse model {Hong, 2010 #898}. I aimed to determine whether 
probiotic supplementation in healthy individuals affects their metabonomic profiles. 
Metabonomic analysis of PROHEMI participants' faecal waters showed no effect on the gross 
and SCFA metabonomic profiles following probiotic supplementation. Ordination techniques 
showed samples clustering together, irrespective of the study period.  
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7.1.4 There are differences in the distal gut bacterial community, functions and 
metabonomic profiles of individuals from the two study centres (Chapters 3, 4 and 
5) 
The PROHEMI study has given rise to an interesting observation as there appears to be 
differences between the two study centres in many respects. Community profiling, through 
LHPCR, showed a difference in the gross bacterial community of individuals. In addition, NGS 
through Illumina-Solexa technology also showed differences between the two study centres 
in terms of distal gut bacterial community. Metabonomic analysis also showed differences 
between the faecal waters of Cardiff/Port Talbot and Sheffield samples. The research has 
inadvertently given rise to results which suggest geographical differences in the gut bacterial 
community, functions and metabonomic profiles of individuals in the UK. Many studies focus 
upon continental differences in the gut bacterial community of individuals {Lin, 2013 
#900}{De Filippo, 2010 #767} and differences in the gut bacterial community and 
metabonomic profiles of single cohorts, such as the elderly {Claesson, 2011 #76}{Claesson, 
2012 #296}. To my knowledge there has been no seminal comparison between individuals 
from the UK, as researchers seem to focus upon a single study centre within the UK. Further 
research needs to be carried out in order to confirm this observation. However, my research 
hints that there are indeed geographical differences within the UK. The exact reason for this 
observation remains unclear. However, lifestyle and diet may play a pivotal role in the 
observed difference. As previously discussed, modifying the diet of over-weight men exerted 
differences upon the abundance of member of the Firmicutes {Walker, 2011 #813}. Another 
reason for the observed difference may the water drank by individuals on the PROHEMI 
study. There appears to be no published research into the effect of different water supplies 
upon the distal gut bacterial community of individuals. However, water in Wales in supplied 
by Dŵr Cymru while water in Sheffield is supplied by Yorkshire Water and this may give rise 
to the observed differences. 
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7.1.5 Freezing faecal material prior to DNA extraction detrimentally affects its 
bacterial composition 
There is a growing body of evidence that leads us to believe that the freezing of faecal 
material at -20°C affects its bacterial composition. Bahl and colleagues highlighted that the 
ratio of Bacteroidetes to Firmicutes is affected by storage at -20°C {Bahl, 2012 #358}. In my 6 
month study I aimed to determine if this observation was true and if so how long could a 
sample be stored before this ratio was affected. The results show that between 2 weeks and 
3 months, the Bacteroidetes become severely depleted in the faecal samples. From this 
observation it is recommended to carry out DNA extractions immediately from fresh 
samples. If samples need to be stored, they should not be stored longer than 2 weeks at -
20°C. Freezing samples also adds further complications as it has been shown that thawing of 
faecal samples can also affect its bacterial composition {Cardona, 2012 #422}. In order to 
avoid detrimentally affecting the bacterial composition of faecal material researchers may 
opt to freeze samples at -80°C. However, these freezers may not be available to those in 
other countries where sampling is taking place. These results have implications for those 
who aim to complete sampling prior to DNA extraction. Indeed, the effect of storage upon 
the bacterial community of a faecal sample may have implications already published studies. 
There is a growing body of evidence implicating the ratio of Bacteroidetes to Firmicutes in 
disorders such as obesity {Ley, 2005 #202}. However, questions need to be asked as to the 
method of storage of this faecal material. Are these observations truly biological or merely 
an artefact of the sampling methodology followed? Searching the NCBI PubMed database 
(http://www.ncbi.nlm.nih.gov/pubmed) with the following search terms “(((bacterial) AND 
faecal) AND DNA) AND extraction” gave 106 publications over the past decade. This stands 
to highlight the importance of bacterial DNA extraction in the field of biology. Researchers 
need to be aware of the effect of storage upon the bacterial community of faecal material. 
Inferred distal gut bacterial community community in humans, and animals also, can be 
affected by something as fundamental as the storage of this source of information. 
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7.2 Knowledge exchange from my research to Cultech (industrial partner) 
Funding for the PROHEMI study came from an EU initiative, KESS, with funding from the ESF. 
This scholarship aims to develop links between SMEs, from convergence areas in Wales, and 
higher education institutions. PhD or Masters students have the opportunity to work with a 
company in their research area and to see how research is translated into viable product or 
services. The company receives research to bolster their products or services and have the 
opportunity to acquire research techniques and skills applicable for future research projects. 
7.2.1 Community profiling of faecal DNA through LHPCR 
The successful application of LHPCR in the PROHEMI study resulted in the adoption of the 
technique by Cultech. This method has been applied to screen faecal DNA obtained from 
babies following probiotic administration. Following this technique, samples of interest were 
subjected to NGS.  
7.2.2 Functional media for faecal material and pure bacterial cultures screening 
During the course of the PROHEMI study agar plates designed to screen for functions of 
interest were developed. One week was spent at the company in order to show how these 
plates were made. Subsequently, these plates have been used to screen other probiotic 
organisms the company has interest in and may be used for future research projects.  
7.2.3 Multivariate statistical methods 
The majority of statistical analysis carried out at Cultech was not multivariate. This was 
probably due to their previous preference and expertise in culture dependent methods, 
which rarely need multivariate analysis. However, as the company began to use more 
culture independent techniques, such as LHPCR and NGS, multivariate data analysis was 
needed. Using R statistical software {R-Core-Team, 2012 #210} custom scripts were 
developed in conjunction with Cultech in order to address their needs. Furthermore, time 
was spent showing how to use R, relevant packages and which techniques should be used in 
order to analyse their data. 
CHAPTER 7 – GENERAL DISCUSSION, PERSPECTIVES AND FUTURE RESEARCH 
250 
 
7.2.4 Research into the effect of Cultech’s probiotic supplement in healthy 
individuals 
The project did not show many effects the company’s probiotic supplement in healthy 
individuals. However, the research gives Cultech an advantage as their scientific portfolio 
has been bolstered by a long-term pilot feeding study. Regardless of the outcome, there is a 
benefit to the company from this research. The pilot study can give Cultech data to work 
with in order to calculate power and sample sizes for future feeding studies in healthy 
males. In addition, the EFSA has applied pressure upon producers of probiotics in recent 
years. Through its Nutrition and Health Claims Regulation (Regulation (EC) No 1924/2006) 
the EFSA aims to protect consumers from products with false health benefit claims or claims 
which simply do not have scientific evidence. It is therefore imperative for companies such 
as Cultech to carry out research into their products in order to ensure that they may sell 
without legislation impacting upon their sales. 
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7.3 General discussion 
7.3.1 The value of the PROHEMI dataset  
Many studies focus on the dysbiosis of the human gut microbiota in infirm and the effects 
from such imbalances. However, this pilot study has provided a useful data source on many 
parameters associated with healthy humans. Probiotic intervention aside, the PROHEMI 
study dataset has provided a wealth of information on healthy human males, by following 
them for a year. The baseline period served to provide information on the characteristics of 
the human gut and was continued throughout the intervention and washout periods. The 
application of other culture independent techniques, such as functional metagenomics, to 
this dataset could shed light onto functions expressed within the healthy human gut. 
Extracted DNA and faecal waters from the PROHEMI study can be stored for use with such 
techniques in the future. 
7.3.2 Probiotic supplementation in healthy individuals 
Probiotic intervention does not appear to impact upon the bacterial community of the distal 
gut in healthy human males. It therefore stands to reason that this community is relatively 
stable and resistant to modulation through probiotic feeding. During the intervention 
period, a reduction in protease expression in cultured bacteria was observed. Therefore, it is 
possible to surmise the probiotic organisms used in the PROHEMI study can modulate 
functions within the human gut without modifying the gross bacterial community. This 
seems advantageous as any detrimental effects exerted by the probiotic may be reversed 
upon cessation of its consumption.  
Metabonomic profiles of PROHEMI participants were also unaffected by probiotic 
supplementation. Recent research has shown that probiotic supplementation with the 
VSL#3 preparation in diet-induced obese mice increased butyrate production {Yadav, 2013 
#919}. This study shows probiotics have the potential to modulate gut metabolites. 
However, this study utilised a murine model which with an induced condition. Metabonomic 
analysis of samples from the PROHEMI showed no effect on gross metabonomic profiles or 
the profiles of SCFAs. It may be possible that in a similar fashion to gut bacterial modulation, 
probiotics do not exert effects in healthy hosts with an established gut microbiota.  
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7.3.3 Geographical differences in the gut microbiota, gut functions and 
metabonomic profiles of faecal waters 
The PROHEMI study has given rise to an interesting observation; there appears to be a 
geographical difference in the gross bacterial community of individuals in the UK. 
Furthermore, there is also a difference in gut functions and the metabonomic profiles of 
PROHEMI participants from the two study centres. The differences observed suggest that 
this is a real biological phenomenon and not an artefact of lab differences in sample 
preparation. To my knowledge, there has not been a comparison of this kind between 
healthy individuals in the UK. Most research seems to focus on a single study centre; this is 
more than likely in effort to overcome study centre differences in results. However, a 
fundamental difference in the gut bacterial community, functions and metabonomic profiles 
has been overlooked. The concept of personalised medicine aims to provide personalised 
healthcare for a given individual based upon the genes that that person expresses. The 
importance of the gut microbiome in this field is becoming increasingly understood. 
Expression of bacterial enzymes and the metabolism of compounds by commensal gut 
bacteria may play a role in drug therapy. Differences in the gut bacterial community of 
individuals will differentially affect the metabolism of compounds in the gut. It therefore 
follows that individuals from Cardiff/Port Talbot and Sheffield could require completely 
different personalised healthcare programmes due to their difference in gut bacterial 
community. 
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7.3.5 The effect of freezing faecal material prior to DNA extraction 
The observed loss of Bacteroidetes following the freezing of faecal samples at -20°C is of 
concern. This phylum is one of the most abundant in the human gut. However, my research 
has shown that storage of faecal material for 6 months at -20°C significantly decreases the 
abundance of this phylum. If researchers stored faecal samples at -20°C for this length of 
time or greater, the sample would no longer be a true representation of the distal gut 
community. The difference in the ratio of Bacteroidetes to Firmicutes was highlighted in my 
community fingerprint study; where Sheffield samples stored at -20°C for some time no 
longer resembled their initial LHPCR profiles (Fig. 3.17). The observation is of particular 
concern to those who have previously published data on the ratio of Bacteroidetes to 
Firmicutes. Researchers may not have been aware of the effect of storage upon the faecal 
microbial community. Samples may have been stored for some time prior to DNA extraction 
and analysis. If so observed differences in the ratio of Bacteroidetes to Firmicutes may not be 
a true biological difference but instead methodologically driven. Research into the effect of 
storage and its effects needs to be carried out as the use of faecal material as a proxy for the 
distal gut bacterial community is widespread. Storage method and DNA extraction method 
needs to be seriously considered by researchers in order to avoid masking true biological 
differences in the distal gut communities of samples.  
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7.4 Future research directions 
7.4.1 qPCR of specific bacterial groups 
While NGS and community profiling showed no difference in the gross bacterial community 
of individuals following probiotic supplementation, qPCR would strengthen this finding. It 
would also be advantageous to use this technique in order to strengthen the finding of 
differences in the ratio of Bacteroidetes to Firmicutes between Cardiff/Port Talbot and 
Sheffield samples. 
7.4.2 Further metabonomic analysis of the PROHEMI samples 
Further analysis into the metabonomic profiles of PROHEMI samples needs to be carried out. 
More sophisticated methods may give rise to differences between samples from the study 
periods. Furthermore, with regards to the observed differences in the metabonomic profiles 
of the two study centres, it may be possible to determine which metabolites are driving the 
separate clustering. My analysis looked a short chain fatty acids, it would be useful to 
include branched chain fatty acids and other metabolites also in future analyses. 
7.4.3 Genotoxicity testing of a greater number of PROHEMI sample faecal waters 
Analysis of more PROHEMI samples would allow independent study centre analysis of the 
effect of probiotic consumption on the genotoxicity of faecal water. Due to costs for 
commercial kits, I was not able to carry this out. Furthermore, inquiring into the diet of 
individuals would be useful as individual differences may be attributable to the diets of 
these individuals. 
7.3.4 Further research into geographical differences in gut bacterial community 
and metabonomic profiles of healthy individuals in the UK 
Studies which research differences in the gut bacterial community of individuals seem to 
compare individuals from disparate locations. Following my research, it would be of value to 
strengthen the notion that there are differences in the gut bacterial community and 
metabonomic profiles of individuals from locations across the UK. Further research would 
also shed light onto the reason behind this observed difference. 
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9. APPENDICES 
Appendix I – Fragment sizes of 16S rRNA sequences obtained from the RDP 
(http://rdp.cme.msu.edu/) following an in silico LHPCR experiment 
 
Generated fragment sizes for an in silico LHPCR experiment are available at: 
https://drive.google.com/file/d/0ByapqDVxrBNqWHFHUmZwbFpTazA/edit?usp=sharing 
 
 
Appendix II – Example R scripts used during the PROHEMI study 
 
Example R scripts are available at: 
https://drive.google.com/file/d/0ByapqDVxrBNqNm1GeWdJR1c5MEU/edit?usp=sharing 
Lines with # symbols have been commented out and do not serve any function in R 
statistical software {R-Core-Team, 2012 #210}. 
 
 
Appendix III – Stability file for Illumina MiSeq contig assembly from 2 paired 
end reads 
 
The stability file utilised by Mothur in the 1st step in MiSeq data analysis is available at: 
https://drive.google.com/file/d/0ByapqDVxrBNqLTNITU9wOHR5LTA/edit?usp=sharing 
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Appendix IV – Mothur batch files used in Mothur analysis of the MiSeq 
dataset 
 
Mothur has the ability to run in batch mode where commands may be stored in a file and 
ran sequentially. Lines with # symbols are comments and are not executed by Mothur. 
Example batch files used for the analysis of the PROHEMI MiSeq dataset are available at: 
https://drive.google.com/file/d/0ByapqDVxrBNqbXk2TjNhU0t0ZUE/edit?usp=sharing  
 
 
Appendix V – Sequence counts for PROHEMI samples subjected to Illumina 
MiSeq NGS 
 
The number of sequences obtained from Illumina MiSeq NGS for given sample is available 
at: 
https://drive.google.com/file/d/0ByapqDVxrBNqQUd5Y2lxY1NrQk0/edit?usp=sharing 
 
 
Appendix VI – Mothur batch files used in 454 analysis of DNA obtained from 
frozen faecal material 
 
Mothur has the ability to run in batch mode where commands may be stored in a file and 
ran sequentially. Lines with # symbols are comments and are not executed by Mothur. 
Example batch files used for the analysis of the 454 dataset obtained from faecal DNA frozen 
at -20°C for up to 6 months are available at: 
https://drive.google.com/file/d/0ByapqDVxrBNqTWJ4NjF5ekh1OHc/edit?usp=sharing 
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Appendix VII – Publications during my PhD studies: 
 
Morris, L. S., Evans, J. and Marchesi, J. R. (2012). A robust plate assay for detection of 
extracellular microbial protease activity in metagenomic screens and pure cultures. Journal 
of Microbiological Methods 91:144-146. 
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Skimmed milk agarA robust, efﬁcient and cost-effective agar that utilises lactose free milk powder for identiﬁcation of bacterial
protease activity in pure cultures and metagenomic screens has been developed and tested on protease
positive bacteria, selected strains and false protease positives isolated from a previously constructed
metagenomic library.
© 2012 Elsevier B.V. All rights reserved.The deﬁciency of current culture techniques to isolate most micro-
organisms from some environments has led to the emergence and
progression of functional metagenomics as a means for unearthing
the vast and relatively untapped biological resources of the microbial
world. Its ability to do so has been demonstrated with the discovery
of novel and biotechnologically useful molecules (Uchiyama and
Miyazaki, 2009) (Schloss and Handelsman, 2003) and clinically rele-
vant antibiotic resistance genes (Allen et al.).
One function of interest here is microbial proteases as these are an
important target for metagenomic screening due to their extensive
possibility for use in industry (Rao et al., 1998) and also because of
their role as virulence factors (Lantz, 1997; Maeda and Molla, 1989;
Miyoshi and Shinoda, 2000). However there is a current deﬁcit in
metagenomic screens successfully isolating these enzymes. While
there are a number of reasons for this scarcity, one problem that we
aim to resolve with this research is the current issue of false positives
arising from the use of skimmed milk agar as a standard means for
screening metagenomic libraries for proteolytic activity. Previous re-
search by Jones et al. (Jones et al., 2007) found that an initial 231
metagenomic clones deemed positive for protease activity by the for-
mation of distinctive halos of clearing around colonies on standard
skimmed milk agar (SSMA) were in fact, glycoside hydrolases which
produced acetic acid from lactose fermentation and the pH drop
was responsible for the phenotype, not protease activity. The demon-
strated ineffectiveness of this agar has lead us to question the validity
of putative proteases detected using this method, for example Pailin
et al. (2001) used SSMA to identify extracellular protease activity in: +44 29 20874305.
esi).
rights reserved.strains of the lactic acid bacteria; Streptococcus thermophilus and
Lactobacillus bulgaricus.
Therefore it can be concluded that while SSMA could be appropri-
ate for identifying lactose utilisation and the presence of galactosi-
dases, it is not a sufﬁciently robust screening technique for protease
activity and an alternative needs to be developed in order to save
time and money. Here, we have developed a simple and easy way
to prepare media which utilises lactose-free and fat-free skimmed
milk powder as the substrate for detecting protease activity and al-
lows discrimination against acid production since lactose hydrolysis
is no longer an issue.
Bacillus subtilisMY2016 was used as a positive control for protease
activity on all types of agar used in this study since it is known to
secrete a number of extracellular proteases. Theses cultures were rou-
tinely grown on all agar at 30 °C. Strains of Streptococcus thermophilus
2483 and Lactobacillus bulgaricus 859 were obtained from the culture
collection of University College cork, Department of Microbiology.
Cultures were revived on MRS agar (Thermo Scientiﬁc, Oxoid) and in-
cubated at 37 °C in an anaerobic chamber (Merck, Darmstadt, Germany)
and examined after 48 hour incubation.
False protease positive glycoside hydrolase metagenomic clones were
obtained from a previous metagenomic library (Jones et al., 2007) and
were routinely revived from freezer stock on LB (Luria-bertani) agar
supplemented with 12.5 μg/ml chloramphenicol. All cultures were rou-
tinely re-streaked every one–two days for the duration of this research.
SSMAwas prepared as follows: 10% semi-skimmedmilk solutionwas
prepared in deionised water and autoclaved at 121 °C for 15 min. 1.5%
(w/v) puriﬁed agar (Thermo Scientiﬁc) was also prepared in deionised
water and autoclaved at 121 °C for 15 min. Upon sterilisation, both
were kept at 55 °C in a water bath then the semi-skimmed milk solution
Fig. 1. Plate assays for protease activity. From top left; B. subtilis MY2016 clearing LF-SMA and a negative control, top middle; S. thermophilus 859 and L. bulgaricus2483 failing to
clear LF-SMA, top right; a glycoside hydrolase positive metagenomic clone failing to clear LF-SMA, bottom left; two glycoside hydrolase positive metagenomic clones clearing SMA,
bottom middle; S. thermophilus 859 clearing SMA, bottom right; L. bulgaricus 2483 beginning to clear SMA. Cultures were incubated according to their appropriate conditions on all
types of agar. Cultures were re-streaked every one to two days for the duration of this research to ensure the initial phenotype observed was replicable.
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Fig. 2. Protease activity as measured by the release of acid-soluble substance from
azocasein (5 mg/ml) in HCl buffered Tris to a pH of 8.0 incubated at 37 °C for 4 h. Re-
sults are shown as the mean value of the results that were in triplicate and are shown
as a relative percentage of total protease activity. 1 = B. subtilis MY2016, 2 = Glyco-
side hydrolase clone, 3 = glycoside hydrolase clone.
145L.S. Morris et al. / Journal of Microbiological Methods 91 (2012) 144–146was added to the agar to give a ﬁnal volume of 1% (w/v) semi-skimmed
milk.
Lactose-free semi-skimmed milk powder was obtained from Valio
(suomikauppa.ﬁ) and agar was prepared in the same manner as
described above to give a ﬁnal concentration of 1% (w/v). After inocula-
tion, cultures were incubated according to their appropriate conditions.
Cultures were re-streaked every one to two days for the duration of this
research to ensure the initial phenotype observed was replicable.
In order to prepare crude cell free extracts (CCFE) for protease as-
says, cells were grown overnight in appropriate media supplemented
with the appropriate antibiotic. An aliquot (1%) of this starting cul-
ture was used to inoculate 50 ml of fresh media and grown to an
optical density of 0.5 (600 nm). After this point cultures were left to
grow for a further 3 h. Cells were harvested by centrifugation at
4000 rpm for 10 min. The pellet was re-suspended in 2 ml of Phos-
phate buffered saline (PBS) and each sample was bead beaten
(0.1 mm diameter glass beads, 0.5 g) for 30 s and repeated a further
2 times with cooling on ice for 5 min between each beating. Samples
were centrifuged at 20,000×g for 10 min and the resulting superna-
tant was taken as the cell free extract. An aliquot of the CCFE
(100 μl) was added to 100 μl azocasein (5 mg/ml in 50 mM Tris–
HCl) protease substrate and the mixture was incubated at 37 °C for
4 h, the reaction was terminated by the addition of 400 μl of 10%
(w/v) trichloroacetic acid (TCA). Protein was precipitated by centrifuga-
tion at 12,000×g for 5 min and the resulting supernatant was trans-
ferred to a clean tube containing 700 μl of a 525 mM NaOH solution.
The absorbance of the liberated azo-dye was measured using a spectro-
photometer at 442 nm. Each reaction was carried out in triplicate.
It was found that the putative protease deﬁcient strains used were
capable of degrading skimmed milk agar but not lactose-free milk
agar. Similarly the metagenomic clones had a corresponding outcome
whereas for the bacterial strains known to be proteolytically active; a
positive phenotype was observed on both types of media (Fig. 1). To
afﬁrm this, cultures were further subject to azocasein assay (Fig. 2)where B. subtilis was shown to degrade the azocasein substrate
and glycoside hydrolase metagenomic clones showed less than 20%
activity.
From our study, Valio™ lactose-free milk agar was found to be an
effective and robust agar for correctly identifying proteases by way of
distinct zones of clearing around a bacterial colony. From the screens
undertaken in this study no false positives arose with the use of this
type of agar. We would suggest that this agar would be much more
appropriate for future screening of metagenomic libraries for prote-
ase activity. The robustness of this agar will allow for more efﬁcient
characterisation of enzyme activity which can then lead to identiﬁca-
tion of clinically or industrially relevant proteases.
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marchesijr@cardiff.ac.ukAbstractThe human microbiome contains a vast array of microbes and genes that show greater
complexity than the host’s own karyome; the functions of many of these microbes are
beneficial and show co-evolution with the host, while others are detrimental. The
microbiota that colonises the gut is now being considered as a virtual organ or emergent
system, with properties that need to be integrated into host biology and physiology. Unlike
other organs, the functions that the gut microbiota plays in the host are as yet not fully
understood and can be quite easily disrupted by antibiotics, diet or surgery. In this review, we
look at some of the best-characterised functions that only the gut microbiota plays and how
it interacts with the host’s endocrine system and we try to make it clear that the 21st-century
biology cannot afford to ignore this facet of biology, if it wants to fully understand what
makes us human.Key Words
" human microbiome
" cross-talk
" gut microbiome
" endocrine systemJournal of Endocrinology
(2013) 218, R37–R47IntroductionIn the many years of studying the human body, it has
become accepted that all the organs are known and well
characterised in terms of their main functions. The whole
discipline of anatomy has been focused on documenting
the fine structure of these organs, while physiology and
biochemistry have been determining their functions and
specific chemical reactions. In the last 10years, a significant
revolution has been progressing, which started with the
notion that for the best part of a hundred years we have
been trying to describe how mammals function while
ignoring one of themain organs in the body. However, this
organ is not found or described in any conventional
textbook and there are no clinical experts who can
understand its functions and the pathologies that arise
when it becomes diseased. This dearth of information is
because this organ does not conform to the currentdefinition of being an organ, i.e. ‘a fully differentiated
and functional unit’, and should probably best be thought
of as a virtual organ (O’Hara & Shanahan 2006) since it is
composedofmicrobes andall its functions arederived from
these parts. In fact, it most probably should be considered
as a system in the samewaywe look at our immune system,
which is made of different cells, each having its own set of
functions and roles. This paradigm shift is still undergoing
some refinement, but it does beg the question ‘what would
biologists do if they were suddenly presented with a whole
new organ/system?’ Furthermore, why should we even
think of it as an organ or system? To answer the last
question first, we see this as a virtual organ/system due to
the genetic and metabolic diversity that resides within it.
Microbiologists have coined a phrase for this system,
the microbiome, which is defined as the ‘the genetic
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218 :3 R38material (DNA) within a microbial community’; this can
also be referred to as the metagenome of the microbiota.
The largest contributors to the humanmicrobiome are the
bacteria present in the intestinal tract, which have been
estimated to be in the range of 100 trillion cells, ten times
more cells than there are human cells in the host’s body.
In terms of the total non-redundant genetic load found in
the human gut microbiome, it is 150 times larger than the
host’s karyome ((Qin et al. 2010), which is between 20 000
and 26 000 genes (Pennisi 2003, Collins et al. 2004)), and
each individual has w540 000 bacterial genes in the gut
(21–27!the human karyome). While the karyome is
generally regarded as fixed with respect to the gene
catalogue, and at this stage ignoring any epigenetic
mechanisms, the gut microbiome is far more random
and each individual will contain a unique collection of
microbes that are easily altered (see below). Humans are
born either sterile or colonised with a very basic
microbiome, and analysis of the meconium has shown
that any microbes that are present are not necessarily
those that ultimately colonise the adult gut (Koenig et al.
2011). The microbiome that is obtained is partly inherited
from the mother and partly from the exposure to the
environment in the first 2 years of life. Hence, there is a
degree of determinism (both by exposure to the mother
and due to genetic selection (Tims et al. 2013)) and also a
significant proportion of random colonisation. However,
it is striking that after 2 years of age, all adults’ colons
will be predominantly colonised with members of two
phyla, namely Bacteroidetes: Gram-negative, anaerobic,
non-spore-forming bacteria, which are enriched with
carbohydrate-degrading enzymes, and Firmicutes: Gram-
positive, formerly called ‘the low-GC bacteria’, anaerobic,
spore-forming bacteria, which ferment simple sugars to
produce a variety of short-chain fatty acids (SCFAs), such
as butyrate, acetate and propionate (Fischbach &
Sonnenburg 2011). Between them, these phyla can
constitute over 90% of the bacteria present in the large
intestinal lumen (Turnbaugh et al. 2009, Qin et al. 2010,
Claesson et al. 2011, HMPC et al. 2012) and mucosa
(Eckburg et al. 2005, Chen et al. 2012, Harrell et al. 2012),
and the proportion of each phylum in the colon ranges
from being nearly 90% Firmicutes, at one end of the
continuum, to 90% Bacteroidetes, at the other end. What
dictates this distribution is unclear, and the consequences
for the host are also unclear. Furthermore, our view of the
intestinal environment is skewed towards the large
intestine and is predominantly focused on faecal material,
and even then we are very bacteria centric (Marchesi
2010). Bearing this biased view of the intestinalhttp://joe.endocrinology-journals.org  2013 Society for Endocrinology
DOI: 10.1530/JOE-13-0131 Printed in Great Britainenvironment in mind, we have begun to determine what
functions this collection of organisms plays in the host.A virtual organ/system with functions
of importance to the host
In the last 10 years, it has become increasingly apparent
that the gut microbiota plays a significant role in host
biology. We have a substantial body of evidence that these
functions can be beneficial or detrimental to the host, and
if they were assets, we would wish to maximise the former
and somehow offset the latter. A significant portion of the
evidence that supports a role for the gutmicrobiota in host
development and function comes from studying sterile
animals, especially rodents (Fig. 1). A recent comprehen-
sive review of the use of such animals has shown how
widespread the impact of not having a gut microbiota is
(Smith et al. 2007). Some of the best studied of these
bacterial functions include providing the host with energy
in the form of SCFAs such as butyrate (Louis & Flint 2009)
and propionate (Macfarlane & Macfarlane 2011), bile salt
metabolism (Jones et al. 2008, Swann et al. 2011) and role
in the brain–gut axis (Collins et al. 2012). Many ecological
analyses of the colonic microbiota have shown that while
it is relatively stable (Scanlan et al. 2006, Jalanka-Tuovinen
et al. 2011, Kolmeder et al. 2012), it can be significantly
perturbed by antibiotics (Dethlefsen et al. 2008, Jernberg
et al. 2010), diet (Claesson et al. 2012, Ravussin et al. 2012)
and surgery (Zhang et al. 2009, Li et al. 2011). Unlike a
conventional organ, the functions of this virtual organ can
be significantly altered or removed due to these environ-
mental factors, which can result in disease in the host, e.g.
Clostridium difficile-associated diarrhoea (Kachrimanidou
&Malisiovas 2011), or a significant alteration of the host’s
metabolite profile (Yap et al. 2008), the significance of
which still remains unclear. The variability in the gut
microbiome and its functions are important in two
respects: the functions that one inherits and acquires are
driven mainly by a random process and once established
they can be perturbed by interventions.Bile metabolism and gut bacteria
Bile acids/salts are cholesterol-derived host metabolites
that play a role in several host processes (Fig. 2). Their
principal functions are to aid in fat adsorption and prevent
small intestinal bacterial overgrowth. Both these functions
can be explained by the fact that bile acids are surfactants
(not detergents), with a hydrophilic taurine or glycine
group covalently bound to a hydrophobic steroidPublished by Bioscientifica Ltd.
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Figure 1
Schematic representation of areas of the rodent system that are significantly
impacted by the absence of a normal microbiome; all the changes are those
that are measured/observed in the sterile animal (adapted from Smith K,
McCoy KD & Macpherson AJ 2007 Use of axenic animals in studying the
adaptation of mammals to their commensal intestinal microbiota. Seminars
in Immunology 19 59–69. (doi:10.1016/j.smim.2006.10.002)).Jo
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218 :3 R39(predominantly a C24 structure (Russell 2003))-derived
moiety that is wholly derived from cholesterol. This
surfactant nature allows them to associate with fat
molecules to formmicelles, which are ultimately absorbed
by the host, thus facilitating fat metabolism. Additionally,
being a surfactant allows them to be antimicrobial also, as
they can disrupt the plasma membrane of the bacteria,
causing them to lyse and die; thus in a niche where food is
plentiful, bile helps to prevent the bacteria in the small
intestine from overgrowing and becoming a health issue.
A secondary role for bile involves regulating the host’s
cholesterol levels, on a typical day,w0.5 g of this steroid is
used to synthesise bile acids in hepatocytes and accounts
for 90% of the cholesterol usage (Russell 2003). Once the
hormonal signal has been sent to the gall bladder, the bile
acids are excreted into the small intestine, where they
interact with the dietary lipids and fat-soluble vitamins.
These complexes are eventually reabsorbed in the terminal
ileum; this process is part of the enterohepatic circulation
that ensures that 95% of the bile acids are recovered from
the gut. The remaining 5% that escapes this pathwayhttp://joe.endocrinology-journals.org  2013 Society for Endocrinology
DOI: 10.1530/JOE-13-0131 Printed in Great Britainenters the large intestine, where it becomes available for
metabolism by bacteria. Interestingly, the gut bacteria
have evolved several enzymes capable of modifying the
primary bile acids such as the taurine- and glycine-
conjugated cholic and chenodeoxycholic acids and
removing the taurine and glycine parts of the molecules
to produce secondary bile salts, such as cholic, lithocholic
and deoxycholic acids. While some of these secondary bile
acids are excreted in the faeces, a significant proportion
are passively absorbed and returned to the liver. These
secondary bile acids then enter the enterohepatic circula-
tion and the general bile metabolite pool. The bacterial
enzymes responsible for the deconjugation of either
taurine or glycine are collectively known as bile salt
hydrolases (BSHs), choloylglycine hydrolases or bile acid
hydrolases (EC 3.5.1.24) and catalyse the hydrolytic
removal of taurine or glycine from the corresponding
primary bile acids. However, as with many gut functions,
the diversity and abundance of BSHs are highly variable as
are their substrate ranges (Jones et al. 2008). Additionally,
studies on germ-free rodents (i.e. sterile or gnotobiotic)Published by Bioscientifica Ltd.
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Schematic representation of some of the functions that the gut microbiota
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play a role in producing molecules that interact with the host’s endocrine
system. The red/green colour scheme implies that it is still unclear whether
these functions are beneficial or detrimental to the host’s physiology.
Jo
u
rn
a
l
o
f
E
n
d
o
cr
in
o
lo
g
y
Review J M EVANS and others Role of a virtual organ in host
endocrinology
218 :3 R40have shown that the bile pool is significantly and
dramatically altered in other non-liver or non-gut
compartments too, e.g. heart tissue (Fig. 3), which begs
the question of the significance of having a specific BSH
profile in the gut and the host’s own physiology. Bile
acids interact at an endocrinological level via three
major signalling mechanisms, as ligands for thehttp://joe.endocrinology-journals.org  2013 Society for Endocrinology
DOI: 10.1530/JOE-13-0131 Printed in Great BritainG-protein-coupled receptor TGR5, activators of the MAPK
pathways and activators of the nuclear hormone receptors
such as farnesoid X receptor a (FXRa; NR1H4). While the
primary bile acids are of significant interest as they have
been shown to regulate lipid, energy and glucose
metabolism, the secondary bile acids can also interact
with these receptors. However, the availability of thePublished by Bioscientifica Ltd.
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Figure 3
Differences in the bile profiles of sterile and normally colonised rats. (A) If
the bar is above the origin (set at 0), the bile salt is enriched in the sterile
animal when compared with the conventional animal and vice versa.
(B) Changes in bile metabolites when rats are treated with the antibiotics
streptomycin and penicillin. (Values are means of the scaled dataGS.E.M.
Statistical significance was determined using Student’s t-test. *P!0.05;
**P!0.01; ***P!0.001 (modified from Swann JR, Want EJ, Geier FM,
Spagou K, Wilson ID, Sidaway JE, Nicholson JK & Holmes E 2011 Systemic
gut microbial modulation of bile acid metabolism in host tissue
compartments. PNAS 108(Suppl 1) 4523–4530. (doi:10.1073/pnas.
1006734107)). Unconjugated bile acids are those that are produced by
bacterial metabolism of the host conjugated acids.
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driven by the variable and dynamic diversity and
expression of BSHs in the gut. Hence, the gut microbiota
can be thought of as another environmental factor
controlling an up-and-coming endocrine factor that is
not stable and influenced by diet and medications.SCFAs and the endocrine system
One of the most fundamental contributions that the gut
microbiota makes to host function is the provision of
SCFAs. These relatively simple molecules, predominantly
butyrate, acetate and propionate, are all produced when
certain classes of bacteria ferment a variety of carbon
sources anaerobically. Although SCFAs are the end
products of metabolism for some bacteria, they are a
significant source of energy for the host. Both termiteshttp://joe.endocrinology-journals.org  2013 Society for Endocrinology
DOI: 10.1530/JOE-13-0131 Printed in Great Britain(Warnecke et al. 2007) and ruminants (Brulc et al. 2009)
have evolved a mutualistic relationship with the organ-
isms that synthesise SCFAs, and it seems that humans
too have co-evolved with these bacterial functions. The
G-protein-coupled receptors free fatty acid receptor 2
(FFAR2, GPR43) and FFAR3 (GPR41) are the two endogen-
ous receptors that have been identified to interact with
SCFAs (Brown et al. 2003, Le Poul et al. 2003, Nilsson et al.
2003). FFAR2 and FFAR3 interact with the SCFAs (mM–mM
range) with a carbon chain length greater than six atoms
and are those that are most likely to have evolved in
response to the fermentation products of the gut bacteria.
Both receptors are found in a variety of tissues including
the gut and have been shown to be expressed in
enteroendocrine cells that are producing peptide YY
(PYY; Table 1). SCFAs have been shown to stimulate the
release of PYY and 5-hydroxytryptamine (5-HT) from thePublished by Bioscientifica Ltd.
Table 1 Characteristics of free fatty acid receptor 2 and free
fatty acid receptor 3
Nomenclature FFAR2 FFAR3
Agonist (FFA) Short-chain
C3wC4wC2
Short-chain C3O
C4[C2
Gene GPR43 GPR41
Localisation 19q13.1 19q13.1
Expression outside
of the gut
Adipose tissue Adipose tissue
Physiological role PYY secretion Leptin production
5-HT secretion PYY secretion
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218 :3 R42ileum and colon (Cherbut et al. 1998, Fukumoto et al.
2003). Mice that have had their FFAR3 knocked out
(Samuel et al. 2008) show an associated reduction in the
expression of PYY, increased intestinal transit rate and
reduced harvest of energy (SCFAs) from the diet. These
authors concluded that FFAR3 is involved in the
regulation of host energy balance, which is ultimately
driven by the gut microbiota and its metabolites.
Additionally, the FFARs have been proposed to be
involved in glucose intolerance and thus diabetes
(Tolhurst et al. 2012). Tolhurst et al. have shown in their
study that both FFAR2 and FFAR3 are more greatly
expressed in glucagon-like peptide-1 (GLP1)-secreting
cells. Additionally, when mice that were homozygous
negative for both FFARs were exposed to SCFAs, there was
a significant reduction in SCFA-triggered GLP1 secretion.
The other significant role that these bacterially derived
metabolites play is the stimulation of leptin production in
adipocytes (Xiong et al. 2004); however, the exact
mechanism is still being elucidated (Zaibi et al. 2010).
Since leptin is involved in a wide range of physiological
processes, such as feeding behaviour, reproduction and
metabolic rate, any molecules that stimulate its pro-
duction are of significant interest. All of the SCFAs have
been shown to stimulate plasma leptin levels (Yonekura
et al. 2003, Xiong et al. 2004), and when propionate is
delivered orally, these levels are raised and the effect can
be blocked by small-interfering RNAs targeted towards
GPR41 in Ob-Luc cells (Xiong et al. 2004).
Although SCFAs have been shown to interact with
their own cognate receptors, they have also been shown to
modulate hepatic glucose production in humans
(Thorburn et al. 1993). The intake of fibre, which acts as
a prebiotic and is only metabolised by the gut bacteria, has
been reported to be inversely associated with the risk of
type 2 diabetes and heart disease (Pereira et al. 2002). The
hypothesis that fibre is digested eventually to SCFAs is an
important one in the area of the gut microbiota, because ithttp://joe.endocrinology-journals.org  2013 Society for Endocrinology
DOI: 10.1530/JOE-13-0131 Printed in Great Britainassumes that fibre ingested will be digested to SCFAs and
that this leads to eventual benefits to the host. However,
this treats the gut microbiota as a ‘black box’ and does not
consider that individuals’ capacity to metabolise the
different components of the fibre and to ferment these
degradation products to SCFAs is conditional on them
having the necessary bacterial functions present in the
first place. Bearing this in mind, it may be explained why
the evidence is not strong as to the beneficial role of fibre
in the reduction of the risk of developing diabetes and
other diseases (Williams 2012, Caricilli & Saad 2013).The brain–gut axis
The hypothalamic–pituitary–adrenal (HPA) axis has
received much attention in recent years, in particular, its
association with the gut and its resident microbiota. It is
becoming increasingly apparent that this association can
both positively and negatively affect host health, with
implications for the gut microbiota itself and the
endocrine system.
Studies using in vitro and in vivomodels have hinted at
the possible underlying mechanisms of the effect of stress
on the gut through the HPA axis. It has been shown that
this axis responds to stress (Herman et al. 2003) through
the secretion of corticotropin-releasing hormone (CRH)
from the hypothalamus, in turn triggering the release of
ACTH from the pituitary gland and driving the release of
catecholamines and cortisol from the cortex (Mawdsley &
Rampton 2005). CRH has been shown to stimulate the
release of pro-inflammatory cytokines such as TNFa, IL1b
and IL6 in in vitro and in vivomurine models (Agelaki et al.
2002), while the in vivo stimulation of b-adrenergic
receptor, a receptor for the catecholamines nor-
epinephrine and epinephrine, has been shown to increase
the levels of circulating IL1 and IL6 (Johnson et al. 2005).
The production of cytokines, in particular, TNFa, has been
shown to affect the gut epithelial barrier function in both
in vitro (Schmitz et al. 1999) and in human studies, where
one study has shown the restoration of the gut epithelial
barrier function in Crohn’s disease patients through the
administration of infliximab, a chimeric MAB against
TNFa (Suenaert et al. 2002). Bacterial cells can also disrupt
the function of the gut epithelial membrane through
lipopolysaccharide (LPS) and its interaction with myosin
light chain kinase, a regulator of tight junctions (Shen
et al. 2006). It has also been shown that the stress response
of the HPA axis and ‘leakiness’ of the gut epithelial barrier
inmice can be attenuated through feeding of the probiotic
organism Lactobacillus farciminis (Ait-Belgnaoui et al.Published by Bioscientifica Ltd.
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and our resident gut microbiota.
A very commondiagnosis in gastroenterological practice
worldwide is irritable bowel syndrome (IBS), which is
characterised by abnormal bowel function, bloating and
abdominal painor discomfort relievedbydefaecation (Spiller
et al. 2007). IBS significantly affects quality of life (Simren et
al. 2006) and is a substantial economic burden to healthcare
systems (Nyrop et al. 2007). IBS has been reported to be
present in up to 10% of the population and responsible for
3.6% of GP consultations. So, understanding this syndrome
is an important goal, and recently, in a landmark study,
Dinan et al. (2006) have shown that in an IBS cohort the
levels of cortisol and thepro-inflammatory cytokines IL6 and
IL8 are elevated. Prior to this study, they had also used a
bacterial intervention, in the form of two separate probiotics
(Lactobacillus salivarius UCC4331 or Bifidobacterium infantis
35624), and shown that B. infantis is able to normalise the
IL10:IL12 ratio. Hence, this again leads us to the conclusion
that the variable levels of some organisms in the gut may be
responsible for diseases/syndromes as they signal to a variety
of host effectors.Microbially derived endocrine molecules
Endocrinemolecules are not solely produced by the human
body; gut microbes can also produce thesemolecules. It has
been shown previously that there is a significant level of
dopamine production in the human gut (Eisenhofer et al.
1997). The importance of the gut microbiota in the
generation of this compound has been overlooked, and in
a subsequent piece of work, it has been shown that the gut
microbiota plays a critical role in the production of
norepinephrine and dopamine in the gut (Asano et al.
2012). This production is due to the expression of
b-glucuronidases by commensal gut bacteria, generating
dopamine and norepinephrine through the cleavage of
their inactive conjugated forms. Gut microbes can also
produce non-noradrenergic, non-cholinergic transmitters
such as nitric oxide, which plays a pivotal role in the
regulation of gastric emptying (Orihata & Sarna 1994),
through the anaerobic reduction of nitrate to nitrogen
(Sobko et al. 2005, Cutruzzola` 2012). The inhibitory
transmitter g-aminobutyric acid can be generated by
Lactobacillus brevis and Bifidobacterium dentium (Barrett
et al. 2012); both of these organisms can be isolated from
humans (Ro¨nka¨et al. 2003, Ventura et al. 2009). Studies
such as these are highlighting the previously unrealised
importance of our own gut microbiota in generating
compounds that interact with our own endocrine system.http://joe.endocrinology-journals.org  2013 Society for Endocrinology
DOI: 10.1530/JOE-13-0131 Printed in Great BritainDiabetes and gut bacteria
Diabetes is a chronic metabolic disorder that affects an
estimated 347million people throughout the world (WHO
2012). Type 1 diabetes, also known as juvenile diabetes, is
a state of absolute deficiency of insulin, while type 2
diabetes is a state of relative insulin deficiency in the
presence of obesity and insulin resistance; the prevalence
of the latter is increasing among children due to the
adoption of a sedentary lifestyle. There is increasing
evidence that the gut microbiota plays a role in the
development of this disorder. In the non-obese diabetic
(NOD) murine model, which was also deficient for the
adapter protein MYD88, researchers have shown that the
gut microbiota plays a role in the development of type 1
diabetes (Wen et al. 2008). In this study, the islets of
Langherans of germ-free, specific pathogen-free and
altered Schaedler flora (Dewhirst et al. 1999) Myd88
knockout NOD mice were histologically compared; the
germ-freemice exhibited a greater level of islet infiltration.
The authors showed that the gut commensal bacteria can
modify the development of this disease. With this in
mind, research has been carried out to determine which
bacterial species and groups in humans are most prevalent
in the sufferers of type 1 diabetes. In a recent study
(Giongo et al. 2011), the distal gut microbiota of four
children with autoimmunity, who went on to develop
type 1 diabetes, has been compared with that of four
healthy children through pyrosequencing of faecal DNA
extracted at three time points. The results highlighted
differences between the two major phyla in the gut,
Bacteroidetes and Firmicutes. There was an increase in the
number of DNA sequences from the Bacteroidetes phylum
as autoimmunity developed to type 1 diabetes and a
reduction in the number of DNA sequences obtained from
the Firmicutes phylum. In contrast, the four healthy
children exhibited the opposite pattern, with the number
of Bacteroidetes sequences decreasing and that of Firmicutes
sequences increasing as each time point was analysed. It
was also shown that the healthy control children had a
higher diversity of bacterial species than the children with
autoimmunity, suggesting a link between low bacterial
species diversity and type 1 diabetes. This low diversity is
indicative of a non-normal gut microbiota, which has
been suggested to combine with intestinal leakiness and
altered intestinal immune responsiveness to generate a
‘perfect storm’ for the development of type 1 diabetes
(Vaarala et al. 2008).
The gut microbiota, through LPS, has been shown to
exert a pro-inflammatory effect and when combined withPublished by Bioscientifica Ltd.
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therefore, the development of type 2 diabetes in a mouse
model (Cani et al. 2007, 2008). In accordance with what
has been observed in type 1 diabetes, a metagenomic
analysis of faecal samples of type 2 diabetes sufferers has
shown a slight level of dysbiosis in their gut bacterial
make-up; type 2 diabetes sufferers exhibited higher levels
of opportunistic pathogens (Qin et al. 2012). Arguably
more important is the fact that this research showed a
reduction in the number of butyrate-producing bacteria, a
SCFA that modulates the activity of NF-kB (Inan et al.
2000), hinting that the loss of bacterial species may not be
as important as the loss of functions that they play.Microbial modulation of neurotransmitters:
serotonin
One metabolic pathway of interest is the metabolism of
tryptophan, a precursor for a number of metabolites, but
particularly for the production of serotonin or 5-HT.
Serotonin is a well-documented monoamine neurotrans-
mitter that has been extensively studied due to its
hypothesised role in the regulation of learning, mood,
sleep, anxiety and other psychiatry-related afflictions. In
recentyears, serotoninhasalsogained increasing interest for
its role in the area of gut pathophysiology (Gershon & Tack
2007) and its role as a signalling molecule linking the brain
and the gut. Research has been fairly conclusive in
demonstrating that bacteria can affect serotonin levels
indirectly by stimulating secretion. However, recent evi-
dence suggests a role for the gut microbiota in actually
modulating the levels of the serotoninprecursor tryptophan
andhencehavinga control over serotonin levels in thehost.
Research by Desbonnet et al. (2008) has suggested a role for
tryptophan producers such as B. infantis as probiotics
specifically to aid in combating psychiatric disorders such
as depression. Other groups have also shown a role for
bacteria in modulating neurotransmitter precursors (Rhee
et al. 2009, Wikoff et al. 2009, Heijtz et al. 2011).
Around 90% of serotonin is located in the enter-
ochromaffin cells of the human gastrointestinal tract
(Keszthelyi et al. 2009) and, therefore, must be intimately
associated with the gastrointestinal mucosa and its
microbiota. Enterochromaffin cells release serotonin in
response to certain bacterial stimuli such as LPS, enzymes
and other bacterial toxins to help increase gastric transit
and rid the host of the toxin as quickly as possible (result is
often diarrhoea). As a result of a bacterial stimulus, there is
release of serotonin, which acts as a signalling molecule to
activate primary sensory neurons to communicate withhttp://joe.endocrinology-journals.org  2013 Society for Endocrinology
DOI: 10.1530/JOE-13-0131 Printed in Great Britainthe brain and ultimately alter secretory reflexes. Conse-
quently, an ongoing brain–gut interaction is developed,
exerting various effects on gut physiology. This relation-
ship has resulted in serotonin potentially being one of the
most significant molecules related to the pathophysiology
of intestinal disorders such as inflammatory bowel disease
and IBS and is also intrinsically linked to the anxiety and
depression associated with such disorders.
If serotonin is in charge of mood and sleep and low
levels are associated with the onset of depression, etc.,
then varying levels of its precursor, tryptophan, are likely
to have an effect on available serotonin levels (Heijtz et al.
2011). Studies have shown that germ-free rats have
depleted levels of tryptophan, but upon administration
of certain bacteria, such as bifidobacterial species, trypto-
phan levels are increased (Desbonnet et al. 2008), thus
suggesting that bacteria can alter the available serotonin
pool and ultimately elicit communication between the gut
and the brain. Some microbes, such as Candida spp.,
Streptococcus spp., Escherichia spp. and Enterococcus spp.,
have been shown to directly produce serotonin (Cryan &
Dinan, 2012), although much more research is needed
into the impact that this has on the host.Conclusions
In the last decade, the paradigm that the human genome
is the predominant driver of host health has shifted
towards a more superorganism-based viewpoint, with the
microbiome playing a significant role in influencing host
physiology and function. This review has not sought to
cover all the areas where there is evidence for a role of the
host’s microbiota and has unapologetically focused on the
gut microbiota, since the gut is the best-studied and most
densely populated niche. There are numerous other niches
in the human body that are colonised and in which the
adapted microbiome interacts with the host, and in due
course, these will be explored and their interactions with
the host described. We hope to have made it more obvious
to the reader that the microbiome needs to be understood
inmore depth and integrated into the endocrine system as
it is being integrated into the immune system. In the
future, more ‘omic’ approaches will further uncover more
associations between the human microbiome and the
endocrine system, which may be drugable and thus
modulated to the benefit of the host.
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